The Coca-Cola Company (KO) 10-K27 Feb 142013 FY Annual reportFinancial data

Company Profile

Document_and_Entity_Informatio

Document and Entity Information Document (USD $)	12 Months Ended
Document and Entity Information Document (USD $)	Dec. 31, 2013	Feb. 24, 2014	Jun. 28, 2013
Entity Information [Line Items]	'	'	'
Entity Registrant Name	'COCA COLA CO	'	'
Entity Central Index Key	'0000021344	'	'
Current Fiscal Year End Date	'--12-31	'	'
Entity Filer Category	'Large Accelerated Filer	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Dec-13	'	'
Document Fiscal Year Focus	'2013	'	'
Document Fiscal Period Focus	'FY	'	'
Amendment Flag	'false	'	'
Entity Common Stock, Shares Outstanding	'	4,405,893,150	'
Entity Well-known Seasoned Issuer	'Yes	'	'
Entity Voluntary Filers	'No	'	'
Entity Current Reporting Status	'Yes	'	'
Entity Public Float	'	'	$176,841,594,528

CONSOLIDATED_STATEMENTS_OF_INC

CONSOLIDATED STATEMENTS OF INCOME (USD $)	12 Months Ended
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013		Dec. 31, 2012		Dec. 31, 2011
NET OPERATING REVENUES	$46,854		$48,017		$46,542
Cost of goods sold	18,421		19,053		18,215
GROSS PROFIT	28,433		28,964		28,327
Selling, general and administrative expenses	17,310		17,738		17,422
Other operating charges	895		447		732
OPERATING INCOME	10,228		10,779		10,173
Interest income	534		471		483
Interest expense	463		397		417
Equity income (loss) - net	602		819		690
Other income (loss) - net	576		137		529
INCOME BEFORE INCOME TAXES	11,477		11,809		11,458
Income taxes	2,851		2,723		2,812
CONSOLIDATED NET INCOME	8,626		9,086		8,646
Less: Net income attributable to noncontrolling interests	42		67		62
NET INCOME ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	$8,584		$9,019		$8,584
BASIC NET INCOME PER SHARE (in dollars per share)	$1.94	[1]	$2	[1]	$1.88	[1]
DILUTED NET INCOME PER SHARE (in dollars per share)	$1.90	[1]	$1.97	[1]	$1.85	[1]
AVERAGE SHARES OUTSTANDING (in shares)	4,434		4,504		4,568
Effect of dilutive securities (in shares)	75		80		78
AVERAGE SHARES OUTSTANDING ASSUMING DILUTION (in shares)	4,509		4,584		4,646

[1]	Calculated based on net income attributable to shareowners of The Coca-Cola Company.

CONSOLIDATED_STATEMENTS_OF_COM

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
CONSOLIDATED NET INCOME	$8,626	$9,086	$8,646
Other comprehensive income	'	'	'
Net foreign currency translation adjustment	-1,187	-182	-692
Net gain (loss) on derivatives	151	99	145
Net urealized gain (loss) on available-for-sale securities	-80	178	-7
Net change in pension and other benefit liabilities	1,066	-668	-763
TOTAL COMPREHENSIVE INCOME	8,576	8,513	7,329
Less: Comprehensive income (loss) attributable to noncontrolling interests	39	105	10
TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	$8,537	$8,408	$7,319

CONSOLIDATED_BALANCE_SHEETS

CONSOLIDATED BALANCE SHEETS (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
CURRENT ASSETS	'	'
Cash and cash equivalents	$10,414	$8,442
Short-term investments	6,707	5,017
TOTAL CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS	17,121	13,459
Marketable securities	3,147	3,092
Trade accounts receivable, less allowances of $61 and $53, respectively	4,873	4,759
Inventories	3,277	3,264
Prepaid expenses and other assets	2,886	2,781
Assets held for sale	0	2,973
TOTAL CURRENT ASSETS	31,304	30,328
EQUITY METHOD INVESTMENTS	10,393	9,216
OTHER INVESTMENTS, PRINCIPALLY BOTTLING COMPANIES	1,119	1,232
OTHER ASSETS	4,661	3,585
PROPERTY, PLANT AND EQUIPMENT - net	14,967	14,476
TRADEMARKS WITH INDEFINITE LIVES	6,744	6,527
BOTTLERS' FRANCHISE RIGHTS WITH INDEFINITE LIVES	7,415	7,405
GOODWILL	12,312	12,255
OTHER INTANGIBLE ASSETS	1,140	1,150
TOTAL ASSETS	90,055	86,174
CURRENT LIABILITIES	'	'
Accounts payable and accrued expenses	9,577	8,680
Loans and notes payable	16,901	16,297
Current maturities of long-term debt	1,024	1,577
Accrued income taxes	309	471
Liabilities held for sale	0	796
TOTAL CURRENT LIABILITIES	27,811	27,821
LONG-TERM DEBT	19,154	14,736
OTHER LIABILITIES	3,498	5,468
DEFERRED INCOME TAXES	6,152	4,981
THE COCA-COLA COMPANY SHAREOWNERS' EQUITY	'	'
Common stock, $0.25 par value; Authorized â€” 11,200 shares; Issued â€” 7,040 and 7,040 shares, respectively	1,760	1,760
Capital surplus	12,276	11,379
Reinvested earnings	61,660	58,045
Accumulated other comprehensive income (loss)	-3,432	-3,385
Treasury stock, at cost â€” 2,638 and 2,571 shares, respectively	-39,091	-35,009
EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	33,173	32,790
EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS	267	378
TOTAL EQUITY	33,440	33,168
TOTAL LIABILITIES AND EQUITY	$90,055	$86,174

CONSOLIDATED_BALANCE_SHEET_Par

CONSOLIDATED BALANCE SHEET (Parentheticals) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, except Per Share data, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Allowance for doubtful accounts	$61	$53
Common stock, par value (in dollars per share)	$0.25	$0.25
Common Stock, Shares Authorized	11,200	11,200
Common stock, shares issued	7,040	7,040
Treasury stock, shares	2,638	2,571

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
OPERATING ACTIVITIES	'	'	'
CONSOLIDATED NET INCOME	$8,626	$9,086	$8,646
Depreciation and amortization	1,977	1,982	1,954
Stock-based compensation expense	227	259	354
Deferred income taxes	648	632	1,035
Equity (income) loss - net of dividends	-201	-426	-269
Foreign currency adjustments	168	-130	7
Significant (gains) losses on sales of assets - net	-670	-98	-220
Other operating charges	465	166	214
Other items	234	254	-354
Net change in operating assets and liabilities	-932	-1,080	-1,893
Net cash provided by operating activities	10,542	10,645	9,474
INVESTING ACTIVITIES	'	'	'
Purchases of investments	-14,782	-14,824	-4,798
Proceeds from disposals of investments	12,791	7,791	5,811
Acquisitions of businesses, equity method investments and nonmarketable securities	-353	-1,486	-971
Proceeds from disposals of businesses, equity method investments and nonmarkatable securities	872	20	398
Purchases of property, plant and equipment	-2,550	-2,780	-2,920
Proceeds from disposals of property, plant and equipment	111	143	101
Other investing activities	-303	-268	-145
Net cash provided by (used in) investing activities	-4,214	-11,404	-2,524
FINANCING ACTIVITIES	'	'	'
Issuances of debt	43,425	42,791	27,495
Payments of debt	-38,714	-38,573	-22,530
Issuances of stock	1,328	1,489	1,569
Purchases of stock for treasury	-4,832	-4,559	-4,513
Dividends	-4,969	-4,595	-4,300
Other financing activities	17	100	45
Net cash provided by (used in) financing activities	-3,745	-3,347	-2,234
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	-611	-255	-430
CASH AND CASH EQUIVALENTS	'	'	'
Net increase (decrease) during the year	1,972	-4,361	4,286
Balance at beginning of year	8,442	12,803	8,517
Balance at end of year	$10,414	$8,442	$12,803

CONSOLIDATED_STATEMENTS_OF_SHA

CONSOLIDATED STATEMENTS OF SHAREOWNERS' EQUITY (USD $)	Total	TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	COMMON STOCK	CAPITAL SURPLUS	REINVESTED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	TREASURY STOCK	EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
In Millions, unless otherwise specified	Total		COMMON STOCK	CAPITAL SURPLUS	REINVESTED EARNINGS	ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)	TREASURY STOCK	EQUITY ATTRIBUTABLE TO NONCONTROLLING INTERESTS
Balance at beginning of year at Dec. 31, 2010	'	'	'	$9,177	$49,337	($1,509)	($27,762)	$314
Balance at beginning of year (in shares) at Dec. 31, 2010	'	'	4,583	'	'	'	'	'
Common Stock	'	'	1,760	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Purchases of treasury stock (in shares)	'	'	-127	'	'	'	'	'
Treasury stock issued to employees related to stock compensation plans (in shares)	'	'	70	'	'	'	'	'
Stock issued to employees related to stock compensation plans	'	'	'	724	'	'	830	'
Tax benefit (charge) from stock compensation plans	'	'	'	79	'	'	'	'
Stock-based compensation	'	'	'	354	'	'	'	'
Other activities	'	'	'	-2	'	'	'	'
Net income attributable to shareowners of The Coca-Cola Company	8,584	'	'	'	8,584	'	'	'
Dividends (per share â€” $1.12, $1.02 and $0.94 in 2013, 2012 and 2011, respectively)	'	'	'	'	-4,300	'	'	'
Net other comprehensive income (loss)	'	-1,265	'	'	'	-1,265	'	'
Purchases of treasury stock	'	'	'	'	'	'	-4,372	'
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	'	31,635	'	'	'	'	'	'
Net income attributable to noncontrolling interests	62	'	'	'	'	'	'	62
Net foreign currency translation adjustment	'	'	'	'	'	'	'	-52
Dividends paid to noncontrolling interests	'	'	'	'	'	'	'	-38
Acquisition of interests held by noncontrolling owners	'	'	'	'	'	'	'	0
Contributions by noncontrolling interests	'	'	'	'	'	'	'	0
Business combinations	'	'	'	'	'	'	'	0
Deconsolidation of certain entities	'	'	'	'	'	'	'	0
Balance at end of year at Dec. 31, 2011	'	'	'	10,332	53,621	-2,774	-31,304	286
Balance at end of year (in shares) at Dec. 31, 2011	'	'	4,526	'	'	'	'	'
Common Stock	1,760	'	1,760	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Purchases of treasury stock (in shares)	'	'	-121	'	'	'	'	'
Treasury stock issued to employees related to stock compensation plans (in shares)	'	'	64	'	'	'	'	'
Stock issued to employees related to stock compensation plans	'	'	'	640	'	'	786	'
Tax benefit (charge) from stock compensation plans	'	'	'	144	'	'	'	'
Stock-based compensation	'	'	'	259	'	'	'	'
Other activities	'	'	'	4	'	'	'	'
Net income attributable to shareowners of The Coca-Cola Company	9,019	'	'	'	9,019	'	'	'
Dividends (per share â€” $1.12, $1.02 and $0.94 in 2013, 2012 and 2011, respectively)	'	'	'	'	-4,595	'	'	'
Net other comprehensive income (loss)	'	-611	'	'	'	-611	'	'
Purchases of treasury stock	'	'	'	'	'	'	-4,491	'
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	32,790	32,790	'	'	'	'	'	'
Net income attributable to noncontrolling interests	67	'	'	'	'	'	'	67
Net foreign currency translation adjustment	'	'	'	'	'	'	'	38
Dividends paid to noncontrolling interests	'	'	'	'	'	'	'	-48
Acquisition of interests held by noncontrolling owners	'	'	'	'	'	'	'	-15
Contributions by noncontrolling interests	'	'	'	'	'	'	'	0
Business combinations	'	'	'	'	'	'	'	50
Deconsolidation of certain entities	'	'	'	'	'	'	'	0
Balance at end of year at Dec. 31, 2012	33,168	'	'	11,379	58,045	-3,385	-35,009	378
Balance at end of year (in shares) at Dec. 31, 2012	'	'	4,469	'	'	'	'	'
Common Stock	1,760	'	1,760	'	'	'	'	'
Increase (Decrease) in Stockholders' Equity	'	'	'	'	'	'	'	'
Purchases of treasury stock (in shares)	'	'	-121	'	'	'	'	'
Treasury stock issued to employees related to stock compensation plans (in shares)	'	'	54	'	'	'	'	'
Stock issued to employees related to stock compensation plans	'	'	'	569	'	'	745	'
Tax benefit (charge) from stock compensation plans	'	'	'	144	'	'	'	'
Stock-based compensation	'	'	'	227	'	'	'	'
Other activities	'	'	'	-43	'	'	'	'
Net income attributable to shareowners of The Coca-Cola Company	8,584	'	'	'	8,584	'	'	'
Dividends (per share â€” $1.12, $1.02 and $0.94 in 2013, 2012 and 2011, respectively)	'	'	'	'	-4,969	'	'	'
Net other comprehensive income (loss)	'	-47	'	'	'	-47	'	'
Purchases of treasury stock	'	'	'	'	'	'	-4,827	'
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	33,173	33,173	'	'	'	'	'	'
Net income attributable to noncontrolling interests	42	'	'	'	'	'	'	42
Net foreign currency translation adjustment	'	'	'	'	'	'	'	-3
Dividends paid to noncontrolling interests	'	'	'	'	'	'	'	-58
Acquisition of interests held by noncontrolling owners	'	'	'	'	'	'	'	-34
Contributions by noncontrolling interests	'	'	'	'	'	'	'	6
Business combinations	'	'	'	'	'	'	'	25
Deconsolidation of certain entities	'	'	'	'	'	'	'	-89
Balance at end of year at Dec. 31, 2013	$33,440	'	'	$12,276	$61,660	($3,432)	($39,091)	$267
Balance at end of year (in shares) at Dec. 31, 2013	'	'	4,402	'	'	'	'	'

CONSOLIDATED_STATEMENTS_OF_SHA1

CONSOLIDATED STATEMENTS OF SHAREOWNERS' EQUITY (Parentheticals) (USD $)	12 Months Ended
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Dividends per share	$1.12	$1.02	$0.94

BUSINESS_AND_SUMMARY_OF_SIGNIF

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Description of Business

The Coca-Cola Company is the world's largest beverage company. We own or license and market more than 500 nonalcoholic beverage brands, primarily sparkling beverages but also a variety of still beverages such as waters, enhanced waters, juices and juice drinks, ready-to-drink teas and coffees, and energy and sports drinks. We own and market four of the world's top five nonalcoholic sparkling beverage brands: Coca-Cola, Diet Coke, Fanta and Sprite. Finished beverage products bearing our trademarks, sold in the United States since 1886, are now sold in more than 200 countries.

We make our branded beverage products available to consumers throughout the world through our network of Company-owned or -controlled bottling and distribution operations, bottling partners, distributors, wholesalers and retailers — the world's largest beverage distribution system. Beverages bearing trademarks owned by or licensed to us account for 1.9 billion of the approximately 57 billion beverage servings of all types consumed worldwide every day.

Our Company markets, manufactures and sells:

•

beverage concentrates, sometimes referred to as "beverage bases," and syrups, including fountain syrups (we refer to this part of our business as our "concentrate business" or "concentrate operations"); and

•

finished sparkling and still beverages (we refer to this part of our business as our "finished product business" or "finished product operations").

Generally, finished product operations generate higher net operating revenues but lower gross profit margins than concentrate operations.

In our concentrate operations, we typically generate net operating revenues by selling concentrates and syrups to authorized bottling and canning operations (to which we typically refer as our "bottlers" or our "bottling partners"). Our bottling partners either combine the concentrates with sweeteners (depending on the product), still water and/or sparkling water, or combine the syrups with sparkling water to produce finished beverages. The finished beverages are packaged in authorized containers — such as cans and refillable and nonrefillable glass and plastic bottles — bearing our trademarks or trademarks licensed to us and are then sold to retailers directly or, in some cases, through wholesalers or other bottlers. Outside the United States, we also sell concentrates for fountain beverages to our bottling partners who are typically authorized to manufacture fountain syrups, which they sell to fountain retailers such as restaurants and convenience stores which use the fountain syrups to produce beverages for immediate consumption, or to authorized fountain wholesalers who in turn sell and distribute the fountain syrups to fountain retailers.

Our finished product operations consist primarily of Company-owned or -controlled bottling, sales and distribution operations, including Coca-Cola Refreshments ("CCR"). Our Company-owned or -controlled bottling, sales and distribution operations, other than CCR, are included in our Bottling Investments operating segment. CCR is included in our North America operating segment. Our finished product operations generate net operating revenues by selling sparkling beverages and a variety of still beverages, such as juices and juice drinks, energy and sports drinks, ready-to-drink teas and coffees, and certain water products, to retailers or to distributors, wholesalers and bottling partners who distribute them to retailers. In addition, in the United States, we manufacture fountain syrups and sell them to fountain retailers, such as restaurants and convenience stores who use the fountain syrups to produce beverages for immediate consumption, or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers. In the United States, we authorize wholesalers to resell our fountain syrups through nonexclusive appointments that neither restrict us in setting the prices at which we sell fountain syrups to the wholesalers nor restrict the territories in which the wholesalers may resell in the United States.

Summary of Significant Accounting Policies

Basis of Presentation

Our consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of our consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our consolidated financial statements and accompanying notes. Although these estimates are based on our knowledge of current events and actions we may undertake in the future, actual results may ultimately differ from these estimates and assumptions. Furthermore, when testing assets for impairment in future periods, if management uses different assumptions or if different conditions occur, impairment charges may result.

We use the equity method to account for investments in companies, if our investment provides us with the ability to exercise significant influence over operating and financial policies of the investee. Our consolidated net income includes our Company's proportionate share of the net income or loss of these companies. Our judgment regarding the level of influence over each equity method investment includes considering key factors such as our ownership interest, representation on the board of directors, participation in policy-making decisions and material intercompany transactions.

We eliminate from our financial results all significant intercompany transactions, including the intercompany transactions with consolidated variable interest entities ("VIEs") and the intercompany portion of transactions with equity method investees.

Certain other amounts in the prior years' consolidated financial statements and notes have been revised to conform to the current year presentation.

Principles of Consolidation

Our Company consolidates all entities that we control by ownership of a majority voting interest as well as VIEs for which our Company is the primary beneficiary. Generally, we consolidate only business enterprises that we control by ownership of a majority voting interest. However, there are situations in which consolidation is required even though the usual condition of consolidation (ownership of a majority voting interest) does not apply. Generally, this occurs when an entity holds an interest in another business enterprise that was achieved through arrangements that do not involve voting interests, which results in a disproportionate relationship between such entity's voting interests in, and its exposure to the economic risks and potential rewards of, the other business enterprise. This disproportionate relationship results in what is known as a variable interest, and the entity in which we have the variable interest is referred to as a "VIE." An enterprise must consolidate a VIE if it is determined to be the primary beneficiary of the VIE. The primary beneficiary has both (1) the power to direct the activities of the VIE that most significantly impact the entity's economic performance, and (2) the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE.

Our Company holds interests in certain VIEs, primarily bottling and container manufacturing operations, for which we were not determined to be the primary beneficiary. Our variable interests in these VIEs primarily relate to profit guarantees or subordinated financial support. Refer to Note 11. Although these financial arrangements resulted in us holding variable interests in these entities, they did not empower us to direct the activities of the VIEs that most significantly impact the VIEs' economic performance. Our Company's investments, plus any loans and guarantees, related to these VIEs totaled $2,171 million and $1,776 million as of December 31, 2013 and 2012, respectively, representing our maximum exposures to loss. The Company's investments, plus any loans and guarantees, related to these VIEs were not significant to the Company's consolidated financial statements.

In addition, our Company holds interests in certain VIEs, primarily bottling and container manufacturing operations, for which we were determined to be the primary beneficiary. As a result, we have consolidated these entities. Our Company's investments, plus any loans and guarantees, related to these VIEs totaled $284 million and $234 million as of December 31, 2013 and 2012, respectively, representing our maximum exposures to loss. The assets and liabilities of VIEs for which we are the primary beneficiary were not significant to the Company's consolidated financial statements.

Creditors of our VIEs do not have recourse against the general credit of the Company, regardless of whether they are accounted for as consolidated entities.

Assets and Liabilities Held for Sale

Our Company classifies long-lived assets (disposal groups) to be sold as held for sale in the period in which all of the following criteria are met: management, having the authority to approve the action, commits to a plan to sell the asset (disposal group); the asset (disposal group) is available for immediate sale in its present condition subject only to terms that are usual and customary for sales of such assets (disposal groups); an active program to locate a buyer and other actions required to complete the plan to sell the asset (disposal group) have been initiated; the sale of the asset (disposal group) is probable, and transfer of the asset (disposal group) is expected to qualify for recognition as a completed sale within one year, except if events or circumstances beyond our control extend the period of time required to sell the asset (disposal group) beyond one year; the asset (disposal group) is being actively marketed for sale at a price that is reasonable in relation to its current fair value; and actions required to complete the plan indicate that it is unlikely that significant changes to the plan will be made or that the plan will be withdrawn.

We initially measure a long-lived asset (disposal group) that is classified as held for sale at the lower of its carrying value or fair value less any costs to sell. Any loss resulting from this measurement is recognized in the period in which the held-for-sale criteria are met. Conversely, gains are not recognized on the sale of a long-lived asset (disposal group) until the date of sale. We assess the fair value of a long-lived asset (disposal group) less any costs to sell each reporting period it remains classified as held for sale and report any subsequent changes as an adjustment to the carrying value of the asset (disposal group), as long as the new carrying value does not exceed the carrying value of the asset at the time it was initially classified as held for sale.

Upon determining that a long-lived asset (disposal group) meets the criteria to be classified as held for sale, the Company reports the assets and liabilities of the disposal group, if material, in the line items assets held for sale and liabilities held for sale, respectively, in our consolidated balance sheet.

Revenue Recognition

Our Company recognizes revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price charged is fixed or determinable, and collectibility is reasonably assured. For our Company, this generally means that we recognize revenue when title to our products is transferred to our bottling partners, resellers or other customers. In particular, title usually transfers upon shipment to or receipt at our customers' locations, as determined by the specific sales terms of the transactions. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part.

Deductions from Revenue

Our customers can earn certain incentives including, but not limited to, cash discounts, funds for promotional and marketing activities, volume-based incentive programs and support for infrastructure programs. The costs associated with these incentives are included in deductions from revenue, a component of net operating revenues in our consolidated statements of income. For customer incentives that must be earned, management must make estimates related to the contractual terms, customer performance and sales volume to determine the total amounts earned and to be recorded in deductions from revenue. In making these estimates, management considers past results. The actual amounts ultimately paid may be different from our estimates.

In some situations, the Company may determine it to be advantageous to make advance payments to specific customers to fund certain marketing activities intended to generate profitable volume and/or invest in infrastructure programs with our bottlers that are directed at strengthening our bottling system and increasing unit case volume. The Company also makes advance payments to certain customers for distribution rights. The advance payments made to customers are initially capitalized and included in our consolidated balance sheets in prepaid expenses and other assets and noncurrent other assets, depending on the duration of the agreements. The assets are amortized over the applicable periods and included in deductions from revenue. The duration of these agreements typically ranges from 4 to 10 years.

Amortization expense for infrastructure programs was $69 million, $86 million and $90 million in 2013, 2012 and 2011, respectively. The aggregate deductions from revenue recorded by the Company in relation to these programs, including amortization expense on infrastructure programs, were $6.9 billion, $6.1 billion and $5.8 billion in 2013, 2012 and 2011, respectively.

Advertising Costs

Our Company expenses production costs of print, radio, television and other advertisements as of the first date the advertisements take place. All other marketing expenditures are expensed in the annual period in which the expenditure is incurred. Advertising costs included in the line item selling, general and administrative expenses in our consolidated statements of income were $3.3 billion, $3.3 billion and $3.3 billion in 2013, 2012 and 2011, respectively. As of December 31, 2013 and 2012, advertising and production costs of $363 million and $295 million, respectively, were primarily recorded in the line item prepaid expenses and other assets in our consolidated balance sheets.

For interim reporting purposes, we allocate our estimated full year marketing expenditures that benefit multiple interim periods to each of our interim reporting periods. We use the proportion of each interim period's actual unit case volume to the estimated full year unit case volume as the basis for the allocation. This methodology results in our marketing expenditures being recognized at a standard rate per unit case. At the end of each interim reporting period, we review our estimated full year unit case volume and our estimated full year marketing expenditures in order to evaluate if a change in estimate is necessary. The impact of any changes in these full year estimates is recognized in the interim period in which the change in estimate occurs. Our full year marketing expenditures are not impacted by this interim accounting policy.

Shipping and Handling Costs

Shipping and handling costs related to the movement of finished goods from manufacturing locations to our sales distribution centers are included in the line item cost of goods sold in our consolidated statements of income. Shipping and handling costs incurred to move finished goods from our sales distribution centers to customer locations are included in the line item selling, general and administrative expenses in our consolidated statements of income. During the years ended December 31, 2013, 2012 and 2011, the Company recorded shipping and handling costs of $2.7 billion, $2.8 billion and $2.4 billion, respectively, in the line item selling, general and administrative expenses. Our customers do not pay us separately for shipping and handling costs related to finished goods.

Net Income Per Share

Basic net income per share is computed by dividing net income by the weighted-average number of common shares outstanding during the reporting period. Diluted net income per share is computed similarly to basic net income per share, except that it includes the potential dilution that could occur if dilutive securities were exercised. Approximately 28 million, 34 million and 32 million stock option awards were excluded from the computations of diluted net income per share in 2013, 2012 and 2011, respectively, because the awards would have been antidilutive for the years presented.

Cash Equivalents

We classify time deposits and other investments that are highly liquid and have maturities of three months or less at the date of purchase as cash equivalents. We manage our exposure to counterparty credit risk through specific minimum credit standards, diversification of counterparties and procedures to monitor our credit risk concentrations.

Short-Term Investments

We classify time deposits and other investments that have maturities of greater than three months but less than one year as short-term investments.

Investments in Equity and Debt Securities

We use the equity method to account for our investments in equity securities if our investment gives us the ability to exercise significant influence over operating and financial policies of the investee. We include our proportionate share of earnings and/or losses of our equity method investees in equity income (loss) — net in our consolidated statements of income. The carrying value of our equity investments is reported in equity method investments in our consolidated balance sheets. Refer to Note 6.

We account for investments in companies that we do not control or account for under the equity method either at fair value or under the cost method, as applicable. Investments in equity securities, other than investments accounted for under the equity method, are carried at fair value if the fair value of the security is readily determinable. Equity investments carried at fair value are classified as either trading or available-for-sale securities with their cost basis determined by the specific identification method. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in other income (loss) — net in our consolidated statements of income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our consolidated balance sheets as a component of accumulated other comprehensive income (loss) ("AOCI"). Trading securities are reported as either marketable securities or other assets in our consolidated balance sheets. Securities classified as available-for-sale are reported as either marketable securities, other investments or other assets in our consolidated balance sheets, depending on the length of time we intend to hold the investment. Refer to Note 3.

Investments in equity securities that we do not control or account for under the equity method and do not have readily determinable fair values for are accounted for under the cost method. Cost method investments are originally recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our consolidated balance sheets, and dividend income from cost method investments is reported in the line item other income (loss) — net in our consolidated statements of income.

Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale.

Each reporting period we review all of our investments in equity and debt securities, except for those classified as trading, to determine whether a significant event or change in circumstances has occurred that may have an adverse effect on the fair value of each investment. When such events or changes occur, we evaluate the fair value compared to our cost basis in the investment. We also perform this evaluation every reporting period for each investment for which our cost basis exceeded the fair value in the prior period. The fair values of most of our investments in publicly traded companies are often readily available based on quoted market prices. For investments in nonpublicly traded companies, management's assessment of fair value is based on valuation methodologies including discounted cash flows, estimates of sales proceeds and appraisals, as appropriate. We consider the assumptions that we believe hypothetical marketplace participants would use in evaluating estimated future cash flows when employing the discounted cash flow or estimates of sales proceeds valuation methodologies.

In the event the fair value of an investment declines below our cost basis, management determines if the decline in fair value is other than temporary. If management determines the decline is other than temporary, an impairment charge is recorded. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis, the financial condition and near-term prospects of the issuer, and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value.

Trade Accounts Receivable

We record trade accounts receivable at net realizable value. This value includes an appropriate allowance for estimated uncollectible accounts to reflect any loss anticipated on the trade accounts receivable balances and charged to the provision for doubtful accounts. We calculate this allowance based on our history of write-offs, the level of past-due accounts based on the contractual terms of the receivables, and our relationships with, and the economic status of, our bottling partners and customers. We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations. Activity in the allowance for doubtful accounts was as follows (in millions):

Year Ended December 31,

2013

2012

2011

Balance at beginning of year

Net charges to costs and expenses

Write-offs

(14

)

(19

)

(12

)

Other1

)

(16

)

Balance at end of year

Other includes foreign currency translation and the impact of transferring the assets of our consolidated Philippine and Brazilian bottling operations to assets held for sale. See Note 2.

A significant portion of our net operating revenues and corresponding accounts receivable is derived from sales of our products in international markets. Refer to Note 19. We also generate a significant portion of our net operating revenues by selling concentrates and syrups to bottlers in which we have a noncontrolling interest, including Coca-Cola FEMSA, S.A.B. de C.V. ("Coca-Cola FEMSA"), Coca-Cola HBC AG ("Coca-Cola Hellenic"), and Coca-Cola Amatil Limited ("Coca-Cola Amatil"). Refer to Note 6.

Inventories

Inventories consist primarily of raw materials and packaging (which includes ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or market. We determine cost on the basis of the average cost or first-in, first-out methods. Refer to Note 4.

Derivative Instruments

Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk. All derivatives are carried at fair value in our consolidated balance sheets in the line items prepaid expenses and other assets; other assets; or accounts payable and accrued expenses; and other liabilities, as applicable. The cash flow impact of the Company's derivative instruments is primarily included in our consolidated statements of cash flows in net cash provided by operating activities. Refer to Note 5.

Property, Plant and Equipment

Property, plant and equipment are stated at cost. Repair and maintenance costs that do not improve service potential or extend economic life are expensed as incurred. Depreciation is recorded principally by the straight-line method over the estimated useful lives of our assets, which are reviewed periodically and generally have the following ranges: buildings and improvements: 40 years or less; and machinery, equipment and vehicle fleet: 20 years or less. Land is not depreciated, and construction in progress is not depreciated until ready for service. Leasehold improvements are amortized using the straight-line method over the shorter of the remaining lease term, including renewals that are deemed to be reasonably assured, or the estimated useful life of the improvement. Depreciation is not recorded during the period in which a long-lived asset (disposal group) is classified as held for sale, even if the asset (disposal group) continues to generate revenue during the period. Depreciation expense, including the depreciation expense of assets under capital lease, totaled $1,727 million, $1,704 million and $1,654 million in 2013, 2012 and 2011, respectively. Amortization expense for leasehold improvements totaled $16 million, $19 million and $18 million in 2013, 2012 and 2011, respectively.

Certain events or changes in circumstances may indicate that the recoverability of the carrying amount of property, plant and equipment should be assessed, including, among others, a significant decrease in market value, a significant change in the business climate in a particular market, or a current period operating or cash flow loss combined with historical losses or projected future losses. When such events or changes in circumstances are present, we estimate the future cash flows expected to result from the use of the asset (or asset group) and its eventual disposition. These estimated future cash flows are consistent with those we use in our internal planning. If the sum of the expected future cash flows (undiscounted and without interest charges) is less than the carrying amount, we recognize an impairment loss. The impairment loss recognized is the amount by which the carrying amount exceeds the fair value. We use a variety of methodologies to determine the fair value of property, plant and equipment, including appraisals and discounted cash flow models, which are consistent with the assumptions we believe hypothetical marketplace participants would use. Refer to Note 7.

Goodwill, Trademarks and Other Intangible Assets

We classify intangible assets into three categories: (1) intangible assets with definite lives subject to amortization, (2) intangible assets with indefinite lives not subject to amortization and (3) goodwill. We determine the useful lives of our identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors we consider when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or other local regulations which could impact the useful life of the asset, and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives, generally ranging from 1 to 20 years. Refer to Note 8.

When facts and circumstances indicate that the carrying value of definite-lived intangible assets may not be recoverable, management assesses the recoverability of the carrying value by preparing estimates of sales volume and the resulting gross profit and cash flows. These estimated future cash flows are consistent with those we use in our internal planning. If the sum of the expected future cash flows (undiscounted and without interest charges) is less than the carrying amount, we recognize an impairment loss. The impairment loss recognized is the amount by which the carrying amount of the asset (or asset group) exceeds the fair value. We use a variety of methodologies to determine the fair value of these assets, including discounted cash flow models, which are consistent with the assumptions we believe hypothetical marketplace participants would use.

We test intangible assets determined to have indefinite useful lives, including trademarks, franchise rights and goodwill, for impairment annually, or more frequently if events or circumstances indicate that assets might be impaired. Our Company performs these annual impairment reviews as of the first day of our third fiscal quarter. We use a variety of methodologies in conducting impairment assessments of indefinite-lived intangible assets, including, but not limited to, discounted cash flow models, which are based on the assumptions we believe hypothetical marketplace participants would use. For indefinite-lived intangible assets, other than goodwill, if the carrying amount exceeds the fair value, an impairment charge is recognized in an amount equal to that excess.

The Company has the option to perform a qualitative assessment of indefinite-lived intangible assets, other than goodwill, prior to completing the impairment test described above. The Company must assess whether it is more likely than not that the fair value of the intangible asset is less than its carrying amount. If the Company concludes that this is the case, it must perform the testing described above. Otherwise, the Company does not need to perform any further assessment. During 2013, the Company performed qualitative assessments on less than 10 percent of our indefinite-lived intangible assets balance.

We perform impairment tests of goodwill at our reporting unit level, which is one level below our operating segments. Our operating segments are primarily based on geographic responsibility, which is consistent with the way management runs our business. Our operating segments are subdivided into smaller geographic regions or territories that we sometimes refer to as "business units." These business units are also our reporting units. The Bottling Investments operating segment includes all Company-owned or consolidated bottling operations, regardless of geographic location, except for bottling operations managed by CCR, which are included in our North America operating segment. Generally, each Company-owned or consolidated bottling operation within our Bottling Investments operating segment is its own reporting unit. Goodwill is assigned to the reporting unit or units that benefit from the synergies arising from each business combination.

The goodwill impairment test consists of a two-step process, if necessary. The first step is to compare the fair value of a reporting unit to its carrying value, including goodwill. We typically use discounted cash flow models to determine the fair value of a reporting unit. The assumptions used in these models are consistent with those we believe hypothetical marketplace participants would use. If the fair value of the reporting unit is less than its carrying value, the second step of the impairment test must be performed in order to determine the amount of impairment loss, if any. The second step compares the implied fair value of the reporting unit's goodwill with the carrying amount of that goodwill. If the carrying amount of the reporting unit's goodwill exceeds its implied fair value, an impairment charge is recognized in an amount equal to that excess. The loss recognized cannot exceed the carrying amount of goodwill.

The Company has the option to perform a qualitative assessment of goodwill prior to completing the two-step process described above to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount, including goodwill and other intangible assets. If the Company concludes that this is the case, it must perform the two-step process. Otherwise, the Company will forego the two-step process and does not need to perform any further testing. During 2013, the Company performed qualitative assessments on approximately 11 percent of our consolidated goodwill balance.

Impairment charges related to intangible assets are generally recorded in the line item other operating charges or, to the extent they relate to equity method investees, in the line item equity income (loss) — net in our consolidated statements of income.

Contingencies

Our Company is involved in various legal proceedings and tax matters. Due to their nature, such legal proceedings and tax matters involve inherent uncertainties including, but not limited to, court rulings, negotiations between affected parties and governmental actions. Management assesses the probability of loss for such contingencies and accrues a liability and/or discloses the relevant circumstances, as appropriate. Refer to Note 11.

Stock-Based Compensation

Our Company currently sponsors stock option plans and restricted stock award plans. The fair value of our stock option grants is estimated on the grant date using a Black-Scholes-Merton option-pricing model. The Company recognizes compensation expense on a straight-line basis over the period the grant is earned by the employee, generally four years.

The fair value of our restricted stock awards is the quoted market value of the Company's stock on the grant date less the present value of the expected dividends not received during the relevant holding period. In the period it becomes probable that the minimum performance criteria specified in the restricted stock award plan will be achieved, we recognize expense for the proportionate share of the total fair value of the award related to the vesting period that has already lapsed. The remaining cost of the award is expensed on a straight-line basis over the balance of the vesting period. In the event the Company determines it is no longer probable that we will achieve the minimum performance criteria specified in the plan, we reverse all of the previously recognized compensation expense in the period such a determination is made. Refer to Note 12.

Pension and Other Postretirement Benefit Plans

Our Company sponsors and/or contributes to pension and postretirement health care and life insurance benefit plans covering substantially all U.S. employees. We also sponsor nonqualified, unfunded defined benefit pension plans for certain associates and participate in multi-employer pension plans in the United States. In addition, our Company and its subsidiaries have various pension plans and other forms of postretirement arrangements outside the United States. Refer to Note 13.

Income Taxes

Income tax expense includes United States, state, local and international income taxes, plus a provision for U.S. taxes on undistributed earnings of foreign subsidiaries not deemed to be indefinitely reinvested. Deferred tax assets and liabilities are recognized for the tax consequences of temporary differences between the financial reporting basis and the tax basis of existing assets and liabilities. The tax rate used to determine the deferred tax assets and liabilities is the enacted tax rate for the year and manner in which the differences are expected to reverse. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. The Company records taxes that are collected from customers and remitted to governmental authorities on a net basis in our consolidated statements of income.

The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. We establish reserves to remove some or all of the tax benefit of any of our tax positions at the time we determine that it becomes uncertain based upon one of the following conditions: (1) the tax position is not "more likely than not" to be sustained, (2) the tax position is "more likely than not" to be sustained, but for a lesser amount, or (3) the tax position is "more likely than not" to be sustained, but not in the financial period in which the tax position was originally taken. For purposes of evaluating whether or not a tax position is uncertain, (1) we presume the tax position will be examined by the relevant taxing authority that has full knowledge of all relevant information; (2) the technical merits of a tax position are derived from authorities such as legislation and statutes, legislative intent, regulations, rulings and case law and their applicability to the facts and circumstances of the tax position; and (3) each tax position is evaluated without consideration of the possibility of offset or aggregation with other tax positions taken. A number of years may elapse before a particular uncertain tax position is audited and finally resolved or when a tax assessment is raised. The number of years subject to tax assessments varies depending on the tax jurisdiction. The tax benefit that has been previously reserved because of a failure to meet the "more likely than not" recognition threshold would be recognized in our income tax expense in the first interim period when the uncertainty disappears under any one of the following conditions: (1) the tax position is "more likely than not" to be sustained, (2) the tax position, amount, and/or timing is ultimately settled through negotiation or litigation, or (3) the statute of limitations for the tax position has expired. Refer to Note 14.

Translation and Remeasurement

We translate the assets and liabilities of our foreign subsidiaries from their respective functional currencies to U.S. dollars at the appropriate spot rates as of the balance sheet date. Generally, our foreign subsidiaries use the local currency as their functional currency. Changes in the carrying value of these assets and liabilities attributable to fluctuations in spot rates are recognized in foreign currency translation adjustment, a component of AOCI. Refer to Note 15. Income statement accounts are translated using the monthly average exchange rates during the year.

Monetary assets and liabilities denominated in a currency that is different from a reporting entity's functional currency must first be remeasured from the applicable currency to the legal entity's functional currency. The effect of this remeasurement process is recognized in the line item other income (loss) — net in our consolidated statements of income and is partially offset by the impact of our economic hedging program for certain exposures on our consolidated balance sheets. Refer to Note 5.

Hyperinflationary Economies

A hyperinflationary economy is one that has cumulative inflation of 100 percent or more over a three-year period. Effective January 1, 2010, Venezuela was determined to be a hyperinflationary economy. In accordance with hyperinflationary accounting under accounting principles generally accepted in the United States, our local subsidiary was required to use the U.S. dollar as its functional currency.

During February 2013, the Venezuelan government devalued its currency to the official rate of exchange ("official rate") of 6.3 bolivars per U.S. dollar. The Company remeasured the net assets of our local subsidiary and recognized the related loss of $140 million from remeasurement in the line item other income (loss) — net in our consolidated statement of income.

The Company will continue to use the official rate to remeasure the net assets of our Venezuelan subsidiary. In December 2013, the Venezuelan government devalued the currency for foreign tourists to 11.3 bolivars per U.S. dollar, which may indicate that another official currency devaluation could occur. If the official rate devalues further, or if we are able to access currency at different rates that are reasonable to the Company, it would result in our Company recognizing additional foreign currency exchange gains or losses in our consolidated financial statements. As of December 31, 2013, our Venezuelan subsidiary held monetary assets of $426 million and monetary liabilities of $45 million.

In addition to the foreign currency exchange exposure related to our Venezuelan subsidiary's net assets, we also sell concentrate to our bottling partner in Venezuela from outside the country. These sales are denominated in U.S. dollars. If a government-approved exchange rate mechanism for future concentrate sales to our bottling partner in Venezuela is not available, the amount of receivables related to these sales will continue to increase. The carrying value of these receivables was $267 million and $109 million as of December 31, 2013 and 2012, respectively. In addition, we have certain U.S. dollar denominated intangible assets associated with products sold in Venezuela. If the bolivar further devalues, it could result in the impairment of these intangible assets. As of December 31, 2013, intangible assets associated with products sold in Venezuela had a carrying value of $107 million.

ACQUISITIONS_AND_DIVESTITURES

ACQUISITIONS AND DIVESTITURES	12 Months Ended
	Dec. 31, 2013
Acquisitions and Divestitures Disclosure [	'
Acquisitions and Divestitures [Text Block]	'
	ACQUISITIONS AND DIVESTITURES
	Acquisitions
	During 2013, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $353 million, which primarily included our acquisition of the majority of the remaining outstanding shares of Fresh Trading Ltd. ("innocent") and a majority interest in bottling operations in Myanmar. The Company previously accounted for our investment in innocent under the equity method of accounting. We remeasured our equity interest in innocent to fair value upon the close of the transaction. The resulting gain on the remeasurement was not significant to our consolidated financial statements.
	During 2012, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $1,486 million. These payments were primarily related to the following: our investments in the existing beverage business of Aujan Industries Company J.S.C. ("Aujan"), one of the largest independent beverage companies in the Middle East; our investment in Mikuni Coca-Cola Bottling Co., Ltd. ("Mikuni"), a bottling partner located in Japan; our acquisition of Sacramento Coca-Cola Bottling Co., Inc. ("Sacramento bottler"); and our acquisition of bottling operations in Vietnam, Cambodia and Guatemala. The Company's investment in Mikuni was accounted for under the equity method of accounting prior to 2013, when this investment was merged with three other bottlers as Coca-Cola East Japan Bottling Company, Ltd. ("CCEJ"). Refer to Note 17 for details on this transaction.
	The Company paid $820 million during 2012 under its definitive agreement with Aujan in exchange for an ownership interest of 50 percent in the Aujan entity that holds the rights to Aujan-owned brands in certain territories and an ownership interest of 49 percent in Aujan's bottling and distribution operations in certain territories. The Company's investments in Aujan are being accounted for under the equity method of accounting.
	During 2011, our Company's acquisitions of businesses, equity method investments and nonmarketable securities totaled $971 million. These payments were primarily related to the acquisitions of Great Plains Coca-Cola Bottling Company ("Great Plains") and Honest Tea, Inc. ("Honest Tea"), and an additional investment in Coca-Cola Central Japan Company ("Central Japan"). In addition, these activities included immaterial cash payments for the finalization of working capital adjustments related to our acquisition of the former North America business of Coca-Cola Enterprises Inc. ("CCE").
	The Company acquired Great Plains on December 30, 2011. The total purchase price for the Great Plains acquisition was approximately $360 million, of which $321 million was paid at closing. The purchase price was primarily allocated to property, plant and equipment, identifiable intangible assets and goodwill. The Company finalized our purchase accounting for Great Plains during the fourth quarter of 2012.
	During 2011, the Company also acquired the remaining ownership interest of Honest Tea not already owned by the Company. Prior to the Company acquiring the remaining ownership interest of Honest Tea, we accounted for our investment under the equity method of accounting. We remeasured our equity interest in Honest Tea to fair value upon the close of the transaction. The resulting gain on the remeasurement was not significant to our consolidated financial statements. The Company finalized our purchase accounting for Honest Tea during the fourth quarter of 2011.
	In December 2011, the Company acquired an additional minority interest in Central Japan. As a result, the Company began to account for our investment in Central Japan under the equity method of accounting beginning in December 2011. In 2013, this investment was subsequently merged with three other bottlers as CCEJ. Refer to Note 17 for details on this transaction.
	Coca-Cola Erfrischungsgetränke AG
	In conjunction with the Company's acquisition of 18 German bottling and distribution operations in 2007, the former owners received put options to sell their respective shares in Coca-Cola Erfrischungsgetränke AG ("CCEAG") back to the Company on January 2, 2014. During 2013, the Company received notification that all of the outstanding put options would be exercised, which will result in the Company paying $498 million to purchase the shares.
	Divestitures
	During 2013, proceeds from disposals of businesses, equity method investments and nonmarketable securities totaled $872 million. These proceeds primarily included the sale of a majority ownership interest in our previously consolidated bottling operations in the Philippines ("Philippine bottling operations"), and separately, the deconsolidation of our bottling operations in Brazil ("Brazilian bottling operations"). See below for further details on each of these transactions.
	In 2011, proceeds from the disposal of bottling companies and other investments totaled $398 million, primarily related to the sale of our investment in Coca-Cola Embonor, S.A. ("Embonor"), a bottling partner with operations primarily in Chile, for $394 million. Prior to this transaction, the Company accounted for our investment in Embonor under the equity method of accounting. Refer to Note 17. None of the Company's other divestitures was individually significant.
	Assets and Liabilities Held for Sale
	On December 13, 2012, the Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our Philippine bottling operations. As of December 31, 2012, our Philippine bottling operations met the criteria to be classified as held for sale, and we were required to record their assets and liabilities at the lower of carrying value or fair value less any costs to sell based on the agreed-upon purchase price. Accordingly, we recorded a total loss of $107 million, primarily during the fourth quarter of 2012, in the line item other income (loss) — net in our consolidated statement of income.
	This transaction was completed on January 25, 2013. The Company now accounts for our remaining 49 percent ownership interest in the Philippine bottling operations under the equity method of accounting. As a result of this transaction, we remeasured our remaining investment in the Philippine bottling operations to fair value taking into consideration the sale price of the majority ownership interest. Coca-Cola FEMSA has an option to purchase our remaining ownership interest in the Philippine bottling operations at any time during the seven years following closing based on the initial purchase price plus a defined return. Coca-Cola FEMSA also has an option exercisable during the sixth year after closing to sell its ownership interest back to the Company at a price not to exceed the initial purchase price.
	On December 17, 2012, the Company entered into an agreement with several parties to combine our Brazilian bottling operations with an independent bottler in Brazil in a transaction involving a disposition of shares for cash and an exchange of shares for a 44 percent minority ownership interest in the newly combined entity, which was recorded at fair value. As of December 31, 2012, our Brazilian bottling operations met the criteria to be classified as held for sale, but we were not required to record their assets and liabilities at fair value less any costs to sell because their fair value exceeded our carrying value. This transaction was completed on July 3, 2013, and resulted in the deconsolidation of our Brazilian bottling operations. The Company recognized a gain of $615 million as a result of this transaction. The owners of the majority interest have the option to acquire up to 24 percent of the new entity's outstanding shares from us at any time for a period of six years beginning December 31, 2013, based on an agreed-upon formula.
	The following table presents information related to the major classes of assets and liabilities of the Company's Philippine and Brazilian bottling operations, both of which are included in our Bottling Investments operating segment, as of December 31, 2012 (in millions):


		Philippine Bottling Operations			Brazilian Bottling Operations		Total Bottling
							Operations
							Held for Sale
	Cash, cash equivalents and short-term investments	$	133		$	45	$	178

	Trade accounts receivable, less allowances	108			88		196

	Inventories	187			85		272

	Prepaid expenses and other assets	223			174		397

	Other assets	7			128		135

	Property, plant and equipment — net	841			419		1,260

	Bottlers' franchise rights with indefinite lives	341			130		471

	Goodwill	148			22		170

	Other intangible assets	—			1		1

	Allowance for reduction of assets held for sale	(107		)	—		(107		)

	Total assets	$	1,881		$	1,092	$	2,973

	Accounts payable and accrued expenses	$	241		$	157	$	398

	Loans and notes payable	—			6		6

	Current maturities of long-term debt	—			28		28

	Accrued income taxes	(4		)	4		—

	Long-term debt	—			147		147

	Other liabilities	20			75		95

	Deferred income taxes	102			20		122

	Total liabilities	$	359		$	437	$	796

	We determined that our Philippine and Brazilian bottling operations did not meet the criteria to be classified as discontinued operations, primarily due to the continued significant involvement we will have in these operations following each transaction.

INVESTMENTS

INVESTMENTS	12 Months Ended
	Dec. 31, 2013
Investments Disclosure [Abstract]	'
INVESTMENTS	'
	INVESTMENTS
	Investments in debt and marketable securities, other than investments accounted for under the equity method, are classified as trading, available-for-sale or held-to-maturity. Our marketable equity investments are classified as either trading or available-for-sale with their cost basis determined by the specific identification method. Our investments in debt securities are carried at either amortized cost or fair value. Investments in debt securities that the Company has the positive intent and ability to hold to maturity are carried at amortized cost and classified as held-to-maturity. Investments in debt securities that are not classified as held-to-maturity are carried at fair value and classified as either trading or available-for-sale. Realized and unrealized gains and losses on trading securities and realized gains and losses on available-for-sale securities are included in net income. Unrealized gains and losses, net of deferred taxes, on available-for-sale securities are included in our consolidated balance sheets as a component of AOCI, except for the change in fair value attributable to the currency risk being hedged. Refer to Note 5 for additional information related to the Company's fair value hedges of available-for-sale securities.
	Trading Securities
	As of December 31, 2013 and 2012, our trading securities had a fair value of $372 million and $266 million, respectively, and consisted primarily of equity securities. The Company had net unrealized gains on trading securities of $12 million and $19 million as of December 31, 2013 and 2012, respectively, and net unrealized losses of $5 million as of December 31, 2011. The Company's trading securities were included in the following captions in our consolidated balance sheets (in millions):


	December 31,	2013				2012

	Marketable securities	$	286			$	184

	Other assets	86				82

	Total trading securities	$	372			$	266

	Available-for-Sale and Held-to-Maturity Securities
	As of December 31, 2013 and 2012, the Company did not have any held-to-maturity securities. Available-for-sale securities consisted of the following (in millions):


						Gross Unrealized						Estimated Fair Value
		Cost				Gains			Losses
	2013
	Available-for-sale securities:1,2
	Equity securities	$	1,097			$	373		$	(17	)	$	1,453

	Debt securities	3,388				24			(23		)	3,389

		$	4,485			$	397		$	(40	)	$	4,842

	2012
	Available-for-sale securities:1,2
	Equity securities	$	957			$	441		$	(10	)	$	1,388

	Debt securities	3,169				46			(10		)	3,205

		$	4,126			$	487		$	(20	)	$	4,593


	1	Refer to Note 16 for additional information related to the estimated fair value.

	2	During 2012, the Company made a change to its overall cash management program. In an effort to manage counterparty risk and diversify our assets, the Company began to make additional investments in high-quality securities. These investments are primarily classified as available-for-sale securities.
	The sale and/or maturity of available-for-sale securities resulted in the following activity (in millions):


	Year Ended December 31,	2013				2012			2011

	Gross gains	$	12			$	41		$	5

	Gross losses	(24		)		(35		)	(1		)
	Proceeds	4,212				5,036			37


	In 2013 and 2012, the Company had investments classified as available-for-sale securities in which our cost basis exceeded the fair value of our investment. Management assessed each of these investments on an individual basis to determine if the decline in fair value was other than temporary. Management's assessment as to the nature of a decline in fair value is based on, among other things, the length of time and the extent to which the market value has been less than our cost basis; the financial condition and near-term prospects of the issuer; and our intent and ability to retain the investment for a period of time sufficient to allow for any anticipated recovery in market value. As a result of these assessments, management determined that the decline in fair value of these investments was not other than temporary and did not record any impairment charges.
	In 2011, the Company realized losses of $17 million due to other-than-temporary impairments of certain available-for-sale securities. These impairment charges were recorded in other income (loss) — net. Refer to Note 16 and Note 17.
	During 2011, the Company began using one of its insurance captives to reinsure group annuity insurance contracts that cover the pension obligations of certain of our European pension plans. In 2013, the Company began using insurance captives for our Canadian pension plans. In accordance with local insurance regulations, our insurance captive is required to meet and maintain minimum solvency capital requirements. The Company elected to invest its solvency capital in a portfolio of available-for-sale securities, which have been classified in the line item other assets in our consolidated balance sheets because the assets are not available to satisfy our current obligations. As of December 31, 2013, and December 31, 2012, the Company's available-for-sale securities included solvency capital funds of $667 million and $451 million, respectively.
	In 2013 and 2012, the Company did not have any held-to-maturity securities. The Company's available-for-sale securities were included in the following captions in our consolidated balance sheets (in millions):


	December 31,	2013				2012

	Cash and cash equivalents	$	245			$	9

	Marketable securities	2,861				2,908

Other investments, principally bottling companies	958				1,087

Other assets	778				589

	$	4,842			$	4,593


The contractual maturities of these investments as of December 31, 2013, were as follows (in millions):


	Available-for-Sale Securities
	Cost				Fair Value

Within 1 year	$	1,227			$	1,227

After 1 year through 5 years	1,669				1,672

After 5 years through 10 years	156				161

After 10 years	336				329

Equity securities	1,097				1,453

	$	4,485			$	4,842


The Company expects that actual maturities may differ from the contractual maturities above because borrowers have the right to call or prepay certain obligations.
Cost Method Investments
Cost method investments are initially recorded at cost, and we record dividend income when applicable dividends are declared. Cost method investments are reported as other investments in our consolidated balance sheets, and dividend income from cost method investments is reported in other income (loss) — net in our consolidated statements of income. We review all of our cost method investments quarterly to determine if impairment indicators are present; however, we are not required to determine the fair value of these investments unless impairment indicators exist. When impairment indicators exist, we generally use discounted cash flow analyses to determine the fair value. We estimate that the fair values of our cost method investments approximated or exceeded their carrying values as of December 31, 2013 and 2012. Our cost method investments had a carrying value of $162 million and $145 million as of December 31, 2013 and 2012, respectively.
In 2012, the Company recorded a charge of $16 million as a result of other-than-temporary declines in the fair values of certain cost method investments. This impairment was recorded in the line item other income (loss) — net in our consolidated statement of income. Refer to Note 16 for additional information related to this impairment.

INVENTORIES

INVENTORIES	12 Months Ended
	Dec. 31, 2013
Inventories [Abstract]	'
INVENTORIES	'
	INVENTORIES
	Inventories consist primarily of raw materials and packaging (which includes ingredients and supplies) and finished goods (which include concentrates and syrups in our concentrate operations and finished beverages in our finished product operations). Inventories are valued at the lower of cost or market. We determine cost on the basis of the average cost or first-in, first-out methods. Inventories consisted of the following (in millions):


	December 31,	2013		2012

	Raw materials and packaging	$	1,692	$	1,773

	Finished goods	1,240		1,171

	Other	345		320

	Total inventories	$	3,277	$	3,264

HEDGING_TRANSACTIONS_AND_DERIV

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS	12 Months Ended
	Dec. 31, 2013
Hedging Transactions and Derivative Financial Instruments Disclosures [Abstract]	'
HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS	'
	HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS
	The Company is directly and indirectly affected by changes in certain market conditions. These changes in market conditions may adversely impact the Company's financial performance and are referred to as "market risks." Our Company, when deemed appropriate, uses derivatives as a risk management tool to mitigate the potential impact of certain market risks. The primary market risks managed by the Company through the use of derivative instruments are foreign currency exchange rate risk, commodity price risk and interest rate risk.
	The Company uses various types of derivative instruments including, but not limited to, forward contracts, commodity futures contracts, option contracts, collars and swaps. Forward contracts and commodity futures contracts are agreements to buy or sell a quantity of a currency or commodity at a predetermined future date, and at a predetermined rate or price. An option contract is an agreement that conveys the purchaser the right, but not the obligation, to buy or sell a quantity of a currency or commodity at a predetermined rate or price during a period or at a time in the future. A collar is a strategy that uses a combination of options to limit the range of possible positive or negative returns on an underlying asset or liability to a specific range, or to protect expected future cash flows. To do this, an investor simultaneously buys a put option and sells (writes) a call option, or alternatively buys a call option and sells (writes) a put option. A swap agreement is a contract between two parties to exchange cash flows based on specified underlying notional amounts, assets and/or indices. We do not enter into derivative financial instruments for trading purposes.
	All derivatives are carried at fair value in our consolidated balance sheets in the following line items, as applicable: prepaid expenses and other assets; other assets; accounts payable and accrued expenses; and other liabilities. The carrying values of the derivatives reflect the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. These master netting agreements allow the Company to net settle positive and negative positions (assets and liabilities) arising from different transactions with the same counterparty.
	The accounting for gains and losses that result from changes in the fair values of derivative instruments depends on whether the derivatives have been designated and qualify as hedging instruments and the type of hedging relationships. Derivatives can be designated as fair value hedges, cash flow hedges or hedges of net investments in foreign operations. The changes in the fair values of derivatives that have been designated and qualify for fair value hedge accounting are recorded in the same line item in our consolidated statements of income as the changes in the fair values of the hedged items attributable to the risk being hedged. The changes in fair values of derivatives that have been designated and qualify as cash flow hedges or hedges of net investments in foreign operations are recorded in AOCI and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. Due to the high degree of effectiveness between the hedging instruments and the underlying exposures being hedged, fluctuations in the value of the derivative instruments are generally offset by changes in the fair values or cash flows of the underlying exposures being hedged. The changes in fair values of derivatives that were not designated and/or did not qualify as hedging instruments are immediately recognized into earnings.
	For derivatives that will be accounted for as hedging instruments, the Company formally designates and documents, at inception, the financial instrument as a hedge of a specific underlying exposure, the risk management objective and the strategy for undertaking the hedge transaction. In addition, the Company formally assesses, both at the inception and at least quarterly thereafter, whether the financial instruments used in hedging transactions are effective at offsetting changes in either the fair values or cash flows of the related underlying exposures. Any ineffective portion of a financial instrument's change in fair value is immediately recognized into earnings.
	The Company determines the fair values of its derivatives based on quoted market prices or using standard valuation models. Refer to Note 16. The notional amounts of the derivative financial instruments do not necessarily represent amounts exchanged by the parties and, therefore, are not a direct measure of our exposure to the financial risks described above. The amounts exchanged are calculated by reference to the notional amounts and by other terms of the derivatives, such as interest rates, foreign currency exchange rates, commodity rates or other financial indices. The Company does not view the fair values of its derivatives in isolation, but rather in relation to the fair values or cash flows of the underlying hedged transactions or other exposures. Virtually all of our derivatives are straightforward over-the-counter instruments with liquid markets.
	The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):


				Fair Value1,2
	Derivatives Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2013				2012
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	211			$	149

	Foreign currency contracts	Other assets		109				—

	Commodity contracts	Prepaid expenses and other assets		1				—

	Interest rate contracts	Prepaid expenses and other assets		—				7

	Interest rate contracts	Other assets		283				335

	Total assets			$	604			$	491

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	84			$	55

	Foreign currency contracts	Other liabilities		40				—

	Commodity contracts	Accounts payable and accrued expenses		1				1

	Interest rate contracts	Other liabilities		—				6

	Total liabilities			$	125			$	62


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
	The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):


				Fair Value1,2
	Derivatives Not Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2013				2012
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	21			$	19

	Foreign currency contracts	Other assets		171				42

	Commodity contracts	Prepaid expenses and other assets		33				72

	Commodity contracts	Other assets		1				—

	Other derivative instruments	Prepaid expenses and other assets		9				6

	Total assets			$	235			$	139

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	24			$	24

Foreign currency contracts	Other liabilities		—				1

Commodity contracts	Accounts payable and accrued expenses		23				43

Commodity contracts	Other liabilities		—				1

Interest rate contracts	Other liabilities		3				—

Other derivative instruments	Accounts payable and accrued expenses		—				2

Total liabilities			$	50			$	71


1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

2	Refer to Note 16 for additional information related to the estimated fair value.
Credit Risk Associated with Derivatives
We have established strict counterparty credit guidelines and enter into transactions only with financial institutions of investment grade or better. We monitor counterparty exposures regularly and review any downgrade in credit rating immediately. If a downgrade in the credit rating of a counterparty were to occur, we have provisions requiring collateral in the form of U.S. government securities for substantially all of our transactions. To mitigate presettlement risk, minimum credit standards become more stringent as the duration of the derivative financial instrument increases. In addition, the Company's master netting agreements reduce credit risk by permitting the Company to net settle for transactions with the same counterparty. To minimize the concentration of credit risk, we enter into derivative transactions with a portfolio of financial institutions. Based on these factors, we consider the risk of counterparty default to be minimal.
Cash Flow Hedging Strategy
The Company uses cash flow hedges to minimize the variability in cash flows of assets or liabilities or forecasted transactions caused by fluctuations in foreign currency exchange rates, commodity prices or interest rates. The changes in the fair values of derivatives designated as cash flow hedges are recorded in AOCI and are reclassified into the line item in our consolidated statement of income in which the hedged items are recorded in the same period the hedged items affect earnings. The changes in fair values of hedges that are determined to be ineffective are immediately reclassified from AOCI into earnings. During the years ended December 31, 2013, 2012 and 2011, the Company did not record any gains or losses into earnings as a result of the discontinuance of cash flow hedges due to forecasted transactions that were no longer expected to occur. The maximum length of time for which the Company hedges its exposure to the variability in future cash flows is typically three years.
The Company maintains a foreign currency cash flow hedging program to reduce the risk that our eventual U.S. dollar net cash inflows from sales outside the United States and U.S. dollar net cash outflows from procurement activities will be adversely affected by changes in foreign currency exchange rates. We enter into forward contracts and purchase foreign currency options (principally euros and Japanese yen) and collars to hedge certain portions of forecasted cash flows denominated in foreign currencies. When the U.S. dollar strengthens against the foreign currencies, the decline in the present value of future foreign currency cash flows is partially offset by gains in the fair value of the derivative instruments. Conversely, when the U.S. dollar weakens, the increase in the present value of future foreign currency cash flows is partially offset by losses in the fair value of the derivative instruments. The total notional values of derivatives that have been designated and qualify for the Company's foreign currency cash flow hedging program were $8,450 million and $4,715 million as of December 31, 2013 and 2012, respectively.
The Company has entered into commodity futures contracts and other derivative instruments on various commodities to mitigate the price risk associated with forecasted purchases of materials used in our manufacturing process. The derivative instruments have been designated and qualify as part of the Company's commodity cash flow hedging program. The objective of this hedging program is to reduce the variability of cash flows associated with future purchases of certain commodities. The total notional values of derivatives that have been designated and qualify for this program were $26 million and $17 million as of December 31, 2013 and 2012, respectively.
Our Company monitors our mix of short-term debt and long-term debt regularly. From time to time, we manage our risk to interest rate fluctuations through the use of derivative financial instruments. The Company has entered into interest rate swap agreements and has designated these instruments as part of the Company's interest rate cash flow hedging program. The objective of this hedging program is to mitigate the risk of adverse changes in benchmark interest rates on the Company's future interest payments. The total notional values of these interest rate swap agreements that were designated and qualified for the Company's interest rate cash flow hedging program were $1,828 million and $1,764 million as of December 31, 2013 and 2012, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


	Gain (Loss)				Location of Gain (Loss)		Gain (Loss)				Gain (Loss)
	Recognized				Recognized in Income1		Reclassified from				Recognized in Income
	in Other						AOCI into Income				(Ineffective Portion and
	Comprehensive						(Effective Portion)				Amount Excluded from
	Income ("OCI")										Effectiveness Testing)
2013
Foreign currency contracts	$	218			Net operating revenues		$	149			$	1

Foreign currency contracts	52				Cost of goods sold		32				—			2

Interest rate contracts	169				Interest expense		(12		)		(3		)

Commodity contracts	2				Cost of goods sold		(2		)		—

Total	$	441					$	167			$	(2	)

2012
Foreign currency contracts	$	59			Net operating revenues		$	(46	)		$	2

Foreign currency contracts	34				Cost of goods sold		(23		)		—

Interest rate contracts	1				Interest expense		(12		)		—			2

Commodity contracts	(4		)		Cost of goods sold		(1		)		—

Total	$	90					$	(82	)		$	2

2011
Foreign currency contracts	$	3			Net operating revenues		$	(231	)		$	—		2

Interest rate contracts	(11		)		Interest expense		(12		)		(1		)
Commodity contracts	(1		)		Cost of goods sold		—				—

Total	$	(9	)				$	(243	)		$	(1	)

1	The Company records gains and losses reclassified from AOCI in income for the effective portion and ineffective portion, if any, to the same line items in our consolidated statements of income.

2	Includes a de minimis amount of ineffectiveness in the hedging relationship.
As of December 31, 2013, the Company estimates that it will reclassify into earnings during the next 12 months gains of approximately $119 million from the pretax amount recorded in AOCI as the anticipated cash flows occur.
Fair Value Hedging Strategy
The Company uses interest rate swap agreements designated as fair value hedges to minimize exposure to changes in the fair value of fixed-rate debt that results from fluctuations in benchmark interest rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items are recognized in earnings. The ineffective portions of these hedges are immediately recognized in earnings. As of December 31, 2013, such adjustments increased the carrying value of our long-term debt by $52 million. Refer to Note 10. When a derivative is no longer designated as a fair value hedge for any reason, including termination and maturity, the remaining unamortized difference between the carrying value of the hedged item at that time and the par value of the hedged item is amortized to earnings over the remaining life of the hedged item, or immediately if the hedged item has matured. The changes in fair values of hedges that are determined to be ineffective are immediately recognized into earnings. The total notional values of derivatives that related to our fair value hedges of this type were $5,600 million and $6,700 million as of December 31, 2013 and 2012, respectively.
During the first quarter of 2012, the Company began using fair value hedges to minimize exposure to changes in the fair value of certain available-for-sale securities from fluctuations in foreign currency exchange rates. The changes in fair values of derivatives designated as fair value hedges and the offsetting changes in fair values of the hedged items are recognized in earnings. The changes in fair values of hedges that are determined to be ineffective are immediately recognized into earnings. The total notional values of derivatives that related to our fair value hedges of this type were $996 million and $850 million as of December 31, 2013 and 2012, respectively.
The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


Hedging Instruments and Hedged Items	Location of Gain (Loss)	Gain (Loss)
	Recognized in Income	Recognized in Income1
2013
Interest rate contracts	Interest expense	$	(193	)
Fixed-rate debt	Interest expense	240

Net impact to interest expense		$	47

Foreign currency contracts	Other income (loss) — net	$	24

Available-for-sale securities	Other income (loss) — net	(48		)
Net impact to other income (loss) — net		$	(24	)
Net impact of fair value hedging instruments		$	23

2012
Interest rate contracts	Interest expense	$	89

Fixed-rate debt	Interest expense	(42		)
Net impact to interest expense		$	47

Foreign currency contracts	Other income (loss) — net	$	42

Available-for-sale securities	Other income (loss) — net	(46		)
Net impact to other income (loss) — net		$	(4	)
Net impact of fair value hedging instruments		$	43

2011
Interest rate contracts	Interest expense	$	343

Fixed-rate debt	Interest expense	(333		)
Net impact to interest expense		$	10

1 The net impacts represent the ineffective portions of the hedge relationships and the amounts excluded from the assessment of hedge effectiveness.
Hedges of Net Investments in Foreign Operations Strategy
The Company uses forward contracts to protect the value of our investments in a number of foreign subsidiaries. For derivative instruments that are designated and qualify as hedges of net investments in foreign operations, the changes in fair values of the derivative instruments are recognized in net foreign currency translation gain (loss), a component of AOCI, to offset the changes in the values of the net investments being hedged. Any ineffective portions of net investment hedges are reclassified from AOCI into earnings during the period of change. The total notional values of derivatives under this hedging program were $2,024 million and $1,718 million as of December 31, 2013 and 2012, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives designated as net investment hedges had on AOCI during the years ended December 31, 2013, 2012 and 2011 (in millions):


	Gain (Loss)
	Recognized in OCI
Year Ended December 31,	2013				2012				2011

Foreign currency contracts	$	61			$	(61	)		$	(3	)

The Company did not reclassify any deferred gains or losses related to net investment hedges from AOCI to earnings during the years ended December 31, 2013, 2012 and 2011. In addition, the Company did not have any ineffectiveness related to net investment hedges during the years ended December 31, 2013, 2012 and 2011.
Economic (Non-Designated) Hedging Strategy
In addition to derivative instruments that are designated and qualify for hedge accounting, the Company also uses certain derivatives as economic hedges of foreign currency, interest rate and commodity exposure. Although these derivatives were not designated and/or did not qualify for hedge accounting, they are effective economic hedges. The changes in fair value of economic hedges are immediately recognized into earnings.
The Company uses foreign currency economic hedges to offset the earnings impact that fluctuations in foreign currency exchange rates have on certain monetary assets and liabilities denominated in nonfunctional currencies. The changes in fair value of economic hedges used to offset the monetary assets and liabilities are recognized into earnings in the line item other income (loss) — net in our consolidated statements of income. In addition, we use foreign currency economic hedges to minimize the variability in cash flows associated with changes in foreign currency exchange rates. The changes in fair value of economic hedges used to offset the variability in U.S. dollar net cash flows are recognized into earnings in the line items net operating revenues and cost of goods sold in our consolidated statements of income. The total notional values of derivatives related to our foreign currency economic hedges were $3,871 million and $3,865 million as of December 31, 2013 and 2012, respectively.
The Company also uses certain derivatives as economic hedges to mitigate the price risk associated with the purchase of materials used in the manufacturing process and for vehicle fuel. The changes in fair values of these economic hedges are immediately recognized into earnings in the line items net operating revenues, cost of goods sold, and selling, general and administrative expenses in our consolidated statements of income, as applicable. The total notional values of derivatives related to our economic hedges of this type were $1,441 million and $1,084 million as of December 31, 2013 and 2012, respectively.
The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


			Gains (Losses)
Derivatives Not Designated	Location of Gains (Losses)		Year Ended December 31,
as Hedging Instruments	Recognized in Income		2013				2012				2011

Foreign currency contracts	Net operating revenues		$	5			$	(7	)		$	7

Foreign currency contracts	Other income (loss) — net		162				24				(37		)

Foreign currency contracts	Cost of goods sold		2				—				(12		)

Commodity contracts	Net operating revenues		5				4				—

Commodity contracts	Cost of goods sold		(122		)		(110		)		(42		)
Commodity contracts	Selling, general and administrative expenses		7				9				(11		)

Interest rate swaps	Interest expense		(3		)		—				—

Other derivative instruments	Selling, general and administrative expenses		55				18				8

Total			$	111			$	(62	)		$	(87	)

EQUITY_METHOD_INVESTMENTS

EQUITY METHOD INVESTMENTS	12 Months Ended
	Dec. 31, 2013
EQUITY METHOD INVESTMENTS [Abstract]	'
EQUITY METHOD INVESTMENTS	'
	EQUITY METHOD INVESTMENTS
	Our consolidated net income includes our Company's proportionate share of the net income or loss of our equity method investees. When we record our proportionate share of net income, it increases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. Conversely, when we record our proportionate share of a net loss, it decreases equity income (loss) — net in our consolidated statements of income and our carrying value in that investment. The Company's proportionate share of the net income or loss of our equity method investees includes significant operating and nonoperating items recorded by our equity method investees. These items can have a significant impact on the amount of equity income (loss) — net in our consolidated statements of income and our carrying value in those investments. Refer to Note 17 for additional information related to significant operating and nonoperating items recorded by our equity method investees. The carrying values of our equity method investments are also impacted by our proportionate share of items impacting the equity investee's AOCI.
	We eliminate from our financial results all significant intercompany transactions, including the intercompany portion of transactions with equity method investees.
	The Company's equity method investments include our ownership interests in Coca-Cola FEMSA, Coca-Cola Hellenic and Coca-Cola Amatil. As of December 31, 2013, we owned 28 percent, 23 percent and 29 percent, respectively, of these companies' outstanding shares. As of December 31, 2013, our investment in our equity method investees in the aggregate exceeded our proportionate share of the net assets of these equity method investees by $2,202 million. This difference is not amortized.
	A summary of financial information for our equity method investees in the aggregate is as follows (in millions):


	Year Ended December 31,	2013		2012		2011

	Net operating revenues	$	53,038	$	47,087	$	42,472

	Cost of goods sold	32,377		28,821		26,271

	Gross profit	$	20,661	$	18,266	$	16,201

	Operating income	$	4,380	$	4,605	$	4,181

	Consolidated net income	$	2,364	$	2,993	$	2,237

	Less: Net income attributable to noncontrolling interests	62		89		99

	Net income attributable to common shareowners	$	2,302	$	2,904	$	2,138

	Equity income (loss) — net	$	602	$	819	$	690



	December 31,	2013		2012

	Current assets	$	19,229	$	16,054

	Noncurrent assets	40,427		32,687

	Total assets	$	59,656	$	48,741

	Current liabilities	$	14,386	$	12,004

	Noncurrent liabilities	17,779		12,272

	Total liabilities	$	32,165	$	24,276

	Equity attributable to shareowners of investees	$	26,668	$	23,827

	Equity attributable to noncontrolling interests	823		638

	Total equity	$	27,491	$	24,465

	Company equity investment	$	10,393	$	9,216

	Net sales to equity method investees, the majority of which are located outside the United States, were $9,178 million, $7,082 million and $6,874 million in 2013, 2012 and 2011, respectively. Total payments, primarily marketing, made to equity method investees were $1,807 million, $1,587 million and $1,147 million in 2013, 2012 and 2011, respectively. In addition, purchases of finished products from equity method investees were $415 million, $392 million and $430 million in 2013, 2012 and 2011, respectively.
	If valued at the December 31, 2013, quoted closing prices of shares actively traded on stock markets, the value of our equity method investments in publicly traded bottlers would have exceeded our carrying value by $9,155 million.
	Net Receivables and Dividends from Equity Method Investees
	Total net receivables due from equity method investees were $1,308 million and $1,280 million as of December 31, 2013 and 2012, respectively. The total amount of dividends received from equity method investees was $401 million, $393 million and $421 million for the years ended December 31, 2013, 2012 and 2011, respectively. Dividends received included a $35 million and $60 million special dividend from Coca-Cola Hellenic during 2012 and 2011, respectively. We classified the receipt of these cash dividends in cash flows from operating activities because our cumulative equity in earnings from Coca-Cola Hellenic exceeded the cumulative distributions received; therefore, the dividends were deemed to be a return on our investment and not a return of our investment.

PROPERTY_PLANT_AND_EQUIPMENT

PROPERTY, PLANT AND EQUIPMENT	12 Months Ended
	Dec. 31, 2013
Property Plant and Equipament [Abstract]	'
PROPERTY, PLANT AND EQUIPMENT	'
	PROPERTY, PLANT AND EQUIPMENT
	The following table summarizes our property, plant and equipment (in millions):


	December 31,	2013		2012

	Land	$	1,011	$	997

	Buildings and improvements	5,605		5,307

	Machinery, equipment and vehicle fleet	17,551		16,203

	Construction in progress	865		979

		$	25,032	$	23,486

	Less accumulated depreciation	10,065		9,010

	Property, plant and equipment — net	$	14,967	$	14,476

INTANGIBLE_ASSETS

INTANGIBLE ASSETS	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
Intangible Assets Disclosure [Text Block]	'
	INTANGIBLE ASSETS
	Indefinite-Lived Intangible Assets
	The following table summarizes information related to indefinite-lived intangible assets (in millions):


	December 31,	2013				2012

	Trademarks1	$	6,744			$	6,527

	Bottlers' franchise rights	7,415				7,405

	Goodwill	12,312				12,255

	Other	171				111

	Indefinite-lived intangible assets2	$	26,642			$	26,298

	1 The increase in 2013 was primarily related to the Company's consolidation of innocent. Refer to Note 2 for additional information. This increase was partially offset by impairments on certain trademarks. Refer to Note 17 for additional information.
	2 During 2010, we entered into license agreements with Dr Pepper Snapple Group, Inc. ("DPSG") to distribute Dr Pepper trademark brands in the United States, Canada Dry in the Northeastern United States, and Canada Dry and C' Plus in Canada. As a result, the Company recorded an asset of $865 million related to the DPSG license agreements. Under the license agreements, the Company agreed to meet certain performance obligations in order to distribute DPSG products in retail and foodservice accounts and vending machines. The license agreements have initial terms of 20 years, with automatic 20-year renewal periods unless otherwise terminated under the terms of the agreements. The Company anticipates using the assets indefinitely. The distribution rights acquired from DPSG are the only significant indefinite-lived intangible assets subject to renewal or extension arrangements.

	The following table provides information related to the carrying value of our goodwill by operating segment (in millions):


		Eurasia &				Europe			Latin			North				Pacific			Bottling			Total
		Africa							America			America							Investments
	2012
	Balance as of January 1	$	35			$	710		$	163		$	10,515			$	117		$	679		$	12,219

	Effect of foreign currency translation	(1		)		(19		)	5			—				6			(4		)	(13		)

	Acquisitions1	—				—			—			100				—			157			257

	Adjustments related to the finalization	—				—			—			(38		)		—			—			(38		)
	of purchase accounting1
	Divestitures, deconsolidations and other2	—				—			—			—				—			(170		)	(170		)

	Balance as of December 31	$	34			$	691		$	168		$	10,577			$	123		$	662		$	12,255

	2013
	Balance as of January 1	$	34			$	691		$	168		$	10,577			$	123		$	662		$	12,255

	Effect of foreign currency translation	(3		)		29			(12		)	—				(6		)	10			18

	Acquisitions1	5				102			—			—				—			20			127

	Adjustments related to the finalization	—				—			—			(4		)		—			(1		)	(5		)
	of purchase accounting1
	Impairment3	—				—			—			—				—			(82		)	(82		)

	Divestitures, deconsolidations and other	—				—			—			(1		)		—			—			(1		)

	Balance as of December 31	$	36			$	822		$	156		$	10,572			$	117		$	609		$	12,312


	1	Refer to Note 2 for information related to the Company's acquisitions and divestitures.

	2	Relates to the transfer of goodwill associated with the Company's consolidated Philippine and Brazilian bottling operations to assets held for sale as of December 31, 2012. Refer to Note 2 for additional information related to these transactions.
	3 Refer to Note 17 for information related to the Company's impairment of goodwill.
	Definite-Lived Intangible Assets
	The following table summarizes information related to definite-lived intangible assets (in millions):


		December 31, 2013									December 31, 2012
	Gross Carrying Amount			Accumulated Amortization			Net			Gross Carrying Amount		Accumulated Amortization			Net

Customer relationships	$	642		$	(202	)	$	440		$	622	$	(166	)	$	456

Bottlers' franchise rights	722			(317		)	405			730		(221		)	509

Trademarks	105			(26		)	79			65		(43		)	22

Other	128			(83		)	45			129		(77		)	52

Total	$	1,597		$	(628	)	$	969		$	1,546	$	(507	)	$	1,039

Total amortization expense for intangible assets subject to amortization was $165 million, $173 million and $192 million in 2013, 2012 and 2011, respectively. Based on the carrying value of definite-lived intangible assets as of December 31, 2013, we estimate our amortization expense for the next five years will be as follows (in millions):


		Amortization
		Expense
2014		$	160

2015		152

2016		145

2017		112

2018		54

ACCOUNTS_PAYABLE_AND_ACCRUED_E

ACCOUNTS PAYABLE AND ACCRUED EXPENSES	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES [Abstract]	'
Accounts Payable and Accrued Expenses Disclosure [Text Block]	'
	ACCOUNTS PAYABLE AND ACCRUED EXPENSES
	Accounts payable and accrued expenses consisted of the following (in millions):


	December 31,	2013		2012

	Accrued marketing	$	2,407	$	2,231

	Other accrued expenses	3,515		2,711

	Trade accounts payable	1,933		1,969

	Accrued compensation	933		1,045

	Sales, payroll and other taxes	450		389

	Container deposits	339		335

	Accounts payable and accrued expenses	$	9,577	$	8,680

DEBT_AND_BORROWING_ARRANGEMENT

DEBT AND BORROWING ARRANGEMENTS	12 Months Ended
DEBT AND BORROWING ARRANGEMENTS	Dec. 31, 2013
Debt and Borrowing Arrangements Disclosure [Abstract]	'
DEBT AND BORROWING ARRANGEMENTS	'
	DEBT AND BORROWING ARRANGEMENTS
	Short-Term Borrowings
	Loans and notes payable consist primarily of commercial paper issued in the United States. As of December 31, 2013 and 2012, we had $16,853 million and $16,204 million, respectively, in outstanding commercial paper borrowings. Our weighted-average interest rates for commercial paper outstanding were approximately 0.2 percent and 0.3 percent per year as of December 31, 2013 and 2012, respectively.
	In addition, we had $7,413 million in lines of credit and other short-term credit facilities as of December 31, 2013. The Company's total lines of credit included $48 million that was outstanding and primarily related to our international operations.
	Included in the credit facilities discussed above, the Company had $6,410 million in lines of credit for general corporate purposes. These backup lines of credit expire at various times from 2014 through 2018. There were no borrowings under these backup lines of credit during 2013. These credit facilities are subject to normal banking terms and conditions. Some of the financial arrangements require compensating balances, none of which is presently significant to our Company.
	Long-Term Debt
	During 2013, the Company issued $7,500 million of long-term debt. The general terms of the notes issued are as follows:

	•	$500 million total principal amount of notes due March 5, 2015, at a variable interest rate equal to the three-month London Interbank Offered Rate ("LIBOR") minus 0.02 percent;

	•	$500 million total principal amount of notes due November 1, 2016, at a variable interest rate equal to the three-month LIBOR plus 0.10 percent;

	•	$500 million total principal amount of notes due November 1, 2016, at a fixed interest rate of 0.75 percent;

	•	$1,250 million total principal amount of notes due April 1, 2018, at a fixed interest rate of 1.15 percent;

	•	$1,250 million total principal amount of notes due November 1, 2018, at a fixed interest rate of 1.65 percent;

	•	$1,250 million total principal amount of notes due November 1, 2020, at a fixed interest rate of 2.45 percent;

	•	$750 million total principal amount of notes due April 1, 2023, at a fixed interest rate of 2.50 percent; and

	•	$1,500 million total principal amount of notes due November 1, 2023, at a fixed interest rate of 3.20 percent.
	During 2013, the Company retired $1,250 million of debt upon maturity. The Company also extinguished $2,154 million of long-term debt prior to maturity, incurring associated extinguishment charges of $50 million. The general terms of the notes that were extinguished were:

	•	$225 million total principal amount of notes due August 15, 2013, at a fixed interest rate of 5.0 percent;

	•	$675 million total principal amount of notes due March 3, 2014, at a fixed interest rate of 7.375 percent;

	•	$900 million total principal amount of notes due March 15, 2014, at a fixed interest rate of 3.625 percent; and

	•	$354 million total principal amount of notes due March 1, 2015, at a fixed interest rate of 4.25 percent.
	During 2012, the Company retired $1,250 million of long-term notes upon maturity and issued $2,750 million of long-term debt. The general terms of the notes issued are as follows:

	•	$1,000 million total principal amount of notes due March 14, 2014, at a variable interest rate equal to the three-month LIBOR minus 0.05 percent;

	•	$1,000 million total principal amount of notes due March 13, 2015, at a fixed interest rate of 0.75 percent; and

	•	$750 million total principal amount of notes due March 14, 2018, at a fixed interest rate of 1.65 percent.
	During 2011, the Company issued $2,979 million of long-term debt. We used $979 million of this debt and paid a premium of $208 million to exchange $1,022 million of existing long-term debt that was assumed in connection with our acquisition of CCE's former North America business. The remaining cash from the issuance was used to reduce the Company's outstanding commercial paper balance and exchange a certain amount of short-term debt.
	The general terms of the notes issued during 2011 are as follows:

	•	$1,655 million total principal amount of notes due September 1, 2016, at a fixed interest rate of 1.8 percent; and

	•	$1,324 million total principal amount of notes due September 1, 2021, at a fixed interest rate of 3.3 percent.
	During 2011, the Company extinguished $20 million of long-term debt prior to maturity. In addition, the Company repurchased long-term debt during 2011, which included $99 million in unamortized fair value adjustments related to purchase accounting for a prior year transaction and was settled throughout the year as follows:

	•	$674 million, which represented the carrying value of all of our outstanding British pound sterling notes, was repurchased; and

	•	$61 million in carrying value of long-term debt was repurchased.
	The Company recorded a net charge of $9 million in the line item interest expense in our consolidated statement of income during the year ended December 31, 2011. This net charge was due to the exchange, repurchase and/or extinguishment of long-term debt described above.
	The Company's long-term debt consisted of the following (in millions, except average rate data):


		December 31, 2013						December 31, 2012
		Amount			Average			Amount			Average
		Amount			Rate 1			Amount			Rate1
	U.S. dollar notes due 2014–2093	$	17,427		1.8	%		$	13,407		1.7	%
	U.S. dollar notes due 2014–2093	$	17,427		1.8	%		$	13,407		1.7	%
	U.S. dollar debentures due 2017–2098	2,191			3.9			2,207			3.7
	U.S. dollar debentures due 2017–2098	2,191			3.9			2,207			3.7
	U.S. dollar zero coupon notes due 20202	138			8.4			135			8.4
	U.S. dollar zero coupon notes due 20202	138			8.4			135			8.4
Other, due through 20983	370			4			291			4.4
Other, due through 20983	370			4			291			4.4
Fair value adjustment4	52			N/A			273			N/A
Fair value adjustment4	52			N/A			273			N/A
Total5,6	$	20,178		2.2	%		$	16,313		2.1	%
Total5,6	$	20,178		2.2	%		$	16,313		2.1	%
Less current portion	1,024						1,577
Less current portion	1,024						1,577
Long-term debt	$	19,154					$	14,736
Long-term debt	$	19,154					$	14,736

1	These rates represent the weighted-average effective interest rate on the balances outstanding as of year end, as adjusted for the effects of interest rate swap agreements as well as fair value adjustments, if applicable. Refer to Note 5 for a more detailed discussion on interest rate management.

2	This amount is shown net of unamortized discounts of $33 million and $36 million as of December 31, 2013 and 2012, respectively.

3	As of December 31, 2013, the amount shown includes $167 million of debt instruments that are due through 2022.

4	Refer to Note 5 for additional information about our fair value hedging strategy.

5	As of December 31, 2013 and 2012, the fair value of our long-term debt, including the current portion, was $20,352 million and $17,157 million, respectively. The fair value of our long-term debt is estimated based on quoted prices for those or similar instruments.

6	The above notes and debentures include various restrictions, none of which is presently significant to our Company.
The carrying value of the Company's long-term debt included fair value adjustments related to the debt assumed from CCE of $514 million and $617 million as of December 31, 2013 and 2012, respectively. These fair value adjustments are being amortized over the number of years remaining until the underlying debt matures. As of December 31, 2013, the weighted-average maturity of the assumed debt to which these fair value adjustments relate was approximately 19 years. The amortization of these fair value adjustments will be a reduction of interest expense in future periods, which will typically result in our interest expense being less than the actual interest paid to service the debt. Total interest paid was $498 million, $574 million and $573 million in 2013, 2012 and 2011, respectively.
Maturities of long-term debt for the five years succeeding December 31, 2013, are as follows (in millions):


	Maturities of
	Long-Term Debt
2014	$	1,024
2014	$	1,024
2015	2,573
2015	2,573
2016	2,681
2016	2,681
2017	1,394
2017	1,394
2018	3,298
2018	3,298

COMMITMENTS_AND_CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
COMMITMENTS AND CONTINGENCIES	'
	COMMITMENTS AND CONTINGENCIES
	Guarantees
	As of December 31, 2013, we were contingently liable for guarantees of indebtedness owed by third parties of $662 million, of which $288 million was related to VIEs. Refer to Note 1 for additional information related to the Company's maximum exposure to loss due to our involvement with VIEs. Our guarantees are primarily related to third-party customers, bottlers, vendors and container manufacturing operations and have arisen through the normal course of business. These guarantees have various terms, and none of these guarantees was individually significant. The amount represents the maximum potential future payments that we could be required to make under the guarantees; however, we do not consider it probable that we will be required to satisfy these guarantees.
	We believe our exposure to concentrations of credit risk is limited due to the diverse geographic areas covered by our operations.
	Legal Contingencies
	The Company is involved in various legal proceedings. We establish reserves for specific legal proceedings when we determine that the likelihood of an unfavorable outcome is probable and the amount of loss can be reasonably estimated. Management has also identified certain other legal matters where we believe an unfavorable outcome is reasonably possible and/or for which no estimate of possible losses can be made. Management believes that the total liabilities to the Company that may arise as a result of currently pending legal proceedings will not have a material adverse effect on the Company taken as a whole.
	During the period from 1970 to 1981, our Company owned Aqua-Chem, Inc., now known as Cleaver-Brooks, Inc. ("Aqua-Chem"). During that time, the Company purchased over $400 million of insurance coverage, which also insures Aqua-Chem for some of its prior and future costs for certain product liability and other claims. A division of Aqua-Chem manufactured certain boilers that contained gaskets that Aqua-Chem purchased from outside suppliers. Several years after our Company sold this entity, Aqua-Chem received its first lawsuit relating to asbestos, a component of some of the gaskets. Aqua-Chem was first named as a defendant in asbestos lawsuits in or around 1985 and currently has approximately 40,000 active claims pending against it. In September 2002, Aqua-Chem notified our Company that it believed we were obligated for certain costs and expenses associated with its asbestos litigations. Aqua-Chem demanded that our Company reimburse it for approximately $10 million for out-of-pocket litigation-related expenses. Aqua-Chem also demanded that the Company acknowledge a continuing obligation to Aqua-Chem for any future liabilities and expenses that are excluded from coverage under the applicable insurance or for which there is no insurance. Our Company disputes Aqua-Chem's claims, and we believe we have no obligation to Aqua-Chem for any of its past, present or future liabilities, costs or expenses. Furthermore, we believe we have substantial legal and factual defenses to Aqua-Chem's claims. The parties entered into litigation in Georgia to resolve this dispute, which was stayed by agreement of the parties pending the outcome of litigation filed in Wisconsin by certain insurers of Aqua-Chem. In that case, five plaintiff insurance companies filed a declaratory judgment action against Aqua-Chem, the Company and 16 defendant insurance companies seeking a determination of the parties' rights and liabilities under policies issued by the insurers and reimbursement for amounts paid by plaintiffs in excess of their obligations. During the course of the Wisconsin insurance coverage litigation, Aqua-Chem and the Company reached settlements with several of the insurers, including plaintiffs, who have or will pay funds into an escrow account for payment of costs arising from the asbestos claims against Aqua-Chem. On July 24, 2007, the Wisconsin trial court entered a final declaratory judgment regarding the rights and obligations of the parties under the insurance policies issued by the remaining defendant insurers, which judgment was not appealed. The judgment directs, among other things, that each insurer whose policy is triggered is jointly and severally liable for 100 percent of Aqua-Chem's losses up to policy limits. The court's judgment concluded the Wisconsin insurance coverage litigation. The Georgia litigation remains subject to the stay agreement. The Company and Aqua-Chem continued to negotiate with various insurers that were defendants in the Wisconsin insurance coverage litigation over those insurers' obligations to defend and indemnify Aqua-Chem for the asbestos-related claims. The Company anticipated that a final settlement with three of those insurers (the “Chartis insurers”) would be finalized in May 2011, but such insurers repudiated their settlement commitments and, as a result, Aqua-Chem and the Company filed suit against them in Wisconsin state court to enforce the coverage-in-place settlement or, in the alternative, to obtain a declaratory judgment validating Aqua-Chem and the Company's interpretation of the court's judgment in the Wisconsin insurance coverage litigation. In February 2012, the parties filed and argued a number of cross-motions for summary judgment related to the issues of the enforceability of the settlement agreement and the exhaustion of policies underlying those of the Chartis insurers. The court granted defendants' motions for summary judgment that the 2011 Settlement Agreement and 2010 Term Sheet were not binding contracts, but denied their similar motions related to plaintiffs' claims for promissory and/or equitable estoppel. On or about May 15, 2012, the parties entered into a mutually agreeable settlement/stipulation resolving two major issues: exhaustion of underlying coverage and control of defense. On or about January 10, 2013, the parties reached a settlement of the estoppel claims and all of the remaining coverage issues, with the exception of one disputed issue relating to the scope of the Chartis insurers' defense obligations in two policy years. The trial court granted summary judgment in favor of the Company and Aqua-Chem on that one open issue and entered a final appealable judgment to that effect following the parties' settlement. On January 23, 2013, the Chartis insurers filed a notice of appeal of the trial court's summary judgment ruling. On October 29, 2013, the Wisconsin Court of Appeals affirmed the grant of summary judgment in favor of the Company and Aqua-Chem. On November 27, 2013, the Chartis insurers filed a petition for review in the Supreme Court of Wisconsin, and on December 11, 2013, the Company filed its opposition to that petition. Whatever the outcome of the Chartis insurers’ appeal to the Wisconsin Supreme Court, the Chartis insurers will remain subject to the court’s judgment in the Wisconsin insurance coverage litigation.
	The Company is unable to estimate at this time the amount or range of reasonably possible loss it may ultimately incur as a result of asbestos-related claims against Aqua-Chem. The Company believes that assuming (1) the defense and indemnity costs for the asbestos-related claims against Aqua-Chem in the future are in the same range as during the past five years, and (2) the various insurers that cover the asbestos-related claims against Aqua-Chem remain solvent, regardless of the outcome of the coverage-in-place settlement litigation but taking into account the issues resolved to date, insurance coverage for substantially all defense and indemnity costs would be available for the next 10 to 15 years.
	Indemnifications
	At the time we acquire or divest our interest in an entity, we sometimes agree to indemnify the seller or buyer for specific contingent liabilities. Management believes that any liability to the Company that may arise as a result of any such indemnification agreements will not have a material adverse effect on the Company taken as a whole.
	Tax Audits
	The Company is involved in various tax matters, with respect to some of which the outcome is uncertain. These audits may result in the assessment of additional taxes that are subsequently resolved with authorities or potentially through the courts. Refer to Note 14.
	Risk Management Programs
	The Company has numerous global insurance programs in place to help protect the Company from the risk of loss. In general, we are self-insured for large portions of many different types of claims; however, we do use commercial insurance above our self-insured retentions to reduce the Company's risk of catastrophic loss. Our reserves for the Company's self-insured losses are estimated through actuarial procedures of the insurance industry and by using industry assumptions, adjusted for our specific expectations based on our claim history. The Company's self-insurance reserves totaled $537 million and $508 million as of December 31, 2013 and 2012, respectively.
	Workforce (Unaudited)
	We refer to our employees as "associates." As of December 31, 2013, our Company had approximately 130,600 associates, of which approximately 66,800 associates were located in the United States. Our Company, through its divisions and subsidiaries, is a party to numerous collective bargaining agreements. As of December 31, 2013, approximately 18,000 associates, excluding seasonal hires, in North America were covered by collective bargaining agreements. These agreements typically have terms of three to five years. We currently expect that we will be able to renegotiate such agreements on satisfactory terms when they expire. The Company believes that its relations with its associates are generally satisfactory.
	Operating Leases
	The following table summarizes our minimum lease payments under noncancelable operating leases with initial or remaining lease terms in excess of one year as of December 31, 2013 (in millions):


	Year Ended December 31,	Operating Lease Payments

	2014	$	252

	2015	180

	2016	142

	2017	107

	2018	88

	Thereafter	276

	Total minimum operating lease payments1	$	1,045


	1	Income associated with sublease arrangements is not significant.

STOCK_COMPENSATION_PLANS

STOCK COMPENSATION PLANS	12 Months Ended
STOCK COMPENSATION PLANS	Dec. 31, 2013
STOCK COMPENSATION PLANS [Abstract]	'
STOCK COMPENSATION PLANS	'
	STOCK COMPENSATION PLANS
	Our Company grants stock options and restricted stock awards to certain employees of the Company. Total stock-based compensation expense was $227 million, $259 million and $354 million in 2013, 2012 and 2011, respectively, and was included as a component of selling, general and administrative expenses in our consolidated statements of income. The total income tax benefit recognized in our consolidated statements of income related to stock-based compensation arrangements was $62 million, $72 million and $99 million in 2013, 2012 and 2011, respectively.
	As of December 31, 2013, we had $416 million of total unrecognized compensation cost related to nonvested share-based compensation arrangements granted under our plans. This cost is expected to be recognized over a weighted-average period of 1.8 years as stock-based compensation expense. This expected cost does not include the impact of any future stock-based compensation awards.
	Stock Option Plans
	The fair value of our stock option grants is amortized over the vesting period, generally four years. The fair value of each option award is estimated on the grant date using a Black-Scholes-Merton option-pricing model. The weighted-average fair value of options granted during the past three years and the weighted-average assumptions used in the Black-Scholes-Merton option-pricing model for such grants were as follows:


		2013				2012				2011
		2013				2012				2011
	Fair value of options at grant date	$	3.73			$	3.8			$	4.64
	Fair value of options at grant date	$	3.73			$	3.8			$	4.64
	Dividend yield1	2.8		%		2.7		%		2.7		%
	Expected volatility2	17		%		18		%		19		%
	Risk-free interest rate3	0.9		%		1		%		2.3		%
	Expected term of the option4	5 years				5 years				5 years
	Expected term of the option4	5 years				5 years				5 years

	1	The dividend yield is the calculated yield on the Company's stock at the time of the grant.

	2	Expected volatility is based on implied volatilities from traded options on the Company's stock, historical volatility of the Company's stock and other factors.

	3	The risk-free interest rate for the period matching the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

	4	The expected term of the option represents the period of time that options granted are expected to be outstanding and is derived by analyzing historical exercise behavior.
	Generally, stock options granted from 1999 through July 2003 expire 15 years from the date of grant and stock options granted in December 2003 and thereafter expire 10 years from the date of grant. The shares of common stock to be issued, transferred and/or sold under the stock option plans are made available from authorized and unissued Company common stock or from the Company's treasury shares. In 2007, the Company began issuing common stock under these plans from the Company's treasury shares.
	The Company had the following active stock option plans as of December 31, 2013:

	•	The Coca-Cola Company 1999 Stock Option Plan (the "1999 Option Plan") was approved by shareowners in April 1999. Under the 1999 Option Plan, a maximum of 240 million shares of our common stock was approved to be issued or transferred, through the grant of stock options, to certain officers and employees.

	•	The Coca-Cola Company 2002 Stock Option Plan (the "2002 Option Plan") was approved by shareowners in April 2002. An amendment to the 2002 Option Plan which permitted the issuance of stock appreciation rights was approved by shareowners in April 2003. Under the 2002 Option Plan, a maximum of 240 million shares of our common stock was approved to be issued or transferred, through the grant of stock options or stock appreciation rights, to certain officers and employees. No stock appreciation rights have been issued under the 2002 Option Plan as of December 31, 2013.

	•	The Coca-Cola Company 2008 Stock Option Plan (the "2008 Option Plan") was approved by shareowners in April 2008. Under the 2008 Option Plan, a maximum of 280 million shares of our common stock was approved to be issued or transferred to certain officers and employees pursuant to stock options granted under the 2008 Option Plan.

	•	As a result of our acquisition of CCE's former North America business, the Company assumed certain stock-based compensation plans previously sponsored by CCE. Shares from these plans remain available for future grant to current employees who were employees of CCE or its subsidiaries prior to the acquisition or who are hired by the Company or its subsidiaries following the acquisition. The assumed Coca-Cola Enterprises Inc. 2001 Stock Option Plan, Coca-Cola Enterprises Inc. 2004 Stock Award Plan and Coca-Cola Enterprises Inc. 2007 Incentive Award Plan previously sponsored by CCE have approximately 29 million shares available for grant after conversion of CCE common stock into our common stock. The Company has not granted any equity awards from the assumed plans.
	As of December 31, 2013, there were 84 million shares available to be granted under the 1999 Option Plan, 2002 Option Plan and 2008 Option Plan. Options to purchase common stock under all of these plans have generally been granted at the fair market value of the Company's stock at the date of grant.
	Stock option activity for all stock option plans for the year ended December 31, 2013, was as follows:


		Shares			Weighted-Average				Weighted-Average		Aggregate
		(In millions)			Exercise Price				Remaining		Intrinsic Value
									Contractual Life		(In millions)
	Outstanding on January 1, 2013	309			$	27.27
	Outstanding on January 1, 2013	309			$	27.27
	Granted	56			37.68
	Granted	56			37.68
	Exercised	(53	)		25.02
	Exercised	(53	)		25.02
	Forfeited/expired	(7	)		34.34
	Forfeited/expired	(7	)		34.34
	Outstanding on December 31, 20131	305			$	29.42			5.82 years		$	3,636
	Outstanding on December 31, 20131	305			$	29.42			5.82 years		$	3,636
	Expected to vest at December 31, 2013	302			$	29.33			5.78 years		$	3,614
	Expected to vest at December 31, 2013	302			$	29.33			5.78 years		$	3,614
	Exercisable on December 31, 2013	187			$	25.87			4.25 years		$	2,887
	Exercisable on December 31, 2013	187			$	25.87			4.25 years		$	2,887

	1	Includes 3 million stock option replacement awards in connection with our acquisition of CCE's former North America business in 2010. These options had a weighted-average exercise price of $18.02, and generally vest over 3 years and expire 10 years from the original date of grant.
	The total intrinsic value of the options exercised was $815 million, $780 million and $631 million in 2013, 2012 and 2011, respectively. The total shares exercised were 53 million, 61 million and 65 million in 2013, 2012 and 2011, respectively.
	Restricted Stock Award Plans
	Under The Coca-Cola Company 1989 Restricted Stock Award Plan and The Coca-Cola Company 1983 Restricted Stock Award Plan (the "Restricted Stock Award Plans"), 80 million and 48 million shares of restricted common stock, respectively, were originally available to be granted to certain officers and key employees of our Company. As of December 31, 2013, 25 million shares remain available for grant under the Restricted Stock Award Plans. The Company issues restricted stock to employees as a result of performance share unit awards, time-based awards and performance-based awards.
	For awards prior to January 1, 2008, under the 1983 Restricted Stock Award Plan, participants are reimbursed by our Company for income taxes imposed on the award, but not for taxes generated by the reimbursement payment. The 1983 Restricted Stock Award Plan has been amended to eliminate this tax reimbursement for awards after January 1, 2008. The shares are subject to certain transfer restrictions and may be forfeited if a participant leaves our Company for reasons other than retirement, disability or death, absent a change in control of our Company.
	Performance Share Unit Awards
	In 2003, the Company established a program to grant performance share units under The Coca-Cola Company 1989 Restricted Stock Award Plan to executives. In 2008, the Company expanded the program to award a mix of stock options and performance share units to eligible employees in addition to executives. The number of shares earned is determined at the end of each performance period, generally three years, based on the actual performance criteria predetermined by the Board of Directors at the time of grant. If the performance criteria are met, the award results in a grant of restricted stock or restricted stock units, which are then generally subject to a holding period in order for the restricted stock to be released. For performance share units granted before 2008, this holding period is generally two years. For performance share units granted in 2008 and after, this holding period is generally one year. Restrictions on such stock generally lapse at the end of the holding period. Performance share units generally do not pay dividends or allow voting rights during the performance period. For awards granted prior to 2011, participants generally receive dividends or dividend equivalents once the performance criteria have been certified and the restricted stock or restricted stock units have been issued. For awards granted in 2011 and later, participants generally receive dividends or dividend equivalents once the shares have been released. Accordingly, the fair value of the performance share units is the quoted market value of the Company stock on the grant date less the present value of the expected dividends not received during the relevant period. In the period it becomes probable that the minimum performance criteria specified in the plan will be achieved, we recognize expense for the proportionate share of the total fair value of the performance share units related to the vesting period that has already lapsed. The remaining cost of the grant is expensed on a straight-line basis over the balance of the vesting period. In the event the Company determines it is no longer probable that we will achieve the minimum performance criteria specified in the plan, we reverse all of the previously recognized compensation expense in the period such a determination is made.
Performance share units under The Coca-Cola Company 1989 Restricted Stock Award Plan require achievement of certain financial measures, primarily compound annual growth in earnings per share or economic profit. These financial measures are adjusted for certain items approved and certified by the Audit Committee of the Board of Directors. The purpose of these adjustments is to ensure a consistent year to year comparison of the specific performance criteria. Economic profit is our net operating profit after tax less the cost of the capital used in our business. In the event the financial results equal the predefined target, the Company will grant the number of restricted shares equal to the target award in the underlying performance share unit agreements. In the event the financial results exceed the predefined target, additional shares up to the maximum award may be granted. In the event the financial results fall below the predefined target, a reduced number of shares may be granted. If the financial results fall below the threshold award performance level, no shares will be granted. Performance share units are generally settled in stock, except for certain circumstances such as death or disability, where former employees or their beneficiaries are provided a cash equivalent payment. As of December 31, 2013, performance share units of 5,365,000, 6,487,000 and 6,122,000 were outstanding for the 2011–2013, 2012–2014 and 2013–2015 performance periods, respectively, based on the target award amounts in the performance share unit agreements.
The following table summarizes information about performance share units based on the target award amounts in the performance share unit agreements:


	Share Units			Weighted-Average
	(In thousands)			Grant Date
				Fair Value
Outstanding on January 1, 2013	17,584			$	28.01
Outstanding on January 1, 2013	17,584			$	28.01
Granted	6,425			32.67
Granted	6,425			32.67
Conversions of restricted stock units1	(5,220	)		25.17
Conversions of restricted stock units1	(5,220	)		25.17
Paid in cash equivalent	(55	)		32.25
Paid in cash equivalent	(55	)		32.25
Canceled/forfeited	(760	)		30.33
Canceled/forfeited	(760	)		30.33
Outstanding on December 31, 20132	17,974			$	30.41
Outstanding on December 31, 20132	17,974			$	30.41

1	Represents the target amount of performance share units converted to restricted stock units based on the financial results for the 2010-2012 performance period. The vesting of restricted stock units is subject to the terms of the performance share unit agreements.

2	The outstanding performance share units as of December 31, 2013, at the threshold award and maximum award levels were 9.0 million and 27.0 million, respectively.
The weighted-average grant date fair value of performance share units granted was $32.67 in 2013, $29.95 in 2012 and $25.58 in 2011. The Company converted performance share units of 54,999 in 2013, 16,267 in 2012 and 19,462 in 2011 to cash equivalent payments of $1.8 million, $0.6 million and $0.7 million, respectively, to former employees who were ineligible for restricted stock grants due to certain events such as death or disability.
The following table summarizes information about the conversions of performance share units to restricted stock and restricted stock units:


	Share Units			Weighted-Average
	(In thousands)			Grant Date
				Fair Value1
Nonvested on January 1, 20132	98			$	26.54
Nonvested on January 1, 20132	98			$	26.54
Conversions of restricted stock units3	7,830			25.17
Conversions of restricted stock units3	7,830			25.17
Vested and released	(406	)		25.52
Vested and released	(406	)		25.52
Canceled/forfeited	(508	)		25.17
Canceled/forfeited	(508	)		25.17
Nonvested on December 31, 20132	7,014			$	25.17
Nonvested on December 31, 20132	7,014			$	25.17

1	The weighted-average grant date fair value is based on the fair values of the performance share units granted.

2	The nonvested shares as of January 1, 2013, and December 31, 2013, are presented at the performance share units' certified award level.

3	The converted shares are presented at the performance share units' certified award level of 150 percent.
The total intrinsic value of restricted shares that were vested and released was $16 million, $148 million and $72 million in 2013, 2012 and 2011, respectively. The total restricted share units vested and released in 2013 were 405,963 at the certified award level. In 2012 and 2011, the total restricted share units vested and released were 4,301,732 and 2,084,912, respectively.
Replacement performance share unit awards issued by the Company in connection with our acquisition of CCE's former North America business are not included in the tables or discussions above and were originally granted under the Coca-Cola Enterprises Inc. 2007 Incentive Award Plan. These awards were converted into equivalent share units of the Company's common stock on the acquisition date and entitle the participant to dividend equivalents (which vest, in some cases, only if the restricted share units vest), but not the right to vote. Accordingly, the fair value of these units was the quoted value of the Company's stock at the grant date.
On the acquisition date, the Company issued 3.3 million replacement performance share unit awards at target with a weighted-average grant date price of $29.56 per share that were either projected to pay out at, or previously certified at a payout rate of 200 percent. In accordance with accounting principles generally accepted in the United States, the portion of the fair value of the replacement awards related to services provided prior to the acquisition was included in the total purchase price. The portion of the fair value associated with future service was recognized as expense in the fourth quarter of 2010. As of January 1, 2011, there were 3.8 million shares subject to release under these plans based on the 200 percent payout. During 2011, the Company released 3.1 million shares at the 200 percent payout with an intrinsic value of $98 million. During 2012, the Company released 0.6 million shares at the 200 percent payout with an intrinsic value of $22 million. During 2013, the Company released 0.1 million shares at the 200 percent payout with an intrinsic value of $5 million. As of December 31, 2013, the Company had no remaining outstanding replacement performance share units.
Time-Based and Performance-Based Restricted Stock and Restricted Stock Unit Awards
The Coca-Cola Company 1989 Restricted Stock Award Plan allows for the grant of time-based and performance-based restricted stock and restricted stock units. The performance-based restricted awards are released only upon the achievement of specific measurable performance criteria. These awards pay dividends during the performance period. The majority of awards have specific performance targets for achievement. If the performance targets are not met, the awards will be canceled. In the period it becomes probable that the performance criteria will be achieved, we recognize expense for the proportionate share of the total fair value of the grant related to the vesting period that has already lapsed. The remaining cost of the grant is expensed on a straight-line basis over the balance of the vesting period.
For time-based and performance-based restricted stock awards, participants are entitled to vote and receive dividends on the restricted shares. The Company also awards time-based and performance-based restricted stock units for which participants may receive payments of dividend equivalents but are not entitled to vote. As of December 31, 2013, the Company had outstanding nonvested time-based and performance-based restricted stock awards, including restricted stock units, of 700,000 and 81,000, respectively. Time-based and performance-based restricted stock awards were not significant to our consolidated financial statements.
In 2010, the Company issued time-based restricted stock replacement awards, including restricted stock units, in connection with our acquisition of CCE's former North America business. These awards were converted into equivalent shares of the Company's common stock. These restricted share awards entitle the participant to dividend equivalents (which vest, in some cases, only if the restricted share unit vests), but not the right to vote. As of December 31, 2013, the Company had 59,000 outstanding nonvested time-based restricted stock replacement awards, including restricted stock units. These time-based restricted awards were not significant to our consolidated financial statements.

PENSION_AND_OTHER_POSTRETIREME

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	Dec. 31, 2013
Pension and Other Postretirement Benefit Plans [Abstract]	'
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS	'
	PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS
	Our Company sponsors and/or contributes to pension and postretirement health care and life insurance benefit plans covering substantially all U.S. employees. We also sponsor nonqualified, unfunded defined benefit pension plans for certain associates. In addition, our Company and its subsidiaries have various pension plans and other forms of postretirement arrangements outside the United States.
	We refer to the funded defined benefit pension plan in the United States that is not associated with collective bargaining organizations as the "primary U.S. plan." As of December 31, 2013, the primary U.S. plan represented 57 percent and 63 percent of the Company's consolidated projected benefit obligation and pension assets, respectively.
	In December 2013, the Company modified The Coca-Cola Company Retiree Health Plan. Effective January 1, 2015, the current prescription drug plan will be replaced by a Company-sponsored Medicare Part D Plan. The change reduced the accumulated postretirement benefit obligation of the plan by approximately $71 million. The Coca-Cola Refreshments Welfare Plan for Retirees will not be impacted by this change because of variations in the design of the plan.
	Obligations and Funded Status
	The following table sets forth the changes in benefit obligations and the fair value of plan assets for our benefit plans (in millions):


		Pension Benefits								Other Benefits
		2013				2012				2013				2012
		2013				2012				2013				2012
	Benefit obligation at beginning of year1	$	9,693			$	8,255			$	1,104			$	953
	Benefit obligation at beginning of year1	$	9,693			$	8,255			$	1,104			$	953
	Service cost	280				291				36				34
	Service cost	280				291				36				34
	Interest cost	378				388				42				43
	Interest cost	378				388				42				43
	Foreign currency exchange rate changes	(69		)		(7		)		(2		)		3
	Foreign currency exchange rate changes	(69		)		(7		)		(2		)		3
	Amendments	(1		)		(3		)		(73		)		(2		)
	Actuarial loss (gain)	(899		)		1,259				(91		)		115
	Actuarial loss (gain)	(899		)		1,259				(91		)		115
	Benefits paid2	(538		)		(420		)		(77		)		(53		)
	Settlements	(9		)		(35		)		—				—
	Settlements	(9		)		(35		)		—				—
	Curtailments	—				6				—				—
	Curtailments	—				6				—				—
	Special termination benefits	2				1				—				—
	Special termination benefits	2				1				—				—
	Other3	8				(42		)		7				11
	Other3	8				(42		)		7				11
	Benefit obligation at end of year1	$	8,845			$	9,693			$	946			$	1,104
	Benefit obligation at end of year1	$	8,845			$	9,693			$	946			$	1,104
	Fair value of plan assets at beginning of year	$	7,584			$	6,171			$	202			$	185
	Fair value of plan assets at beginning of year	$	7,584			$	6,171			$	202			$	185
	Actual return on plan assets	1,043				822				40				16
	Actual return on plan assets	1,043				822				40				16
	Employer contributions	639				1,056				—				—
	Employer contributions	639				1,056				—				—
	Foreign currency exchange rate changes	(43		)		(17		)		—				—
	Foreign currency exchange rate changes	(43		)		(17		)		—				—
	Benefits paid	(474		)		(366		)		(2		)		(2		)
	Settlements	(5		)		(34		)		—				—
	Settlements	(5		)		(34		)		—				—
	Other3	2				(48		)		3				3
	Other3	2				(48		)		3				3
	Fair value of plan assets at end of year	$	8,746			$	7,584			$	243			$	202
	Fair value of plan assets at end of year	$	8,746			$	7,584			$	243			$	202
	Net liability recognized	$	(99	)		$	(2,109	)		$	(703	)		$	(902	)

	1	For pension benefit plans, the benefit obligation is the projected benefit obligation. For other benefit plans, the benefit obligation is the accumulated postretirement benefit obligation. The accumulated benefit obligation for our pension plans was $8,523 million and $9,345 million as of December 31, 2013 and 2012, respectively.

	2	Benefits paid to pension plan participants during 2013 and 2012 included $64 million and $54 million, respectively, in payments related to unfunded pension plans that were paid from Company assets. Benefits paid to participants of other benefit plans during 2013 and 2012 included $75 million and $51 million, respectively, that were paid from Company assets.

	3	In 2012, primarily relates to the transfer of assets and liabilities associated with the Company's consolidated Philippine bottling operations to assets held for sale and liabilities held for sale as of December 31, 2012. Refer to Note 2 for additional information.
	Pension and other benefit amounts recognized in our consolidated balance sheets are as follows (in millions):


		Pension Benefits								Other Benefits
	December 31,	2013				2012				2013				2012
	December 31,	2013				2012				2013				2012
	Noncurrent asset	$	1,067			$	395			$	—			$	—
	Noncurrent asset	$	1,067			$	395			$	—			$	—
Current liability	(76		)		(73		)		(21		)		(21		)
Long-term liability	(1,090		)		(2,431		)		(682		)		(881		)
Net liability recognized	$	(99	)		$	(2,109	)		$	(703	)		$	(902	)
Certain of our pension plans have projected benefit obligations in excess of the fair value of plan assets. For these plans, the projected benefit obligations and the fair value of plan assets were as follows (in millions):


December 31,	2013				2012
December 31,	2013				2012
Projected benefit obligation	$	1,521			$	9,161
Projected benefit obligation	$	1,521			$	9,161
Fair value of plan assets	374				6,659
Fair value of plan assets	374				6,659
Certain of our pension plans have accumulated benefit obligations in excess of the fair value of plan assets. For these plans, the accumulated benefit obligations and the fair value of plan assets were as follows (in millions):


December 31,	2013				2012
December 31,	2013				2012
Accumulated benefit obligation	$	1,446			$	8,736
Accumulated benefit obligation	$	1,446			$	8,736
Fair value of plan assets	351				6,546
Fair value of plan assets	351				6,546
Pension Plan Assets
The following table presents total assets for our U.S. and non-U.S. pension plans (in millions):


	U.S. Plans								Non-U.S. Plans
December 31,	2013				2012				2013				2012
December 31,	2013				2012				2013				2012
Cash and cash equivalents	$	240			$	299			$	274			$	87
Cash and cash equivalents	$	240			$	299			$	274			$	87
Equity securities:
U.S.-based companies	1,422				1,844				280				37
U.S.-based companies	1,422				1,844				280				37
International-based companies	698				324				586				640
International-based companies	698				324				586				640
Fixed-income securities:
Government bonds	464				399				304				163
Government bonds	464				399				304				163
Corporate bonds and debt securities	1,369				856				137				126
Corporate bonds and debt securities	1,369				856				137				126
Mutual, pooled and commingled funds1	1,134				1,057				453				453
Mutual, pooled and commingled funds1	1,134				1,057				453				453
Hedge funds/limited partnerships	526				496				17				29
Hedge funds/limited partnerships	526				496				17				29
Real estate	245				248				6				9
Real estate	245				248				6				9
Other	245				26				346				491
Other	245				26				346				491
Total pension plan assets2	$	6,343			$	5,549			$	2,403			$	2,035
Total pension plan assets2	$	6,343			$	5,549			$	2,403			$	2,035

1	Mutual, pooled and commingled funds include investments in equity securities, fixed-income securities and combinations of both. There are a significant number of mutual, pooled and commingled funds from which investors can choose. The selection of the type of fund is dictated by the specific investment objectives and needs of a given plan. These objectives and needs vary greatly between plans.

2	Fair value disclosures related to our pension assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our pension assets.
Investment Strategy for U.S. Pension Plans
The Company utilizes the services of investment managers to actively manage the pension assets of our U.S. plans. We have established asset allocation targets and investment guidelines with each investment manager. Our asset allocation targets promote optimal expected return and volatility characteristics given the long-term time horizon for fulfilling the obligations of the plan. Selection of the targeted asset allocation for U.S. plan assets was based upon a review of the expected return and risk characteristics of each asset class, as well as the correlation of returns among asset classes. During 2012, the Company revised the asset allocation targets and restructured the investment manager composition to further diversify investment risk and reduce volatility while maintaining long-term return objectives. Our revised target allocation is a mix of 42 percent equity investments, 30 percent fixed-income investments and 28 percent alternative investments. We believe this target allocation will enable us to achieve the following long-term investment objectives:

-1	optimize the long-term return on plan assets at an acceptable level of risk;

-2	maintain a broad diversification across asset classes and among investment managers; and

-3	maintain careful control of the risk level within each asset class.
The guidelines that have been established with each investment manager provide parameters within which the investment managers agree to operate, including criteria that determine eligible and ineligible securities, diversification requirements and credit quality standards, where applicable. Unless exceptions have been approved, investment managers are prohibited from buying or selling commodities, futures or option contracts, as well as from short selling of securities. Additionally, investment managers agree to obtain written approval for deviations from stated investment style or guidelines. As of December 31, 2013, no investment manager was responsible for more than 10 percent of total U.S. plan assets.
Our target allocation of 42 percent equity investments is composed of 60 percent global equities, 16 percent emerging market equities and 24 percent domestic small- and mid-cap equities. Optimal returns through our investments in global equities are achieved through security selection as well as country and sector diversification. Investments in the common stock of our Company accounted for approximately 5 percent of our global equities allocation and approximately 2 percent of total U.S. plan assets. Our investments in global equities are intended to provide diversified exposure to both U.S. and non-U.S. equity markets. Our investments in both emerging market equities and domestic small- and mid-cap equities are expected to experience larger swings in their market value on a periodic basis. Our investments in these asset classes are selected based on capital appreciation potential.
Our target allocation of 30 percent fixed-income investments is composed of 33 percent long-duration bonds and 67 percent with multi-strategy alternative credit managers. Long-duration bonds provide a stable rate of return through investments in high-quality publicly traded debt securities. Our investments in long-duration bonds are diversified in order to mitigate duration and credit exposure. Multi-strategy alternative credit managers invest in a combination of high-yield bonds, bank loans, structured credit and emerging market debt. These investments are in lower-rated and non-rated debt securities, which generally produce higher returns compared to long-duration bonds and also help to diversify our overall fixed-income portfolio.
In addition to equity investments and fixed-income investments, we have a target allocation of 28 percent in alternative investments. These alternative investments include hedge funds, reinsurance, private equity limited partnerships, leveraged buyout funds, international venture capital partnerships and real estate. The objective of investing in alternative investments is to provide a higher rate of return than that available from publicly traded equity securities. These investments are inherently illiquid and require a long-term perspective in evaluating investment performance.
Investment Strategy for Non-U.S. Pension Plans
As of December 31, 2013, the long-term target allocation for 41 percent of our international subsidiaries' plan assets, primarily certain of our European plans, is 62 percent equity securities and 38 percent fixed-income securities. The actual allocation for the remaining 59 percent of the Company's international subsidiaries' plan assets consisted of 31 percent mutual, pooled and commingled funds; 21 percent equity securities; 7 percent fixed-income securities; and 41 percent other investments. The investment strategies of our international subsidiaries differ greatly, and in some instances are influenced by local law. None of our pension plans outside the United States is individually significant for separate disclosure.
Other Postretirement Benefit Plan Assets
Plan assets associated with other postretirement benefits primarily represents funding of one of the U.S. postretirement benefit plans through a U.S. Voluntary Employee Beneficiary Association ("VEBA"), a tax-qualified trust. The VEBA assets remain segregated from the U.S. pension master trust and are primarily invested in liquid assets due to the level of expected future benefit payments.
The following table presents total assets for our other postretirement benefit plans (in millions):


December 31,	2013				2012
December 31,	2013				2012
Cash and cash equivalents	$	10			$	13
Cash and cash equivalents	$	10			$	13
Equity securities:
U.S.-based companies	112				81
U.S.-based companies	112				81
International-based companies	8				4
International-based companies	8				4
Fixed-income securities:
Government bonds	79				78
Government bonds	79				78
Corporate bonds and debt securities	9				5
Corporate bonds and debt securities	9				5
Mutual, pooled and commingled funds	18				16
Mutual, pooled and commingled funds	18				16
Hedge funds/limited partnerships	3				3
Hedge funds/limited partnerships	3				3
Real estate	2				2
Real estate	2				2
Other	2				—
Other	2				—
Total other postretirement benefit plan assets1	$	243			$	202
Total other postretirement benefit plan assets1	$	243			$	202

1	Fair value disclosures related to our other postretirement benefit plan assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our other postretirement benefit plan assets.
Components of Net Periodic Benefit Cost
Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions):


	Pension Benefits												Other Benefits
Year Ended December 31,	2013				2012				2011				2013				2012			2011
Year Ended December 31,	2013				2012				2011				2013				2012			2011
Service cost	$	280			$	291			$	249			$	36			$	34		$	32
Service cost	$	280			$	291			$	249			$	36			$	34		$	32
Interest cost	378				388				391				42				43			45
Interest cost	378				388				391				42				43			45
Expected return on plan assets1	(659		)		(573		)		(508		)		(9		)		(8		)	(8		)
Amortization of prior service cost (credit)	(2		)		(2		)		5				(10		)		(52		)	(61		)
Amortization of prior service cost (credit)	(2		)		(2		)		5				(10		)		(52		)	(61		)
Amortization of actuarial loss	197				137				82				13				6			2
Amortization of actuarial loss	197				137				82				13				6			2
Net periodic benefit cost	$	194			$	241			$	219			$	72			$	23		$	10
Net periodic benefit cost	$	194			$	241			$	219			$	72			$	23		$	10
Settlement charge	1				3				3				—				—			—
Settlement charge	1				3				3				—				—			—
Curtailment charge	—				6				—				—				—			—
Curtailment charge	—				6				—				—				—			—
Special termination benefits2	2				1				8				—				—			3
Special termination benefits2	2				1				8				—				—			3
Total cost recognized in the statements of income	$	197			$	251			$	230			$	72			$	23		$	13
Total cost recognized in the statements of income	$	197			$	251			$	230			$	72			$	23		$	13

1	The Company has elected to use the actual fair value of plan assets as the market-related value of assets in the determination of the expected return on plan assets.

2	The special termination benefits primarily relate to the Company's productivity, restructuring and integration initiatives. Refer to Note 18 for additional information related to our productivity, restructuring and integration initiatives.
The following table sets forth the changes in AOCI for our benefit plans (in millions, pretax):


	Pension Benefits								Other Benefits
	2013				2012				2013				2012
	2013				2012				2013				2012
Beginning balance in AOCI	$	(3,032	)		$	(2,169	)		$	(186	)		$	(34	)
Recognized prior service cost (credit)	(2		)		(2		)		(10		)		(52		)
Recognized net actuarial loss (gain)	198				140				13				6
Recognized net actuarial loss (gain)	198				140				13				6
Prior service credit (cost) arising in current year	1				3				73				2
Prior service credit (cost) arising in current year	1				3				73				2
Net actuarial (loss) gain arising in current year	1,283				(1,009		)		122				(107		)
Net actuarial (loss) gain arising in current year	1,283				(1,009		)		122				(107		)
Foreign currency translation gain (loss)	15				5				1				(1		)
Foreign currency translation gain (loss)	15				5				1				(1		)
Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
The following table sets forth amounts in AOCI for our benefit plans (in millions, pretax):


	Pension Benefits								Other Benefits
December 31,	2013				2012				2013				2012
December 31,	2013				2012				2013				2012
Prior service credit (cost)	$	12			$	16			$	86			$	23
Prior service credit (cost)	$	12			$	16			$	86			$	23
Net actuarial loss	(1,549		)		(3,048		)		(73		)		(209		)
Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13			$	(186	)
Amounts in AOCI expected to be recognized as components of net periodic pension cost in 2014 are as follows (in millions, pretax):


	Pension Benefits				Other Benefits
Amortization of prior service cost (credit)	$	(2	)		$	(17	)
Amortization of actuarial loss	76				2
Amortization of actuarial loss	76				2
	$	74			$	(15	)
	$	74			$	(15	)
Assumptions
Certain weighted-average assumptions used in computing the benefit obligations are as follows:


	Pension Benefits						Other Benefits
December 31,	2013			2012			2013			2012
December 31,	2013			2012			2013			2012
Discount rate	4.75	%		4	%		4.75	%		4	%
Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
Certain weighted-average assumptions used in computing net periodic benefit cost are as follows:


	Pension Benefits									Other Benefits
Year Ended December 31,	2013			2012			2011			2013			2012			2011
Year Ended December 31,	2013			2012			2011			2013			2012			2011
Discount rate	4	%		4.75	%		5.5	%		4	%		4.75	%		5.25	%
Rate of increase in compensation levels	3.5	%		3.25	%		4	%		N/A			N/A			N/A
Rate of increase in compensation levels	3.5	%		3.25	%		4	%		N/A			N/A			N/A
Expected long-term rate of return on plan assets	8.25	%		8.25	%		8.25	%		4.75	%		4.75	%		4.75	%
The expected long-term rate of return assumption for U.S. pension plan assets is based upon the target asset allocation and is determined using forward-looking assumptions in the context of historical returns and volatilities for each asset class, as well as correlations among asset classes. We evaluate the rate of return assumption on an annual basis. The expected long-term rate of return assumption used in computing 2013 net periodic pension cost for the U.S. plans was 8.5 percent. As of December 31, 2013, the 10-year annualized return on plan assets in the primary U.S. plan was 6.9 percent, the 15-year annualized return was 6.2 percent, and the annualized return since inception was 11.1 percent.

The assumed health care cost trend rates are as follows:


December 31,	2013			2012
December 31,	2013			2012
Health care cost trend rate assumed for next year	8	%		8	%
Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5	%		5	%
Year that the rate reaches the ultimate trend rate	2020			2019
Year that the rate reaches the ultimate trend rate	2020			2019
The Company's U.S. postretirement benefit plans are primarily defined dollar benefit plans that limit the effects of medical inflation because the plans have established dollar limits for determining our contributions. As a result, the effect of a 1 percentage point change in the assumed health care cost trend rate would not be significant to the Company.
The discount rate assumptions used to account for pension and other postretirement benefit plans reflect the rates at which the benefit obligations could be effectively settled. Rates for each of our U.S. plans at December 31, 2013, were determined using a cash flow matching technique whereby the rates of a yield curve, developed from high-quality debt securities, were applied to the benefit obligations to determine the appropriate discount rate. For our non-U.S. plans, we base the discount rate on comparable indices within each of the countries. The rate of compensation increase assumption is determined by the Company based upon annual reviews. We review external data and our own historical trends for health care costs to determine the health care cost trend rate assumptions.
Cash Flows
Our estimated future benefit payments for funded and unfunded plans are as follows (in millions):


Year Ended December 31,	2014				2015				2016				2017				2018			2019–2023
Year Ended December 31,	2014				2015				2016				2017				2018			2019–2023
Pension benefit payments	$	471			$	483			$	512			$	554			$	558		$	3,084
Pension benefit payments	$	471			$	483			$	512			$	554			$	558		$	3,084
Other benefit payments1	59				62				64				65				66			346
Other benefit payments1	59				62				64				65				66			346
Total estimated benefit payments	$	530			$	545			$	576			$	619			$	624		$	3,430
Total estimated benefit payments	$	530			$	545			$	576			$	619			$	624		$	3,430

1	The expected benefit payments for our other postretirement benefit plans are net of estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003. Federal subsidies are estimated to be approximately $8 million for the period 2014–2018, and $5 million for the period 2019–2023.
The Company anticipates making pension contributions in 2014 of approximately $175 million, all of which will be allocated to our international plans. The majority of these contributions are discretionary.
Defined Contribution Plans
Our Company sponsors qualified defined contribution plans covering substantially all U.S. employees. Under the largest U.S. defined contribution plan, we match participants' contributions up to a maximum of 3.5 percent of compensation, subject to certain limitations. Company costs related to the U.S. plans were $97 million, $93 million and $78 million in 2013, 2012 and 2011, respectively. We also sponsor defined contribution plans in certain locations outside the United States. Company costs associated with those plans were $32 million, $29 million and $31 million in 2013, 2012 and 2011, respectively.
Multi-Employer Plans
As a result of our acquisition of CCE's former North America business during the fourth quarter of 2010, the Company now participates in various multi-employer pension plans in the United States. Multi-employer pension plans are designed to cover employees from multiple employers and are typically established under collective bargaining agreements. These plans allow multiple employers to pool their pension resources and realize efficiencies associated with the daily administration of the plan.
Multi-employer plans are generally governed by a board of trustees composed of management and labor representatives and are funded through employer contributions.
The Company's expense for U.S. multi-employer pension plans totaled $37 million, $31 million, and $69 million in 2013, 2012, and 2011, respectively. In 2011, the Company's expense for U.S. multi-employer pension plans included charges of $32 million related to the withdrawal from certain of these plans in connection with the Company's integration initiatives in North America. Refer to Note 18 for additional information related to these initiatives. The plans we currently participate in have contractual arrangements that extend into 2018. If, in the future, we choose to withdraw from any of the multi-employer pension plans in which we currently participate, we would need to record the appropriate withdrawal liabilities at that time.

INCOME_TAXES

INCOME TAXES	12 Months Ended
INCOME TAXES	Dec. 31, 2013
Income Taxes [Abstract]	'
INCOME TAXES	'
	INCOME TAXES
	Income before income taxes consisted of the following (in millions):


	Year Ended December 31,	2013				2012				2011
	Year Ended December 31,	2013				2012				2011
	United States	$	2,451			$	3,526			$	3,029
	United States	$	2,451			$	3,526			$	3,029
	International	9,026				8,283				8,429
	International	9,026				8,283				8,429
	Total	$	11,477			$	11,809			$	11,458
	Total	$	11,477			$	11,809			$	11,458
	Income tax expense consisted of the following for the years ended December 31, 2013, 2012 and 2011 (in millions):


		United States				State and Local				International			Total
		United States				State and Local				International			Total
	2013
	Current	$	713			$	102			$	1,388		$	2,203
	Current	$	713			$	102			$	1,388		$	2,203
	Deferred	305				38				305			648
	Deferred	305				38				305			648
	2012
	Current	$	602			$	74			$	1,415		$	2,091
	Current	$	602			$	74			$	1,415		$	2,091
	Deferred	936				33				(337		)	632
	Deferred	936				33				(337		)	632
	2011
	Current	$	286			$	66			$	1,425		$	1,777
	Current	$	286			$	66			$	1,425		$	1,777
	Deferred	898				27				110			1,035
	Deferred	898				27				110			1,035
	We made income tax payments of $2,162 million, $981 million and $1,612 million in 2013, 2012 and 2011, respectively.
	A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows:


	Year Ended December 31,	2013			2012			2011
	Year Ended December 31,	2013			2012			2011
	Statutory U.S. federal tax rate	35	%		35	%		35	%
	State and local income taxes — net of federal benefit	1			1.1			0.9
	State and local income taxes — net of federal benefit	1			1.1			0.9
	Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate	(10.3	)	1,2,3	(9.5	)	6,7	(9.5	)	10,11,12
	Reversal of valuation allowances	—			(2.4	)	8	—
	Reversal of valuation allowances	—			(2.4	)	8	—
	Equity income or loss	(1.4	)	4	(2.0	)		(1.4	)	13
	Other operating charges	1.2		5	0.4		9	0.3		14
	Other operating charges	1.2		5	0.4		9	0.3		14
	Other — net	(0.7	)		0.5			(0.8	)	15,16,17,18
	Other — net	(0.7	)		0.5			(0.8	)	15,16,17,18
	Effective tax rate	24.8	%		23.1	%		24.5	%

	1	Includes a tax benefit of $26 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	2	Includes a tax expense of $279 million on pretax net gains of $501 million (or a 0.9 percent impact on our effective tax rate) related to the deconsolidation of our Brazilian bottling operations upon their combination with an independent bottler and a loss due to the merger of four of the Company's Japanese bottling partners. Refer to Note 2 and Note 17.

	3	Includes a tax expense of $3 million (or a 0.5 percent impact on our effective tax rate) related to a charge of $149 million due to the devaluation of the Venezuelan bolivar. Refer to Note 19.

	4	Includes an $8 million tax benefit on a pretax charge of $159 million (or a 0.4 percent impact on our effective tax rate) related to our proportionate share of unusual or infrequent items recorded by our equity method investees. Refer to Note 17.

	5	Includes a tax benefit of $175 million on pretax charges of $877 million (or a 1.2 percent impact on our effective tax rate) primarily related to impairment charges recorded on certain of the Company's intangible assets and charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 17 and Note 18.

	6	Includes a tax expense of $133 million (or a 1.1 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

7	Includes a tax expense of $57 million on pretax net gains of $76 million (or a 0.3 percent impact on our effective tax rate) related to the following: a gain recognized as a result of the merger of Embotelladora Andina S.A. ("Andina") and Embotelladoras Coca-Cola Polar S.A. ("Polar"); a gain recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment; the loss recognized on the pending sale of a majority ownership interest in our consolidated Philippine bottling operations to Coca-Cola FEMSA; and the expense recorded for the premium the Company paid over the publicly traded market price to acquire an ownership interest in Mikuni. Refer to Note 17.

8	Relates to a net tax benefit of $283 million associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions.

9	Includes a tax benefit of $95 million on pretax charges of $416 million (or a 0.4 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives; the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives; and the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18.

10	Includes a tax benefit of $6 million related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

11	Includes a zero percent effective tax rate on pretax charges of $17 million due to the impairment of available-for-sale securities. Refer to Note 3 and Note 17.

12	Includes a tax expense of $299 million on pretax net gains of $641 million (or a 0.7 percent impact on our effective tax rate) related to the net gain recognized as a result of the merger of Embotelladoras Arca, S.A.B. de C.V. ("Arca") and Grupo Continental S.A.B. ("Contal"); the gain recognized on the sale of our investment in Embonor; and gains the Company recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at per share amounts greater than the carrying value of the Company's per share investment. These gains were partially offset by charges associated with certain of the Company's equity method investments in Japan. Refer to Note 17.

13	Includes a tax benefit of $7 million on pretax net charges of $53 million (or a 0.1 percent impact on our effective tax rate) related to our proportionate share of asset impairments and restructuring charges recorded by certain of our equity method investees. Refer to Note 17.

14	Includes a tax benefit of $224 million on pretax charges of $732 million (or a 0.3 percent impact on our effective tax rate) primarily related to the Company's productivity, integration and restructuring initiatives; transaction costs incurred in connection with the merger of Arca and Contal; costs associated with the earthquake and tsunami that devastated northern and eastern Japan; and costs associated with the flooding in Thailand. Refer to Note 17.

15	Includes a tax benefit of $8 million on pretax charges of $19 million related to the amortization of favorable supply contracts acquired in connection with our acquisition of CCE's former North America business.

16	Includes a tax benefit of $3 million on pretax net charges of $9 million related to the repurchase and/or exchange of certain long-term debt assumed in connection with our acquisition of CCE's former North America business as well as the early extinguishment of certain other long-term debt. Refer to Note 10.

17	Includes a tax benefit of $14 million on pretax charges of $41 million related to the impairment of an investment in an entity accounted for under the equity method of accounting. Refer to Note 17.

18	Includes a tax benefit of $2 million related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in certain domestic jurisdictions.
Our effective tax rate reflects the tax benefits of having significant operations outside the United States, which are generally taxed at rates lower than the U.S. statutory rate of 35 percent. As a result of employment actions and capital investments made by the Company, certain tax jurisdictions provide income tax incentive grants, including Brazil, Costa Rica, Singapore and Swaziland. The terms of these grants expire from 2015 to 2022. We expect each of these grants to be renewed indefinitely. Tax incentive grants favorably impacted our income tax expense by $279 million, $280 million and $193 million for the years ended December 31, 2013, 2012 and 2011, respectively. In addition, our effective tax rate reflects the benefits of having significant earnings generated in investments accounted for under the equity method of accounting, which are generally taxed at rates lower than the U.S. statutory rate.
The Company or one of its subsidiaries files income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. U.S. tax authorities have completed their federal income tax examinations for all years prior to 2005. With respect to state and local jurisdictions and countries outside the United States, with limited exceptions, the Company and its subsidiaries are no longer subject to income tax audits for years before 2002. For U.S. federal and state tax purposes, the net operating losses and tax credit carryovers acquired in connection with our acquisition of CCE's former North America business that were generated between the years of 1990 through 2010 are subject to adjustments until the year in which they are actually utilized is no longer subject to examination.
Although the outcome of tax audits is always uncertain, the Company believes that adequate amounts of tax, including interest and penalties, have been provided for any adjustments that are expected to result from those years.
As of December 31, 2013, the gross amount of unrecognized tax benefits was $230 million. If the Company were to prevail on all uncertain tax positions, the net effect would be a benefit to the Company's effective tax rate of $166 million, exclusive of any benefits related to interest and penalties. The remaining $64 million, which was recorded as a deferred tax asset, primarily represents tax benefits that would be received in different tax jurisdictions in the event the Company did not prevail on all uncertain tax positions.
A reconciliation of the changes in the gross balance of unrecognized tax benefit amounts is as follows (in millions):


Year Ended December 31,	2013				2012				2011
Year Ended December 31,	2013				2012				2011
Beginning balance of unrecognized tax benefits	$	302			$	320			$	387
Beginning balance of unrecognized tax benefits	$	302			$	320			$	387
Increases related to prior period tax positions	1				69				9
Increases related to prior period tax positions	1				69				9
Decreases related to prior period tax positions	(7		)		(15		)		(19		)
Increases related to current period tax positions	8				23				6
Increases related to current period tax positions	8				23				6
Decreases related to current period tax positions	—				—				(1		)
Decreases related to current period tax positions	—				—				(1		)
Decreases related to settlements with taxing authorities	(4		)		(45		)		(5		)
Reductions as a result of a lapse of the applicable statute of limitations	(59		)		(36		)		(46		)
Increases (decreases) from effects of foreign currency exchange rates	(11		)		(14		)		(11		)
Ending balance of unrecognized tax benefits	$	230			$	302			$	320
Ending balance of unrecognized tax benefits	$	230			$	302			$	320
The Company recognizes accrued interest and penalties related to unrecognized tax benefits in income tax expense. The Company had $105 million, $113 million and $110 million in interest and penalties related to unrecognized tax benefits accrued as of December 31, 2013, 2012 and 2011, respectively. Of these amounts, $8 million of benefit, $33 million of expense and $2 million of benefit were recognized through income tax expense in 2013, 2012 and 2011, respectively. If the Company were to prevail on all uncertain tax positions, the reversal of this accrual would also be a benefit to the Company's effective tax rate.
It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, we do not expect the change to have a significant impact on our consolidated statements of income or consolidated balance sheets. These changes may be the result of settlements of ongoing audits, statute of limitations expiring, or final settlements in transfer pricing matters that are the subject of litigation. At this time, an estimate of the range of the reasonably possible outcomes cannot be made.
As of December 31, 2013, undistributed earnings of the Company's foreign subsidiaries amounted to $30.6 billion. Those earnings are considered to be indefinitely reinvested and, accordingly, no U.S. federal and state income taxes have been provided thereon. Upon distribution of those earnings in the form of dividends or otherwise, the Company would be subject to both U.S. income taxes (subject to an adjustment for foreign tax credits) and withholding taxes payable to the various foreign countries. Determination of the amount of unrecognized deferred U.S. income tax liability is not practical because of the complexities associated with its hypothetical calculation; however, unrecognized foreign tax credits would be available to reduce a portion of the U.S. tax liability.
The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consist of the following (in millions):


December 31,	2013				2012
December 31,	2013				2012
Deferred tax assets:
Property, plant and equipment	$	102			$	89
Property, plant and equipment	$	102			$	89
Trademarks and other intangible assets	63				77
Trademarks and other intangible assets	63				77
Equity method investments (including foreign currency translation adjustment)	243				209
	243				209
Derivative financial instruments	50				116
Derivative financial instruments	50				116
Other liabilities	1,102				1,178
Other liabilities	1,102				1,178
Benefit plans	1,237				1,808
Benefit plans	1,237				1,808
Net operating/capital loss carryforwards	790				782
Net operating/capital loss carryforwards	790				782
Other	225				320
Other	225				320
Gross deferred tax assets	$	3,812			$	4,579
Gross deferred tax assets	$	3,812			$	4,579
Valuation allowances	(586		)		(487		)
Total deferred tax assets1,2	$	3,226			$	4,092
Total deferred tax assets1,2	$	3,226			$	4,092
Deferred tax liabilities:
Property, plant and equipment	$	(2,417	)		$	(2,204	)
Trademarks and other intangible assets	(4,192		)		(4,133		)
Equity method investments (including foreign currency translation adjustment)	(1,070		)		(712		)
Derivative financial instruments	(147		)		(140		)
Other liabilities	(69		)		(144		)
Benefit plans	(473		)		(495		)
Other	(810		)		(929		)
Total deferred tax liabilities3	$	(9,178	)		$	(8,757	)
Net deferred tax liabilities	$	(5,952	)		$	(4,665	)

1	Noncurrent deferred tax assets of $328 million and $403 million were included in the line item other assets in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.

2	Current deferred tax assets of $211 million and $244 million were included in the line item prepaid expenses and other assets in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.

3	Current deferred tax liabilities of $339 million and $331 million were included in the line item accounts payable and accrued expenses in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.
As of December 31, 2013 and 2012, we had $198 million of net deferred tax liabilities and $70 million of net deferred tax assets located in countries outside the United States.
As of December 31, 2013, we had $6,914 million of loss carryforwards available to reduce future taxable income. Loss carryforwards of $488 million must be utilized within the next five years, and the remainder can be utilized over a period greater than five years.
An analysis of our deferred tax asset valuation allowances is as follows (in millions):


Year Ended December 31,	2013				2012				2011
Year Ended December 31,	2013				2012				2011
Balance at beginning of year	$	487			$	859			$	950
Balance at beginning of year	$	487			$	859			$	950
Additions	169				126				138
Additions	169				126				138
Decrease due to transfer to assets held for sale	—				(146		)		—
Decrease due to transfer to assets held for sale	—				(146		)		—
Deductions	(70		)		(352		)		(229		)
Balance at end of year	$	586			$	487			$	859
Balance at end of year	$	586			$	487			$	859
The Company's deferred tax asset valuation allowances are primarily the result of uncertainties regarding the future realization of recorded tax benefits on tax loss carryforwards from operations in various jurisdictions. These valuation allowances were primarily related to deferred tax assets generated from net operating losses. Current evidence does not suggest we will realize sufficient taxable income of the appropriate character within the carryforward period to allow us to realize these deferred tax benefits. If we were to identify and implement tax planning strategies to recover these deferred tax assets or generate sufficient income of the appropriate character in these jurisdictions in the future, it could lead to the reversal of these valuation allowances and a reduction of income tax expense. The Company believes that it will generate sufficient future taxable income to realize the tax benefits related to the remaining net deferred tax assets in our consolidated balance sheets.
In 2013, the Company recognized a net increase of $99 million in its valuation allowances. This increase was primarily due to the addition of a deferred tax asset and related valuation allowance on certain equity method investments and increases in net operating losses during the normal course of business operations. In addition, the Company recognized a reduction in the valuation allowances primarily due to the reversal of a deferred tax asset and related valuation allowance on certain equity method investments.
In 2012, the Company recognized a net decrease of $372 million in its valuation allowances. This decrease was primarily related to the reversal of valuation allowances in several foreign jurisdictions. As a result of considering recent significant positive evidence, including, among other items, a consistent pattern of earnings in the past three years, as well as business plans showing continued profitability, it was determined that a valuation allowance was no longer required for certain deferred tax assets primarily recorded on net operating losses in foreign jurisdictions. This decrease was also partially due to a transfer of a valuation allowance into assets held for sale as required by accounting principles generally accepted in the United States upon execution of the share purchase agreement for the sale of a majority interest in our consolidated Philippine bottling operations. Refer to Note 1 for additional information on the Company's accounting policy related to assets and liabilities held for sale. Refer to Note 2 for additional information on the Company's Philippine bottling operations. In addition, the Company recognized an increase in its valuation allowances primarily due to the addition of a deferred tax asset and related valuation allowance on certain equity method investments and increases in net operating losses during the normal course of business operations.
In 2011, the Company recognized a net decrease of $91 million in its valuation allowances. This decrease was primarily related to the utilization of net operating losses during the normal course of business operations; the reversal of a deferred tax asset and related valuation allowance on certain expiring attributes; and the reversal of a deferred tax asset and related valuation allowance on certain equity method investments. In addition, the Company recognized an increase in the valuation allowances primarily due to the carryforward of expenses disallowed in 2011 and increases in net operating losses during the normal course of business operations.

OTHER_COMPREHENSIVE_INCOME

OTHER COMPREHENSIVE INCOME	12 Months Ended
	Dec. 31, 2013
OTHER COMPREHENSIVE INCOME [Abstract]	'
OTHER COMPREHENSIVE INCOME	'
	OTHER COMPREHENSIVE INCOME
	AOCI attributable to shareowners of The Coca-Cola Company is separately presented on our consolidated balance sheets as a component of The Coca-Cola Company's shareowners' equity, which also includes our proportionate share of equity method investees' AOCI. Other comprehensive income (loss) ("OCI") attributable to noncontrolling interests is allocated to, and included in, our balance sheets as part of the line item equity attributable to noncontrolling interests. AOCI attributable to shareowners of The Coca-Cola Company consisted of the following (in millions):


	December 31,	2013				2012

	Foreign currency translation adjustment	$	(2,849	)		$	(1,665	)
	Accumulated derivative net gains (losses)	197				46

	Unrealized net gains (losses) on available-for-sale securities	258				338

	Adjustments to pension and other benefit liabilities	(1,038		)		(2,104		)
	Accumulated other comprehensive income (loss)	$	(3,432	)		$	(3,385	)
	The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):


		Year Ended December 31, 2013
		Shareowners of			Noncontrolling			Total
		The Coca-Cola Company			Interests
	Consolidated net income	$	8,584		$	42		$	8,626

	Other comprehensive income:
	Net foreign currency translation adjustment	(1,184		)	(3		)	(1,187		)
	Net gain (loss) on derivatives1	151			—			151

	Net unrealized gain (loss) on available-for-sale securities2	(80		)	—			(80		)

	Net change in pension and other benefit liabilities3	1,066			—			1,066

	Total comprehensive income	$	8,537		$	39		$	8,576


	1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

	2	Refer to Note 3 for information related to the net unrealized gain or loss on available-for-sale securities.

	3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
	OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI, for the years ended December 31, 2013, 2012 and 2011, is as follows (in millions):


		Before-Tax Amount				Income Tax				After-Tax Amount

	2013
	Foreign currency translation adjustments:
	Translation adjustment arising in the period	$	(1,046	)		$	56			$	(990	)

	Reclassification adjustments recognized in net income	(194		)		—				(194		)

	Net foreign currency translation adjustment	(1,240		)		56				(1,184		)

	Derivatives:
	Unrealized gains (losses) arising during the year	425				(173		)		252

	Reclassification adjustments recognized in net income	(167		)		66				(101		)

	Net gain (loss) on derivatives1	258				(107		)		151

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	(134		)		42				(92		)

	Reclassification adjustments recognized in net income	12				—				12

	Net change in unrealized gain (loss) on available-for-sale securities2	(122		)		42				(80		)

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	1,490				(550		)		940

Reclassification adjustments recognized in net income	198				(72		)		126

Net change in pension and other benefit liabilities3	1,688				(622		)		1,066

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	584			$	(631	)		$	(47	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2012
Net foreign currency translation adjustment	$	(219	)		$	(1	)		$	(220	)
Derivatives:
Unrealized gains (losses) arising during the year	77				(29		)		48

Reclassification adjustments recognized in net income	82				(31		)		51

Net gain (loss) on derivatives1	159				(60		)		99

Available-for-sale securities:
Unrealized gains (losses) arising during the year	248				(64		)		184

Reclassification adjustments recognized in net income	(6		)		—				(6		)

Net change in unrealized gain (loss) on available-for-sale securities2	242				(64		)		178

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,132		)		405				(727		)

Reclassification adjustments recognized in net income	92				(33		)		59

Net change in pension and other benefit liabilities3	(1,040		)		372				(668		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(858	)		$	247			$	(611	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2011
Net foreign currency translation adjustment	$	(639	)		$	(1	)		$	(640	)
Derivatives:
Unrealized gains (losses) arising during the year	(3		)		(1		)		(4		)
Reclassification adjustments recognized in net income	243				(94		)		149

Net gain (loss) on derivatives1	240				(95		)		145

Available-for-sale securities:
Unrealized gains (losses) arising during the year	(4		)		(8		)		(12		)
Reclassification adjustments recognized in net income	10				(5		)		5

Net change in unrealized gain (loss) on available-for-sale securities2	6				(13		)		(7		)

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,206		)		423				(783		)

Reclassification adjustments recognized in net income	31				(11		)		20

Net change in pension and other benefit liabilities3	(1,175		)		412				(763		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(1,568	)		$	303			$	(1,265	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
The following table presents the amounts and line items in our condensed consolidated statements of income where adjustments reclassified from AOCI into income were recorded during the year ended December 31, 2013 (in millions):


Description of AOCI Component	Location of Gain (Loss)	Amount Reclassified from
	Recognized in Income	AOCI into Income
Foreign currency translation adjustments:
Divestitures, deconsolidations and other	Other income (loss) — net	$	(194	)	1
	Income before income taxes	$	(194	)
	Income taxes	—

	Consolidated net income	$	(194	)
Derivatives:
Foreign currency contracts	Net operating revenues	$	(149	)
Foreign currency contracts	Cost of goods sold	(30		)
Interest rate contracts	Interest expense	12

	Income before income taxes	$	(167	)
	Income taxes	66

	Consolidated net income	$	(101	)
Available-for-sale securities:
Sale of securities	Other income (loss) — net	$	12

	Income before income taxes	$	12

	Income taxes	—

	Consolidated net income	$	12

Pension and other benefit liabilities:
Insignificant items	Other income (loss) — net	$	(1	)
Amortization of net actuarial loss	*	211

Amortization of prior service cost (credit)	*	(12		)
	Income before income taxes	$	198

	Income taxes	(72		)
	Consolidated net income	$	126


*	This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our condensed consolidated statements of income in its entirety. Refer to Note 13 for additional information.

1	Related to the disposition of our Philippine bottling operations in January 2013, the deconsolidation of our Brazilian bottling operations in July 2013 and the merger of four of the Company's Japanese bottling partners in July 2013. Refer to Note 2 and Note 17 for additional information related to these transactions.

FAIR_VALUE_MEASUREMENTS

FAIR VALUE MEASUREMENTS	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements Disclosure [Abstract]	'
FAIR VALUE MEASUREMENTS	'
	FAIR VALUE MEASUREMENTS
	Accounting principles generally accepted in the United States define fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants at the measurement date. Additionally, the inputs used to measure fair value are prioritized based on a three-level hierarchy. This hierarchy requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs. The three levels of inputs used to measure fair value are as follows:

	•	Level 1 — Quoted prices in active markets for identical assets or liabilities.

	•	Level 2 — Observable inputs other than quoted prices included in Level 1. We value assets and liabilities included in this level using dealer and broker quotations, certain pricing models, bid prices, quoted prices for similar assets and liabilities in active markets, or other inputs that are observable or can be corroborated by observable market data.

	•	Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. This includes certain pricing models, discounted cash flow methodologies and similar techniques that use significant unobservable inputs.
	Recurring Fair Value Measurements
	In accordance with accounting principles generally accepted in the United States, certain assets and liabilities are required to be recorded at fair value on a recurring basis. For our Company, the only assets and liabilities that are adjusted to fair value on a recurring basis are investments in equity and debt securities classified as trading or available-for-sale and derivative financial instruments. Additionally, the Company adjusts the carrying value of certain long-term debt as a result of the Company's fair value hedging strategy.
	Investments in Trading and Available-for-Sale Securities
	The fair values of our investments in trading and available-for-sale securities using quoted market prices from daily exchange traded markets are based on the closing price as of the balance sheet date and are classified as Level 1. The fair values of our investments in trading and available-for-sale securities classified as Level 2 are priced using quoted market prices for similar instruments or nonbinding market prices that are corroborated by observable market data. Inputs into these valuation techniques include actual trade data, benchmark yields, broker/dealer quotes and other similar data. These inputs are obtained from quoted market prices, independent pricing vendors or other sources.
	Derivative Financial Instruments
	The fair values of our futures contracts are primarily determined using quoted contract prices on futures exchange markets. The fair values of these instruments are based on the closing contract price as of the balance sheet date and are classified as Level 1.
	The fair values of our derivative instruments other than futures are determined using standard valuation models. The significant inputs used in these models are readily available in public markets, or can be derived from observable market transactions, and therefore have been classified as Level 2. Inputs used in these standard valuation models for derivative instruments other than futures include the applicable exchange rates, forward rates, interest rates and discount rates. The standard valuation model for options also uses implied volatility as an additional input. The discount rates are based on the historical U.S. Deposit or U.S. Treasury rates, and the implied volatility specific to options is based on quoted rates from financial institutions.
	Included in the fair value of derivative instruments is an adjustment for nonperformance risk. The adjustment is based on current credit default swap ("CDS") rates applied to each contract, by counterparty. We use our counterparty's CDS rate when we are in an asset position and our own CDS rate when we are in a liability position. The adjustment for nonperformance risk did not have a significant impact on the estimated fair value of our derivative instruments.
	The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):


		December 31, 2013
		Level 1				Level 2				Level 3				Netting				Fair Value
														Adjustment1				Measurements
	Assets:
	Trading securities2	$	206			$	163			$	3			$	—			$	372

	Available-for-sale securities2	1,453				3,281				108			3	—				4,842

	Derivatives4	17				822				—				(150		)		689		5

	Total assets	$	1,676			$	4,266			$	111			$	(150	)		$	5,903

	Liabilities:
	Derivatives4	$	10			$	165			$	—			$	(151	)		$	24	5

	Total liabilities	$	10			$	165			$	—			$	(151	)		$	24


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

	5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $129 million in the line item prepaid expenses and other assets; $560 million in the line item other assets; $12 million in the line item accounts payable and accrued expenses; and $12 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.


		December 31, 2012
		Level 1				Level 2				Level 3				Netting				Fair Value
														Adjustment1				Measurements
	Assets:
	Trading securities2	$	146			$	116			$	4			$	—			$	266

	Available-for-sale securities2	1,390				3,068				135			3	—				4,593

	Derivatives4	47				583				—				(116		)		514		5

	Total assets	$	1,583			$	3,767			$	139			$	(116	)		$	5,373

	Liabilities:
	Derivatives4	$	35			$	98			$	—			$	(121	)		$	12	5

Total liabilities	$	35			$	98			$	—			$	(121	)		$	12


1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

3	Primarily related to long-term debt securities that mature in 2018.

4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $145 million in the line item prepaid expenses and other assets; $369 million in the line item other assets; $11 million in the line item accounts payable and accrued expenses; and $1 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.

Gross realized and unrealized gains and losses on Level 3 assets and liabilities were not significant for the years ended December 31, 2013 and 2012.
The Company recognizes transfers between levels within the hierarchy as of the beginning of the reporting period. Gross transfers between levels within the hierarchy were not significant for the years ended December 31, 2013 and 2012.
Nonrecurring Fair Value Measurements
In addition to assets and liabilities that are recorded at fair value on a recurring basis, the Company records assets and liabilities at fair value on a nonrecurring basis as required by accounting principles generally accepted in the United States. Generally, assets are recorded at fair value on a nonrecurring basis as a result of impairment charges. Assets measured at fair value on a nonrecurring basis for the years ended December 31, 2013 and 2012, are summarized below (in millions):


	Gains (Losses)
December 31,	2013				2012

Exchange of investment in equity securities	$	(114	)	1	$	185		4

Valuation of shares in equity method investee	139			2	10			5

Intangible assets	(195		)	3	—

Assets held for sale	—				(108		)	6

Cost method investments	—				(16		)	7

Total	$	(170	)		$	71


1	The Company recognized a net loss of $114 million on the exchange of shares it previously owned in certain equity method investees for shares in the newly formed entity CCEJ. CCEJ is also an equity method investee. The net loss represents the difference between the carrying value of the shares the Company relinquished and the fair value of the CCEJ shares received as a result of the transaction. The net loss and the initial carrying value of the Company's investment were calculated based on Level 1 inputs. Refer to Note 17.

2	The Company recognized a gain of $139 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. These gains were determined using Level 1 inputs. Refer to Note 17.

3	The Company recognized a loss of $195 million due to impairment charges on certain intangible assets. The charges were primarily determined by comparing the fair value of the assets to the current carrying value. The fair value of the assets was derived using discounted cash flow analyses based on Level 3 inputs. Refer to Note 17.

4	As a result of the merger of Andina and Polar, the Company recognized a gain of $185 million on the exchange of shares we previously owned in Polar for shares in Andina. This gain primarily represents the difference between the carrying value of the Polar shares we relinquished and the fair value of the Andina shares we received as a result of the transaction. The gain was calculated based on Level 1 inputs. Refer to Note 17.

5	The Company recognized a gain of $92 million as a result of Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if we sold a proportionate share of our investment in Coca-Cola FEMSA. This gain was partially offset by a loss of $82 million the Company recognized due to the Company acquiring an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. This premium was expensed on the acquisition date. The gain and loss described above were determined using Level 1 inputs. Refer to Note 17.

6	The Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our consolidated Philippine bottling operations. As a result of this agreement, the Company was required to classify our Philippine bottling operations as held for sale in our consolidated balance sheet as of December 31, 2012. We also recognized a loss of $108 million during the year ended December 31, 2012, based on the agreed-upon sale price and related transaction costs. The loss was calculated based on Level 3 inputs. Refer to Note 17.

7	The Company recognized impairment charges of $16 million due to other-than-temporary declines in the fair values of certain cost method investments. These charges were determined using Level 3 inputs. Refer to Note 17.
Fair Value Measurements for Pension and Other Postretirement Benefit Plans
The fair value hierarchy discussed above is not only applicable to assets and liabilities that are included in our consolidated balance sheets, but is also applied to certain other assets that indirectly impact our consolidated financial statements. For example, our Company sponsors and/or contributes to a number of pension and other postretirement benefit plans. Assets contributed by the Company become the property of the individual plans. Even though the Company no longer has control over these assets, we are indirectly impacted by subsequent fair value adjustments to these assets. The actual return on these assets impacts the Company's future net periodic benefit cost, as well as amounts recognized in our consolidated balance sheets. Refer to Note 13. The Company uses the fair value hierarchy to measure the fair value of assets held by our various pension and other postretirement benefit plans.
Pension Plan Assets
The following table summarizes the levels within the fair value hierarchy for our pension plan assets as of December 31, 2013 and 2012 (in millions):


	December 31, 2013																December 31, 2012
	Level 1				Level 2				Level 3				Total				Level 1			Level 2				Level 3				Total

Cash and cash equivalents	$	331			$	183			$	—			$	514			$	187		$	199			$	—			$	386

Equity securities:
U.S.-based companies	1,680				7				15				1,702				1,847			20				14				1,881

International-based companies	1,271				13				—				1,284				910			54				—				964

Fixed-income securities:
Government bonds	—				719				49				768				—			562				—				562

Corporate bonds and debt securities	—				1,466				40				1,506				—			982				—				982

Mutual, pooled and commingled funds	56				1,531				—				1,587				504			1,006				—				1,510

Hedge funds/limited partnerships	—				190				353				543				—			125				400				525

Real estate	—				—				251				251				—			—				257				257

Other	—				7				584			1	591				—			7				510			1	517

Total	$	3,338			$	4,116			$	1,292			$	8,746			$	3,448		$	2,955			$	1,181			$	7,584


1	Includes purchased annuity contracts and insurance-linked securities.
The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans for the years ended December 31, 2013 and 2012 (in millions):


	Corporate				Hedge				Real Estate				Equity				Mutual,			Other				Total
	Bonds and				Funds/Limited								Securities				Pooled and
	Debt Securities				Partnerships												Commingled
																	Funds
2012
Balance at beginning of year	$	—			$	349			$	270			$	20			$	5		$	518			$	1,162

Actual return on plan assets:
Related to assets still held at the reporting date	—				(8		)		13				—				—			1				6

Related to assets sold during the year	—				24				3				—				—			—				27

Purchases, sales and settlements — net	—				35				(27		)		—				(5		)	(2		)		1

Transfers in or out of Level 3 — net	—				—				(2		)		(6		)		—			(4		)		(12		)

Foreign currency translation	—				—				—				—				—			(3		)		(3		)

Balance at end of year	$	—			$	400			$	257			$	14			$	—		$	510		1	$	1,181

2013
Balance at beginning of year	$	—			$	400			$	257			$	14			$	—		$	510			$	1,181

Actual return on plan assets:
Related to assets still held at the reporting date	(4		)		(6		)		13				—				—			39				42

Related to assets sold during the year	(2		)		24				6				—				—			—				28

Purchases, sales and settlements — net	95				14				(24		)		1				—			193				279

Transfers in or out of Level 3 — net	—				(78		)		—				—				—			(172		)		(250		)

Foreign currency translation	—				(1		)		(1		)		—				—			14				12

Balance at end of year	$	89			$	353			$	251			$	15			$	—		$	584		1	$	1,292


1	Includes purchased annuity contracts and insurance-linked securities.
Other Postretirement Benefit Plan Assets
The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets as of December 31, 2013 and 2012 (in millions):


	December 31, 2013																December 31, 2012
	Level 1				Level 2				Level 3 1				Total				Level 1			Level 2				Level 3 1				Total

Cash and cash equivalents	$	—			$	10			$	—			$	10			$	1		$	12			$	—			$	13

Equity securities:
U.S.-based companies	112				—				—				112				81			—				—				81

International-based companies	8				—				—				8				4			—				—				4

Fixed-income securities:
Government bonds	76				3				—				79				75			3				—				78

Corporate bonds and debt securities	—				9				—				9				—			5				—				5

Mutual, pooled and commingled funds	11				7				—				18				11			5				—				16

Hedge funds/limited partnerships	—				1				2				3				—			1				2				3

Real estate	—				—				2				2				—			—				2				2

Other	—				—				2				2				—			—				—				—

Total	$	207			$	30			$	6			$	243			$	172		$	26			$	4			$	202


1	Level 3 assets are not a significant portion of other postretirement benefit plan assets.
Other Fair Value Disclosures
The carrying amounts of cash and cash equivalents; short-term investments; receivables; accounts payable and accrued expenses; and loans and notes payable approximate their fair values because of the relatively short-term maturities of these financial instruments.
The fair value of our long-term debt is estimated using Level 2 inputs based on quoted prices for those instruments. Where quoted prices are not available, fair value is estimated using discounted cash flows and market-based expectations for interest rates, credit risk and the contractual terms of the debt instruments. As of December 31, 2013, the carrying amount and fair value of our long-term debt, including the current portion, were $20,178 million and $20,352 million, respectively. As of December 31, 2012, the carrying amount and fair value of our long-term debt, including the current portion, were $16,313 million and $17,157 million, respectively.

SIGNIFICANT_OPERATING_AND_NONO

SIGNIFICANT OPERATING AND NONOPERATING ITEMS	12 Months Ended
SIGNIFICANT OPERATING AND NONOPERATING ITEMS	Dec. 31, 2013
Significant Operating and Nonoperating Items disclosure [Abstract]	'
SIGNIFICANT OPERATING AND NONOPERATING ITEMS	'
	SIGNIFICANT OPERATING AND NONOPERATING ITEMS
	Other Operating Items
	In December 2011, the Company detected that orange juice being imported from Brazil contained residues of carbendazim, a fungicide that is not registered in the United States for use on citrus products. As a result, we began purchasing additional supplies of Florida orange juice at a higher cost than Brazilian orange juice and incurred charges of $13 million during the year ended December 31, 2012. These charges were recorded in the line item cost of goods sold in our consolidated statement of income.
	On March 11, 2011, a major earthquake struck off the coast of Japan, resulting in a tsunami that devastated the northern and eastern regions of the country. As a result of these events, the Company made a donation to a charitable organization to establish the Coca-Cola Japan Reconstruction Fund, which has helped rebuild schools and community facilities across the impacted areas of the country. The Company recorded total charges of $84 million related to these events during the year ended December 31, 2011, including $23 million in deductions from revenue, $11 million in cost of goods sold and $50 million in other operating charges. The charges of $23 million recorded in deductions from revenue were primarily related to funds we provided our local bottling partners to enable them to continue producing and distributing our beverage products in the affected regions. This support not only helped restore our business operations in the impacted areas, but it also assisted our bottling partners in meeting the evolving customer and consumer needs as the recovery and rebuilding efforts advanced. The charges of $11 million recorded in cost of goods sold were primarily related to Company-owned inventory that was destroyed or lost. The charges of $50 million recorded in other operating charges were primarily related to the donation discussed above and included an impairment charge of $1 million related to certain Company-owned fixed assets. These fixed assets primarily consisted of Company-owned vending equipment and coolers that were damaged or lost as a result of these events. Refer to Note 19 for the impact these charges had on our operating segments.
	Other Operating Charges
	In 2013, the Company incurred other operating charges of $895 million, which primarily consisted of $494 million associated with the Company's productivity and reinvestment program; $195 million due to the impairment of certain intangible assets described below; $188 million due to the Company's other restructuring and integration initiatives; and $22 million due to charges associated with certain of the Company's fixed assets. Refer to Note 18 for additional information on our productivity and reinvestment program as well as the Company's other productivity, integration and restructuring initiatives. Refer to Note 19 for the impact these charges had on our operating segments.
	During the year ended December 31, 2013, the Company recorded charges of $195 million related to certain intangible assets. These charges included $113 million related to the impairment of trademarks recorded in our Bottling Investments and Pacific operating segments. These impairments were primarily due to a strategic decision to phase out certain local-market value brands which resulted in a change in the expected useful life of the intangible assets. The charges were determined by comparing the fair value of the trademarks, derived using discounted cash flow analyses, to the current carrying value. Additionally, the remaining charge of $82 million was related to goodwill recorded in our Bottling Investments operating segment. This charge was primarily the result of management's revised outlook on market conditions and volume performance.
	In 2012, the Company incurred other operating charges of $447 million, which primarily consisted of $270 million associated with the Company's productivity and reinvestment program; $163 million related to the Company's other restructuring and integration initiatives; $20 million due to changes in the Company's ready-to-drink tea strategy as a result of our U.S. license agreement with Nestlé S.A. ("Nestlé") terminating at the end of 2012; and $8 million due to costs associated with the Company detecting carbendazim in orange juice imported from Brazil for distribution in the United States as described above. These charges were partially offset by reversals of $10 million associated with the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives as well as reversals of $6 million associated with the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18 for additional information on our productivity and reinvestment program as well as the Company's other productivity, integration and restructuring initiatives. Refer to Note 19 for the impact these charges had on our operating segments.
	In 2011, the Company incurred other operating charges of $732 million, which primarily consisted of $633 million associated with the Company's productivity, integration and restructuring initiatives; $50 million related to weather-related events in Japan described above; $35 million of costs associated with the merger of Arca and Contal; and $10 million associated with the floods in Thailand that impacted the Company's supply chain operations in the region. Refer to Note 18 for additional information on our productivity, integration and restructuring initiatives. Refer to the discussion of the merger of Arca and Contal below for additional information on the transaction. Refer to Note 19 for the impact these charges had on our operating segments.
	Other Nonoperating Items
	Equity Income (Loss) — Net
	The Company recorded a net charge of $159 million, a net gain of $8 million, and a net charge of $53 million in equity income (loss) — net during the years ended December 31, 2013, 2012 and 2011, respectively. These amounts primarily represent the Company's proportionate share of unusual or infrequent items recorded by certain of our equity method investees.
	In 2012, the Company also recorded a charge of $11 million related to changes in the structure of Beverage Partners Worldwide ("BPW"), our 50/50 joint venture with Nestlé in the ready-to-drink tea category. These changes resulted in the joint venture focusing its geographic scope primarily on Europe and Canada. The Company accounts for our investment in BPW under the equity method of accounting.
	Refer to Note 19 for the impact these items had on our operating segments.
	Other Income (Loss) — Net
	In 2013, the Company recorded a gain of $615 million due to the deconsolidation of our Brazilian bottling operations as a result of their combination with an independent bottling partner. Refer to Note 2 for additional information on this transaction. Refer to Note 19 for the impact this gain had on our operating segments.
	Effective July 1, 2013, four of the Company's Japanese bottling partners merged as CCEJ, a publicly traded entity, through a share exchange. The terms of the agreement included the issuance of new shares of one of the publicly traded bottlers in exchange for 100 percent of the outstanding shares of the remaining three bottlers according to an agreed-upon share exchange ratio. As a result, the Company recorded a net charge of $114 million for those investments in which the Company's carrying value was less than the fair value of the shares received. Refer to Note 19 for the impact this loss had on our operating segments.
	In 2013, the Company recorded a charge of $140 million due to the Venezuelan government announcing a currency devaluation. As a result of this devaluation, the Company remeasured the net assets related to its operations in Venezuela. Refer to Note 19 for the impact this charge had on our operating segments. The Company also recognized a gain of $139 million due to Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company sold a proportionate share of its investment in Coca-Cola FEMSA. Refer to Note 19 for the impact this charge had on our operating segments.
	In 2012, the Company recognized a gain of $185 million as a result of the merger of Andina and Polar, with Andina being the acquiring company. Prior to this transaction, the Company held an investment in Andina that we accounted for as an available-for-sale security as well as an investment in Polar that we accounted for under the equity method of accounting. The merger of the two companies was a noncash transaction that resulted in Polar shareholders exchanging their existing Polar shares for newly issued shares of Andina at a specified exchange rate. As a result, the Company now holds an investment in Andina that we account for as an equity method investment. This gain impacted the Corporate operating segment. Refer to Note 19. Refer to Note 16 for additional information on the measurement of the gain.
	On December 13, 2012, the Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our consolidated Philippine bottling operations. This transaction was completed on January 25, 2013. As a result of this agreement, the Company was required to classify our Philippine bottling operations as held for sale in our consolidated balance sheet as of December 31, 2012. We also recognized a loss of $108 million during the year ended December 31, 2012, based on the agreed-upon sale price and related transaction costs. This loss impacted the Corporate operating segment. Refer to Note 19.
	The Company also recognized a gain of $92 million in 2012 as a result of Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's investment. Accordingly, the Company is required to treat this type of transaction as if we sold a proportionate share of our investment in Coca-Cola FEMSA. This gain impacted the Corporate operating segment. Refer to Note 19. Refer to Note 16 for additional information on the measurement of the gain.
	During the year ended December 31, 2012, the Company recorded a charge of $82 million due to the acquisition of an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. Although the Company paid this premium to obtain specific rights that have an economic and strategic value to the Company, they do not qualify as an asset and were recorded as expense on the acquisition date. This charge impacted the Corporate operating segment. Refer to Note 19. The Company accounted for our investment in Mikuni under the equity method of accounting prior to the merger of the four bottlers into CCEJ discussed above.
	The Company also recognized charges of $16 million during the year ended December 31, 2012, due to other-than-temporary declines in the fair values of certain cost method investments. These charges impacted the Corporate operating segment. Refer to Note 19.
	In 2011, the Company recognized a net gain of $417 million, primarily as a result of the merger of Arca and Contal, two bottling partners headquartered in Mexico, into a combined entity known as Arca Contal. Prior to this transaction the Company held an investment in Contal that we accounted for under the equity method of accounting. The merger of the two companies was a noncash transaction that resulted in Contal shareholders exchanging their existing Contal shares for new shares in Arca Contal at a specified exchange rate. Refer to Note 16 for additional information on the measurement of the gain. As a result, the Company now holds an investment in Arca Contal that we account for as an available-for-sale security. This net gain impacted the Corporate operating segment. Refer to Note 19.
	The Company also recognized a net gain of $122 million during 2011, primarily as a result of Coca-Cola FEMSA issuing additional shares of its own stock at per share amounts greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if we sold a proportionate share of our investment in Coca-Cola FEMSA. The gains the Company recognized as a result of the previous transactions were partially offset by charges associated with certain of the Company's equity method investments in Japan. In addition, the Company recognized a gain of $102 million during 2011 related to the sale of our investment in Embonor. Refer to Note 2 for additional information. Refer to Note 19 for the impact these items had on our operating segments.
	During 2011, the Company recorded charges of $41 million due to the impairment of an investment in an entity accounted for under the equity method of accounting and $17 million due to other-than-temporary declines in the fair value of certain of the Company's available-for-sale securities. Refer to Note 16 for additional fair value information related to these impairments. The Company also recorded a charge of $5 million related to the finalization of working capital adjustments associated with the sale of our Norwegian and Swedish Bottling operations to CCE during the fourth quarter of 2010. This charge reduced the amount of our previously reported gain on the sale of these bottling operations. Refer to Note 19 for the impact these charges had on our operating segments.

PRODUCTIVITY_INTEGRATION_AND_R

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES	12 Months Ended
	Dec. 31, 2013
Restructuring and Related Activities [Abstract]	'
Productivity, Integration and Restructuring Initiatives Disclosure [Text Block]	'
	PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES
	Productivity and Reinvestment
	In February 2012, the Company announced a four-year productivity and reinvestment program which will further enable our efforts to strengthen our brands and reinvest our resources to drive long-term profitable growth. This program will be focused on the following initiatives: global supply chain optimization; global marketing and innovation effectiveness; operating expense leverage and operational excellence; data and information technology systems standardization; and further integration of CCE's former North America business.
	The Company incurred total pretax expenses of $764 million related to this program since the plan commenced. These expenses were recorded in the line item other operating charges in our consolidated statement of income. Refer to Note 19 for the impact these charges had on our operating segments. Outside services reported in the table below primarily relate to expenses in connection with legal, outplacement and consulting activities. Other direct costs reported in the table below include, among other items, internal and external costs associated with the development, communication, administration and implementation of these initiatives; accelerated depreciation on certain fixed assets; contract termination fees; and relocation costs.
	The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts since the commencement of the plan (in millions):


		Severance Pay			Outside Services			Other			Total
		and Benefits						Direct Costs
	2012
	Costs incurred	$	21		$	61		$	188		$	270

	Payments	(8		)	(55		)	(167		)	(230		)
	Noncash and exchange	(1		)	—			(13		)	(14		)

	Accrued balance as of December 31	$	12		$	6		$	8		$	26

	2013
	Costs incurred	$	188		$	59		$	247		$	494

	Payments	(113		)	(59		)	(209		)	(381		)
	Noncash and exchange	1			—			(28		)	(27		)

	Accrued balance as of December 31	$	88		$	6		$	18		$	112

	Productivity Initiatives
	During 2008, the Company announced a transformation effort centered on productivity initiatives to provide additional flexibility to invest for growth. The initiatives impacted a number of areas, including aggressively managing operating expenses supported by lean techniques; redesigning key processes to drive standardization and effectiveness; better leveraging our size and scale; and driving savings in indirect costs through the implementation of a "procure-to-pay" program.
	In 2011, we completed this program. The Company reversed charges of $2 million and $10 million, during the years ended December 31, 2013 and 2012, respectively. The Company incurred expenses of $156 million during the year ended December 31, 2011, and has incurred total pretax expenses of $496 million related to these productivity initiatives since they commenced. These expenses were recorded in the line item other operating charges in our consolidated statements of income. Refer to Note 19 for the impact these charges had on our operating segments. The Company had $11 million accrued related to these productivity initiatives as of December 31, 2012. As of December 31, 2013, the Company did not have any remaining accruals related to these initiatives.
	Integration Initiatives
	Integration of CCE's Former North America Business
	In 2010, we acquired CCE's former North America business and began an integration initiative to develop, design and implement our operating framework. In 2011, we completed this program. The Company reversed charges of $1 million and $6 million, respectively, during the years ended December 31, 2013 and 2012. The Company incurred expenses of $358 million during the year ended December 31, 2011, and has incurred total pretax expenses of $486 million related to this initiative since the plan commenced. These expenses were recorded in the line item other operating charges in our consolidated statements of income. Refer to Note 19 for the impact these charges had on our operating segments. The Company had $3 million accrued related to these integration initiatives as of December 31, 2012. As of December 31, 2013, the Company did not have any remaining accruals related to these initiatives.
	Integration of Our German Bottling and Distribution Operations
	In 2008, the Company began an integration initiative related to the 18 German bottling and distribution operations acquired in 2007. The Company incurred $187 million, $148 million and $67 million of expenses related to this initiative in 2013, 2012 and 2011, respectively, and has incurred total pretax expenses of $627 million related to this initiative since it commenced. These expenses were recorded in the line item other operating charges in our consolidated statements of income and impacted the Bottling Investments operating segment. The expenses recorded in connection with these integration activities have been primarily due to involuntary terminations. The Company had $127 million and $96 million accrued related to these integration costs as of December 31, 2013 and 2012, respectively.
	The Company is currently reviewing other restructuring opportunities within the German bottling and distribution operations, which if implemented will result in additional charges in future periods. However, as of December 31, 2013, the Company had not finalized any additional plans.
	Restructuring Initiatives
	The Company incurred charges of $15 million and $52 million related to other restructuring initiatives during 2012 and 2011, respectively. These other restructuring initiatives were outside the scope of the productivity and reinvestment, productivity and integration initiatives discussed above and were related to individually insignificant activities throughout many of our business units. These charges were recorded in the line item other operating charges in our consolidated statements of income. Refer to Note 19 for the impact these charges had on our operating segments.

OPERATING_SEGMENTS

OPERATING SEGMENTS	12 Months Ended
OPERATING SEGMENTS	Dec. 31, 2013
Operations, Reportable Information, by Operating Segment	'
Segment Reporting Disclosure [Text Block]	'
	OPERATING SEGMENTS
	As of December 31, 2013, our organizational structure consisted of the following operating segments: Eurasia and Africa; Europe; Latin America; North America; Pacific; Bottling Investments; and Corporate.
	Segment Products and Services
	The business of our Company is nonalcoholic beverages. With the exception of North America, our geographic operating segments (Eurasia and Africa; Europe; Latin America; North America; and Pacific) derive a majority of their revenues from the manufacture and sale of beverage concentrates and syrups and, in some cases, the sale of finished beverages. The North America operating segment derives the majority of its revenues from the sale of finished beverages. Our Bottling Investments operating segment is composed of our Company-owned or consolidated bottling operations outside of North America, regardless of the geographic location of the bottler, and equity income from the majority of our equity method investments. Company-owned or consolidated bottling operations derive the majority of their revenues from the sale of finished beverages. Generally, bottling and finished product operations produce higher net revenues but lower gross profit margins compared to concentrate and syrup operations.
	The following table sets forth the percentage of total net operating revenues related to concentrate operations and finished product operations:


	Year Ended December 31,	2013		2012			2011
	Year Ended December 31,	2013		2012			2011
	Concentrate operations1	38	%	38	%		39	%
	Finished product operations2	62		62			61
	Finished product operations2	62		62			61
	Net operating revenues	100	%	100	%		100	%

	1	Includes concentrates sold by the Company to authorized bottling partners for the manufacture of fountain syrups. The bottlers then typically sell the fountain syrups to wholesalers or directly to fountain retailers.

	2	Includes fountain syrups manufactured by the Company, including consolidated bottling operations, and sold to fountain retailers or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers.
	Method of Determining Segment Income or Loss
	Management evaluates the performance of our operating segments separately to individually monitor the different factors affecting financial performance. Our Company manages income taxes and certain treasury-related items, such as interest income and expense, on a global basis within the Corporate operating segment. We evaluate segment performance based on income or loss before income taxes.
	Geographic Data
	The following table provides information related to our net operating revenues (in millions):


	Year Ended December 31,	2013			2012				2011
	Year Ended December 31,	2013			2012				2011
	United States	$	19,820		$	19,732			$	18,699
	United States	$	19,820		$	19,732			$	18,699
	International	27,034			28,285				27,843
	International	27,034			28,285				27,843
	Net operating revenues	$	46,854		$	48,017			$	46,542
	Net operating revenues	$	46,854		$	48,017			$	46,542
	The following table provides information related to our property, plant and equipment — net (in millions):


	Year Ended December 31,	2013			2012				2011
	Year Ended December 31,	2013			2012				2011
	United States	$	8,841		$	8,509			$	8,043
	United States	$	8,841		$	8,509			$	8,043
	International	6,126			5,967				6,896
	International	6,126			5,967				6,896
	Property, plant and equipment — net	$	14,967		$	14,476			$	14,939
	Property, plant and equipment — net	$	14,967		$	14,476			$	14,939
	Information about our Company's operations by operating segment for the years ended December 31, 2013, 2012 and 2011, is as follows (in millions):


		Eurasia &			Europe				Latin			North			Pacific			Bottling				Corporate				Eliminations				Consolidated
		Africa			Europe				America			America			Pacific			Investments				Corporate				Eliminations				Consolidated
	2013
	Net operating revenues:
	Third party	$	2,763		$	4,645			$	4,748		$	21,574		$	5,372		$	7,598			$	154			$	—			$	46,854
	Third party	$	2,763		$	4,645			$	4,748		$	21,574		$	5,372		$	7,598			$	154			$	—			$	46,854
	Intersegment	—			689				191			16			497			78				—				(1,471		)		—
	Intersegment	—			689				191			16			497			78				—				(1,471		)		—
	Total net revenues	2,763			5,334				4,939			21,590			5,869			7,676				154				(1,471		)		46,854
	Total net revenues	2,763			5,334				4,939			21,590			5,869			7,676				154				(1,471		)		46,854
	Operating income (loss)	1,087			2,859				2,908			2,432			2,478			115				(1,651		)		—				10,228
	Operating income (loss)	1,087			2,859				2,908			2,432			2,478			115				(1,651		)		—				10,228
	Interest income	—			—				—			—			—			—				534				—				534
	Interest income	—			—				—			—			—			—				534				—				534
	Interest expense	—			—				—			—			—			—				463				—				463
	Interest expense	—			—				—			—			—			—				463				—				463
	Depreciation and amortization	42			86				58			1,192			130			335				134				—				1,977
	Depreciation and amortization	42			86				58			1,192			130			335				134				—				1,977
Equity income (loss) — net	22			24				13			2			19			524				(2		)		—				602
Equity income (loss) — net	22			24				13			2			19			524				(2		)		—				602
Income (loss) before income taxes	1,109			2,923				2,920			2,434			2,494			679				(1,082		)		—				11,477
Income (loss) before income taxes	1,109			2,923				2,920			2,434			2,494			679				(1,082		)		—				11,477
Identifiable operating assets1	1,273			3,713			2	2,918			33,964			1,922			7,011			2	27,742				—				78,543
Identifiable operating assets1	1,273			3,713			2	2,918			33,964			1,922			7,011			2	27,742				—				78,543
Investments3	1,157			106				545			49			143			9,424				88				—				11,512
Investments3	1,157			106				545			49			143			9,424				88				—				11,512
Capital expenditures	40			34				63			1,374			117			643				279				—				2,550
Capital expenditures	40			34				63			1,374			117			643				279				—				2,550
2012
Net operating revenues:
Third party	$	2,697		$	4,481			$	4,560		$	21,665		$	5,680		$	8,807			$	127			$	—			$	48,017
Third party	$	2,697		$	4,481			$	4,560		$	21,665		$	5,680		$	8,807			$	127			$	—			$	48,017
Intersegment	—			642				271			15			628			88				—				(1,644		)		—
Intersegment	—			642				271			15			628			88				—				(1,644		)		—
Total net revenues	2,697			5,123				4,831			21,680			6,308			8,895				127				(1,644		)		48,017
Total net revenues	2,697			5,123				4,831			21,680			6,308			8,895				127				(1,644		)		48,017
Operating income (loss)	1,078			2,960				2,879			2,597			2,516			140				(1,391		)		—				10,779
Operating income (loss)	1,078			2,960				2,879			2,597			2,516			140				(1,391		)		—				10,779
Interest income	—			—				—			—			—			—				471				—				471
Interest income	—			—				—			—			—			—				471				—				471
Interest expense	—			—				—			—			—			—				397				—				397
Interest expense	—			—				—			—			—			—				397				—				397
Depreciation and amortization	33			100				70			1,083			119			406				171				—				1,982
Depreciation and amortization	33			100				70			1,083			119			406				171				—				1,982
Equity income (loss) — net	20			45				4			13			2			732				3				—				819
Equity income (loss) — net	20			45				4			13			2			732				3				—				819
Income (loss) before income taxes	1,101			3,015				2,882			2,624			2,523			904				(1,240		)		—				11,809
Income (loss) before income taxes	1,101			3,015				2,882			2,624			2,523			904				(1,240		)		—				11,809
Identifiable operating assets1	1,299			2,976			2	2,759			34,114			2,163			9,648			2	22,767				—				75,726
Identifiable operating assets1	1,299			2,976			2	2,759			34,114			2,163			9,648			2	22,767				—				75,726
Investments3	1,155			271				539			39			127			8,253				64				—				10,448
Investments3	1,155			271				539			39			127			8,253				64				—				10,448
Capital expenditures	51			30				88			1,447			107			867				190				—				2,780
Capital expenditures	51			30				88			1,447			107			867				190				—				2,780
2011
Net operating revenues:
Third party	$	2,590		$	4,777			$	4,403		$	20,559		$	5,553		$	8,501			$	159			$	—			$	46,542
Third party	$	2,590		$	4,777			$	4,403		$	20,559		$	5,553		$	8,501			$	159			$	—			$	46,542
Intersegment	—			697				287			12			536			90				—				(1,622		)		—
Intersegment	—			697				287			12			536			90				—				(1,622		)		—
Total net revenues	2,590			5,474				4,690			20,571			6,089			8,591				159				(1,622		)		46,542
Total net revenues	2,590			5,474				4,690			20,571			6,089			8,591				159				(1,622		)		46,542
Operating income (loss)	1,003			3,090				2,815			2,319			2,239			224				(1,517		)		—				10,173
Operating income (loss)	1,003			3,090				2,815			2,319			2,239			224				(1,517		)		—				10,173
Interest income	—			—				—			—			—			—				483				—				483
Interest income	—			—				—			—			—			—				483				—				483
Interest expense	—			—				—			—			—			—				417				—				417
Interest expense	—			—				—			—			—			—				417				—				417
Depreciation and amortization	30			109				63			1,065			115			403				169				—				1,954
Depreciation and amortization	30			109				63			1,065			115			403				169				—				1,954
Equity income (loss) — net	(3		)	33				20			6			1			646				(13		)		—				690
Equity income (loss) — net	(3		)	33				20			6			1			646				(13		)		—				690
Income (loss) before income taxes	1,001			3,134				2,832			2,327			2,242			897				(975		)		—				11,458
Income (loss) before income taxes	1,001			3,134				2,832			2,327			2,242			897				(975		)		—				11,458
Identifiable operating assets1	1,160			3,204			2	2,446			33,422			2,170			8,905			2	20,293				—				71,600
Identifiable operating assets1	1,160			3,204			2	2,446			33,422			2,170			8,905			2	20,293				—				71,600
Investments3	284			243				475			26			133			7,140				73				—				8,374
Investments3	284			243				475			26			133			7,140				73				—				8,374
Capital expenditures	50			38				105			1,364			128			1,039				196				—				2,920
Capital expenditures	50			38				105			1,364			128			1,039				196				—				2,920

1	Principally cash and cash equivalents, short-term investments, marketable securities, trade accounts receivable, inventories, goodwill, trademarks and other intangible assets and property, plant and equipment — net.

2	Property, plant and equipment — net in Germany represented 11 percent of consolidated property, plant and equipment — net in 2013, 10 percent in 2012 and 10 percent in 2011.

3	Principally equity method investments, available-for-sale securities and nonmarketable investments in bottling companies.
In 2013, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $2 million for Eurasia and Africa, $57 million for Europe, $282 million for North America, $26 million for Pacific, $194 million for Bottling Investments and $121 million for Corporate due to charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

•	Operating income (loss) and income (loss) before income taxes were reduced by $195 million for Corporate due to impairment charges recorded on certain of the Company's intangible assets. Refer to Note 8 and Note 17.

•	Operating income (loss) and income (loss) before income taxes were reduced by $22 million for Pacific due to charges associated with certain of the Company's fixed assets. Refer to Note 17.

•	Income (loss) before income taxes was increased by $615 million for Corporate due to a gain the Company recognized on the deconsolidation of our Brazilian bottling operations as a result of their combination with an independent bottling partner. Refer to Note 2.

•	Income (loss) before income taxes was reduced by $9 million for Bottling Investments and $140 million for Corporate due to the devaluation of the Venezuelan bolivar, including our proportionate share of the charge incurred by an equity method investee that has operations in Venezuela. Refer to Note 1 and Note 17.

•	Income (loss) before income taxes was reduced by a net $114 million for Corporate due to the merger of four of the Company's Japanese bottling partners in which we held equity method investments prior to their merger into CCEJ. Refer to Note 2 and Note 17.

•	Income (loss) before income taxes was increased by $139 million for Corporate due to a gain the Company recognized as a result of Coca-Cola FEMSA issuing additional shares of its own stock during the year at a per share amount greater than the carrying value of the Company's per share investment. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by a net $159 million for Bottling Investments due to the Company’s proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $53 million for Corporate due to charges the Company recognized on the early extinguishment of certain long-term debt, including the hedge accounting adjustments reclassified from accumulated other comprehensive income to earnings. Refer to Note 10.
In 2012, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $1 million for Europe, $227 million for North America, $3 million for Pacific, $164 million for Bottling Investments and $38 million for Corporate due to charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 18.

•	Operating income (loss) and income (loss) before income taxes were reduced by $21 million for North America due to costs associated with the Company detecting residues of carbendazim, a fungicide that is not registered in the United States for use on citrus products, in orange juice imported from Brazil for distribution in the United States. As a result, the Company began purchasing additional supplies of Florida orange juice at a higher cost than Brazilian orange juice. Refer to Note 17.

•	Operating income (loss) and income (loss) before income taxes were reduced by $20 million for North America due to changes in the Company's ready-to-drink tea strategy as a result of our U.S. license agreement with Nestlé that terminated at the end of 2012. Refer to Note 17.

•	Equity income (loss) — net and income (loss) before income taxes were increased by $8 million for Bottling Investments due to the Company’s proportionate share of unusual or infrequent items recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was increased by $185 million for Corporate due to the gain the Company recognized as a result of the merger of Andina and Polar. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $108 million for Corporate due to the loss the Company recognized on the pending sale of a majority ownership interest in our Philippine bottling operations to Coca-Cola FEMSA, which was completed in January 2013. As of December 31, 2012, the assets and liabilities associated with our Philippine bottling operations were classified as held for sale in our consolidated balance sheets. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was increased by $92 million for Corporate due to a gain the Company recognized as a result of Coca-Cola FEMSA issuing additional shares of its own stock during the year at a per share amount greater than the carrying amount of the Company's per share investment. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $82 million for Corporate due to the Company acquiring an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. This premium was expensed on the acquisition date. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $16 million for Corporate due to other-than-temporary declines in the fair values of certain cost method investments. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $1 million for Eurasia and Africa, $4 million for Europe, $2 million for Latin America and $4 million for Pacific due to changes in the structure of BPW, our 50/50 joint venture with Nestlé in the ready-to-drink tea category. Refer to Note 17.
In 2011, the results of our operating segments were impacted by the following items:

•	Operating income (loss) and income (loss) before income taxes were reduced by $12 million for Eurasia and Africa, $25 million for Europe, $4 million for Latin America, $374 million for North America, $4 million for Pacific, $89 million for Bottling Investments and $164 million for Corporate, primarily due to the Company's ongoing productivity, integration and restructuring initiatives as well as costs associated with the merger of Arca and Contal. Refer to Note 18 for additional information on our productivity, integration and restructuring initiatives. Refer to Note 17 for additional information related to the merger of Arca and Contal.

•	Operating income (loss) and income (loss) before income taxes were reduced by $82 million for Pacific and $2 million for North America due to charges associated with the earthquake and tsunami that devastated northern and eastern Japan on March 11, 2011. Refer to Note 17.

•	Operating income (loss) and income (loss) before income taxes were reduced by $10 million for Corporate due to charges associated with the floods in Thailand that impacted the Company's supply chain operations in the region. Refer to Note 17.

•	Equity income (loss) — net and income (loss) before income taxes were reduced by $53 million for Bottling Investments, primarily attributable to the Company's proportionate share of asset impairments and restructuring charges recorded by certain of our equity method investees. Refer to Note 17.

•	Income (loss) before income taxes was increased by a net $417 million for Corporate, primarily due to the gain the Company recognized as a result of the merger of Arca and Contal. Refer to Note 17.

•	Income (loss) before income taxes was increased by a net $122 million for Corporate, primarily due to gains the Company recognized as a result of Coca-Cola FEMSA issuing additional shares of its own stock during the year at per share amounts greater than the carrying value of the Company's per share investment. These gains were partially offset by charges associated with certain of the Company's equity method investments in Japan. Refer to Note 17.

•	Income (loss) before income taxes was increased by $102 million for Corporate, primarily due to the gain on the sale of our investment in Embonor, a bottling partner with operations primarily in Chile. Prior to this transaction, the Company accounted for our investment in Embonor under the equity method of accounting. Refer to Note 17.

•	Income (loss) before income taxes was reduced by $41 million for Corporate due to the impairment of an investment in an entity accounted for under the equity method of accounting. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $17 million for Corporate due to other-than-temporary impairments of certain available-for-sale securities. Refer to Note 16 and Note 17.

•	Income (loss) before income taxes was reduced by $9 million for Corporate due to the net charge we recognized on the repurchase and/or exchange of certain long-term debt assumed in connection with our acquisition of CCE's former North America business as well as the early extinguishment of certain other long-term debt. Refer to Note 10.

•	Income (loss) before income taxes was reduced by $5 million for Corporate due to the finalization of working capital adjustments related to the sale of our Norwegian and Swedish bottling operations to CCE. Refer to Note 2 and Note 17.

NET_CHANGE_IN_OPERATING_ASSETS

NET CHANGE IN OPERATING ASSETS AND LIABILITIES	12 Months Ended
	Dec. 31, 2013
NET CHANGE IN OPERATING ASSETS AND LIABILITIES DISCLOSURE [Abstract]	'
NET CHANGE IN OPERATING ASSETS AND LIABILITIES	'
	NET CHANGE IN OPERATING ASSETS AND LIABILITIES
	Net cash provided by (used in) operating activities attributable to the net change in operating assets and liabilities is composed of the following (in millions):


	Year Ended December 31,	2013			2012			2011

	(Increase) decrease in trade accounts receivable	$	28		$	(33	)	$	(562	)

	(Increase) decrease in inventories	(105		)	(286		)	(447		)
	(Increase) decrease in prepaid expenses and other assets	(163		)	(29		)	(350		)
	Increase (decrease) in accounts payable and accrued expenses	(158		)	(556		)	63

	Increase (decrease) in accrued taxes	22			770			(132		)

	Increase (decrease) in other liabilities	(556		)	(946		)	(465		)
	Net change in operating assets and liabilities	$	(932	)	$	(1,080	)	$	(1,893	)

SUBSEQUENT_EVENT

SUBSEQUENT EVENT	12 Months Ended
SUBSEQUENT EVENT	Dec. 31, 2013
Subsequent Events [Abstract]	'
Subsequent Event [Text Block]	'
	SUBSEQUENT EVENT
	On February 5, 2014, the Company entered into agreements with Green Mountain Coffee Roasters, Inc. ("GMCR"), providing for the development and introduction of the Company’s global brand portfolio for use in GMCR’s forthcoming Keurig ColdTM at-home beverage system and the acquisition by the Company of an approximate 10 percent equity position in GMCR. Under the terms of the equity agreement, a wholly-owned subsidiary of the Company agreed to purchase 16,684,139 newly issued shares in GMCR for approximately $1.25 billion. The newly issued shares have been priced at $74.98, which represents the trailing 50-trading-day volume weighted-average price as of the agreement date. The transaction closed on February 27, 2014.

BUSINESS_AND_SUMMARY_OF_SIGNIF1

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)

12 Months Ended

Dec. 31, 2013

Summary of Significant Accounting Policies [Abstract]

Principles of Consolidation

Creditors of our VIEs do not have recourse against the general credit of the Company, regardless of whether they are accounted for as consolidated entities.

Revenue Recognition

Deductions from Revenue

Advertising Costs

Shipping and Handling Costs

Net Income Per Share

Cash Equivalents

Short-term Investments

Short-Term Investments

We classify time deposits and other investments that have maturities of greater than three months but less than one year as short-term investments.

Investments in Equity and Debt Securities

Trade Accounts Receivable

Year Ended December 31,

2013

2012

2011

Balance at beginning of year

Net charges to costs and expenses

Write-offs

(14

)

(19

)

(12

)

Other1

)

(16

)

Balance at end of year

Other includes foreign currency translation and the impact of transferring the assets of our consolidated Philippine and Brazilian bottling operations to assets held for sale. See Note 2.

Inventories

Derivative Instruments

Property, Plant and Equipment

Goodwill, Trademarks and Other Intangible Assets

Contingencies

Stock-Based Compensation

Pension and Other Postretirement Benefit Plans

Income Taxes

Translation and Remeasurement

Hyperinflationary Economies

BUSINESS_AND_SUMMARY_OF_SIGNIF2

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2013
Summary of Significant Accounting Policies [Abstract]	'
Activity in allowance for doubtful accounts	'
	Activity in the allowance for doubtful accounts was as follows (in millions):


	Year Ended December 31,	2013			2012			2011

	Balance at beginning of year	$	53		$	83		$	48

	Net charges to costs and expenses	30			5			56

	Write-offs	(14		)	(19		)	(12		)
	Other1	(8		)	(16		)	(9		)
	Balance at end of year	$	61		$	53		$	83


	1	Other includes foreign currency translation and the impact of transferring the assets of our consolidated Philippine and Brazilian bottling operations to assets held for sale. See Note 2.

ACQUISITIONS_AND_DIVESTITURES_

ACQUISITIONS AND DIVESTITURES (Tables)	12 Months Ended
	Dec. 31, 2013
Acquisitions and Divestitures Disclosure [	'
Disclosure of Assets and Liabilities Held-for-sale [Table Text Block]	'
	The following table presents information related to the major classes of assets and liabilities of the Company's Philippine and Brazilian bottling operations, both of which are included in our Bottling Investments operating segment, as of December 31, 2012 (in millions):


		Philippine Bottling Operations			Brazilian Bottling Operations		Total Bottling
							Operations
							Held for Sale
	Cash, cash equivalents and short-term investments	$	133		$	45	$	178

	Trade accounts receivable, less allowances	108			88		196

	Inventories	187			85		272

	Prepaid expenses and other assets	223			174		397

	Other assets	7			128		135

	Property, plant and equipment — net	841			419		1,260

	Bottlers' franchise rights with indefinite lives	341			130		471

	Goodwill	148			22		170

	Other intangible assets	—			1		1

	Allowance for reduction of assets held for sale	(107		)	—		(107		)

	Total assets	$	1,881		$	1,092	$	2,973

	Accounts payable and accrued expenses	$	241		$	157	$	398

	Loans and notes payable	—			6		6

	Current maturities of long-term debt	—			28		28

	Accrued income taxes	(4		)	4		—

	Long-term debt	—			147		147

	Other liabilities	20			75		95

	Deferred income taxes	102			20		122

	Total liabilities	$	359		$	437	$	796

INVESTMENTS_Tables

INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Investments Disclosure [Abstract]	'
Schedule of trading securities	'
	The Company's trading securities were included in the following captions in our consolidated balance sheets (in millions):


	December 31,	2013			2012

	Marketable securities	$	286		$	184

	Other assets	86			82

	Total trading securities	$	372		$	266

Certain Debt and Marketable Equity Securities, Available-for-Sale And Held-To-Maturity Securities, Value and Maturities	'
	As of December 31, 2013 and 2012, the Company did not have any held-to-maturity securities. Available-for-sale securities consisted of the following (in millions):


					Gross Unrealized						Estimated Fair Value
		Cost			Gains			Losses
	2013
	Available-for-sale securities:1,2
	Equity securities	$	1,097		$	373		$	(17	)	$	1,453

	Debt securities	3,388			24			(23		)	3,389

		$	4,485		$	397		$	(40	)	$	4,842

	2012
	Available-for-sale securities:1,2
	Equity securities	$	957		$	441		$	(10	)	$	1,388

	Debt securities	3,169			46			(10		)	3,205

		$	4,126		$	487		$	(20	)	$	4,593


	1	Refer to Note 16 for additional information related to the estimated fair value.

	2	During 2012, the Company made a change to its overall cash management program. In an effort to manage counterparty risk and diversify our assets, the Company began to make additional investments in high-quality securities. These investments are primarily classified as available-for-sale securities.
Schedule of Realized Gain (Loss) [Table Text Block]	'
	The sale and/or maturity of available-for-sale securities resulted in the following activity (in millions):


	Year Ended December 31,	2013			2012			2011

	Gross gains	$	12		$	41		$	5

	Gross losses	(24		)	(35		)	(1		)
	Proceeds	4,212			5,036			37

Investments By Balance Sheet Grouping	'
	The Company's available-for-sale securities were included in the following captions in our consolidated balance sheets (in millions):


	December 31,	2013			2012

	Cash and cash equivalents	$	245		$	9

	Marketable securities	2,861			2,908

	Other investments, principally bottling companies	958			1,087

	Other assets	778			589

		$	4,842		$	4,593

Contractual maturity amounts of the investment securities	'
	The contractual maturities of these investments as of December 31, 2013, were as follows (in millions):


		Available-for-Sale Securities
		Cost			Fair Value

	Within 1 year	$	1,227		$	1,227

	After 1 year through 5 years	1,669			1,672

	After 5 years through 10 years	156			161

	After 10 years	336			329

	Equity securities	1,097			1,453

		$	4,485		$	4,842

INVENTORIES_Tables

INVENTORIES (Tables)	12 Months Ended
	Dec. 31, 2013
Inventories [Abstract]	'
Inventories [Table Text Block]	'
	Inventories consisted of the following (in millions):


	December 31,	2013		2012

	Raw materials and packaging	$	1,692	$	1,773

	Finished goods	1,240		1,171

	Other	345		320

	Total inventories	$	3,277	$	3,264

HEDGING_TRANSACTIONS_AND_DERIV1

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Hedging Transactions and Derivative Financial Instruments Disclosures [Abstract]	'
Derivative instruments, fair value, designated as hedging instruments	'
	The following table presents the fair values of the Company's derivative instruments that were designated and qualified as part of a hedging relationship (in millions):


				Fair Value1,2
	Derivatives Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2013				2012
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	211			$	149

	Foreign currency contracts	Other assets		109				—

	Commodity contracts	Prepaid expenses and other assets		1				—

	Interest rate contracts	Prepaid expenses and other assets		—				7

	Interest rate contracts	Other assets		283				335

	Total assets			$	604			$	491

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	84			$	55

	Foreign currency contracts	Other liabilities		40				—

	Commodity contracts	Accounts payable and accrued expenses		1				1

	Interest rate contracts	Other liabilities		—				6

	Total liabilities			$	125			$	62


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
Derivative instruments, fair value, not designated as hedging instruments	'
	The following table presents the fair values of the Company's derivative instruments that were not designated as hedging instruments (in millions):


				Fair Value1,2
	Derivatives Not Designated as Hedging Instruments	Balance Sheet Location1		December 31,				December 31,
				2013				2012
	Assets:
	Foreign currency contracts	Prepaid expenses and other assets		$	21			$	19

	Foreign currency contracts	Other assets		171				42

	Commodity contracts	Prepaid expenses and other assets		33				72

	Commodity contracts	Other assets		1				—

	Other derivative instruments	Prepaid expenses and other assets		9				6

	Total assets			$	235			$	139

	Liabilities:
	Foreign currency contracts	Accounts payable and accrued expenses		$	24			$	24

	Foreign currency contracts	Other liabilities		—				1

	Commodity contracts	Accounts payable and accrued expenses		23				43

	Commodity contracts	Other liabilities		—				1

	Interest rate contracts	Other liabilities		3				—

	Other derivative instruments	Accounts payable and accrued expenses		—				2

	Total liabilities			$	50			$	71


	1	All of the Company's derivative instruments are carried at fair value in our consolidated balance sheets after considering the impact of legally enforceable master netting agreements and cash collateral held or placed with the same counterparties, as applicable. Current disclosure requirements mandate that derivatives must also be disclosed without reflecting the impact of master netting agreements and cash collateral. Refer to Note 16 for the net presentation of the Company's derivative instruments.

	2	Refer to Note 16 for additional information related to the estimated fair value.
Derivative instruments, pretax impact that changes in the fair value of the derivatives designated as hedges had on AOCI and earnings	'
	The following table presents the pretax impact that changes in the fair values of derivatives designated as cash flow hedges had on AOCI and earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


		Gain (Loss)				Location of Gain (Loss)		Gain (Loss)				Gain (Loss)
		Recognized				Recognized in Income1		Reclassified from				Recognized in Income
		in Other						AOCI into Income				(Ineffective Portion and
		Comprehensive						(Effective Portion)				Amount Excluded from
		Income ("OCI")										Effectiveness Testing)
	2013
	Foreign currency contracts	$	218			Net operating revenues		$	149			$	1

	Foreign currency contracts	52				Cost of goods sold		32				—			2

	Interest rate contracts	169				Interest expense		(12		)		(3		)

	Commodity contracts	2				Cost of goods sold		(2		)		—

	Total	$	441					$	167			$	(2	)

	2012
	Foreign currency contracts	$	59			Net operating revenues		$	(46	)		$	2

	Foreign currency contracts	34				Cost of goods sold		(23		)		—

	Interest rate contracts	1				Interest expense		(12		)		—			2

	Commodity contracts	(4		)		Cost of goods sold		(1		)		—

	Total	$	90					$	(82	)		$	2

	2011
	Foreign currency contracts	$	3			Net operating revenues		$	(231	)		$	—		2

	Interest rate contracts	(11		)		Interest expense		(12		)		(1		)
	Commodity contracts	(1		)		Cost of goods sold		—				—

	Total	$	(9	)				$	(243	)		$	(1	)

	1	The Company records gains and losses reclassified from AOCI in income for the effective portion and ineffective portion, if any, to the same line items in our consolidated statements of income.

	2	Includes a de minimis amount of ineffectiveness in the hedging relationship.
Derivative instruments, fair value hedges, gain (loss) recognized in income	'
	The following table summarizes the pretax impact that changes in the fair values of derivatives designated as fair value hedges had on earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


	Hedging Instruments and Hedged Items	Location of Gain (Loss)	Gain (Loss)
		Recognized in Income	Recognized in Income1
	2013
	Interest rate contracts	Interest expense	$	(193	)
	Fixed-rate debt	Interest expense	240

	Net impact to interest expense		$	47

	Foreign currency contracts	Other income (loss) — net	$	24

	Available-for-sale securities	Other income (loss) — net	(48		)
	Net impact to other income (loss) — net		$	(24	)
	Net impact of fair value hedging instruments		$	23

	2012
	Interest rate contracts	Interest expense	$	89

	Fixed-rate debt	Interest expense	(42		)
	Net impact to interest expense		$	47

	Foreign currency contracts	Other income (loss) — net	$	42

	Available-for-sale securities	Other income (loss) — net	(46		)
	Net impact to other income (loss) — net		$	(4	)
	Net impact of fair value hedging instruments		$	43

	2011
	Interest rate contracts	Interest expense	$	343

	Fixed-rate debt	Interest expense	(333		)
	Net impact to interest expense		$	10

Derivative instruments,fair value of net investment hedges, gain (loss) recognized in AOCI	'
	The following table presents the pretax impact that changes in the fair values of derivatives designated as net investment hedges had on AOCI during the years ended December 31, 2013, 2012 and 2011 (in millions):


		Gain (Loss)
		Recognized in OCI
	Year Ended December 31,	2013				2012				2011

	Foreign currency contracts	$	61			$	(61	)		$	(3	)

Derivative instruments, not designated as hedging instruments, gain (loss) in earnings	'
	The following table presents the pretax impact that changes in the fair values of derivatives not designated as hedging instruments had on earnings during the years ended December 31, 2013, 2012 and 2011 (in millions):


				Gains (Losses)
	Derivatives Not Designated	Location of Gains (Losses)		Year Ended December 31,
	as Hedging Instruments	Recognized in Income		2013				2012				2011

	Foreign currency contracts	Net operating revenues		$	5			$	(7	)		$	7

	Foreign currency contracts	Other income (loss) — net		162				24				(37		)

	Foreign currency contracts	Cost of goods sold		2				—				(12		)

	Commodity contracts	Net operating revenues		5				4				—

	Commodity contracts	Cost of goods sold		(122		)		(110		)		(42		)
	Commodity contracts	Selling, general and administrative expenses		7				9				(11		)

	Interest rate swaps	Interest expense		(3		)		—				—

	Other derivative instruments	Selling, general and administrative expenses		55				18				8

	Total			$	111			$	(62	)		$	(87	)

EQUITY_METHOD_INVESTMENTS_Tabl

EQUITY METHOD INVESTMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
EQUITY METHOD INVESTMENTS [Abstract]	'
Summary of financial information for equity method investees	'
	A summary of financial information for our equity method investees in the aggregate is as follows (in millions):


	Year Ended December 31,	2013		2012		2011

	Net operating revenues	$	53,038	$	47,087	$	42,472

	Cost of goods sold	32,377		28,821		26,271

	Gross profit	$	20,661	$	18,266	$	16,201

	Operating income	$	4,380	$	4,605	$	4,181

	Consolidated net income	$	2,364	$	2,993	$	2,237

	Less: Net income attributable to noncontrolling interests	62		89		99

	Net income attributable to common shareowners	$	2,302	$	2,904	$	2,138

	Equity income (loss) — net	$	602	$	819	$	690



	December 31,	2013		2012

	Current assets	$	19,229	$	16,054

	Noncurrent assets	40,427		32,687

	Total assets	$	59,656	$	48,741

	Current liabilities	$	14,386	$	12,004

	Noncurrent liabilities	17,779		12,272

	Total liabilities	$	32,165	$	24,276

	Equity attributable to shareowners of investees	$	26,668	$	23,827

	Equity attributable to noncontrolling interests	823		638

	Total equity	$	27,491	$	24,465

	Company equity investment	$	10,393	$	9,216

PROPERTY_PLANT_AND_EQUIPMENT_T

PROPERTY, PLANT AND EQUIPMENT (Tables)	12 Months Ended
	Dec. 31, 2013
Property Plant and Equipament [Abstract]	'
Property, Plant and Equipment [Table Text Block]	'
	The following table summarizes our property, plant and equipment (in millions):


	December 31,	2013		2012

	Land	$	1,011	$	997

	Buildings and improvements	5,605		5,307

	Machinery, equipment and vehicle fleet	17,551		16,203

	Construction in progress	865		979

		$	25,032	$	23,486

	Less accumulated depreciation	10,065		9,010

	Property, plant and equipment — net	$	14,967	$	14,476

INTANGIBLE_ASSETS_Tables

INTANGIBLE ASSETS (Tables)	12 Months Ended
	Dec. 31, 2013
INTANGIBLE ASSETS [Abstract]	'
Indefinite-lived intangible assets	'
	The following table summarizes information related to indefinite-lived intangible assets (in millions):


	December 31,	2013				2012

	Trademarks1	$	6,744			$	6,527

	Bottlers' franchise rights	7,415				7,405

	Goodwill	12,312				12,255

	Other	171				111

	Indefinite-lived intangible assets2	$	26,642			$	26,298

	1 The increase in 2013 was primarily related to the Company's consolidation of innocent. Refer to Note 2 for additional information. This increase was partially offset by impairments on certain trademarks. Refer to Note 17 for additional information.
	2 During 2010, we entered into license agreements with Dr Pepper Snapple Group, Inc. ("DPSG") to distribute Dr Pepper trademark brands in the United States, Canada Dry in the Northeastern United States, and Canada Dry and C' Plus in Canada. As a result, the Company recorded an asset of $865 million related to the DPSG license agreements. Under the license agreements, the Company agreed to meet certain performance obligations in order to distribute DPSG products in retail and foodservice accounts and vending machines. The license agreements have initial terms of 20 years, with automatic 20-year renewal periods unless otherwise terminated under the terms of the agreements. The Company anticipates using the assets indefinitely. The distribution rights acquired from DPSG are the only significant indefinite-lived intangible assets subject to renewal or extension arrangements.
Carrying value of goodwill by operating segment	'
	The following table provides information related to the carrying value of our goodwill by operating segment (in millions):


		Eurasia &				Europe				Latin				North				Pacific			Bottling			Total
		Africa								America				America							Investments
	2012
	Balance as of January 1	$	35			$	710			$	163			$	10,515			$	117		$	679		$	12,219

	Effect of foreign currency translation	(1		)		(19		)		5				—				6			(4		)	(13		)

	Acquisitions1	—				—				—				100				—			157			257

	Adjustments related to the finalization	—				—				—				(38		)		—			—			(38		)
	of purchase accounting1
	Divestitures, deconsolidations and other2	—				—				—				—				—			(170		)	(170		)

	Balance as of December 31	$	34			$	691			$	168			$	10,577			$	123		$	662		$	12,255

	2013
	Balance as of January 1	$	34			$	691			$	168			$	10,577			$	123		$	662		$	12,255

	Effect of foreign currency translation	(3		)		29				(12		)		—				(6		)	10			18

	Acquisitions1	5				102				—				—				—			20			127

	Adjustments related to the finalization	—				—				—				(4		)		—			(1		)	(5		)
	of purchase accounting1
	Impairment3	—				—				—				—				—			(82		)	(82		)

	Divestitures, deconsolidations and other	—				—				—				(1		)		—			—			(1		)

	Balance as of December 31	$	36			$	822			$	156			$	10,572			$	117		$	609		$	12,312


	1	Refer to Note 2 for information related to the Company's acquisitions and divestitures.

	2	Relates to the transfer of goodwill associated with the Company's consolidated Philippine and Brazilian bottling operations to assets held for sale as of December 31, 2012. Refer to Note 2 for additional information related to these transactions.
	3 Refer to Note 17 for information related to the Company's impairment of goodwill.
Definite-lived intangible assets	'
	The following table summarizes information related to definite-lived intangible assets (in millions):


		December 31, 2013										December 31, 2012
		Gross Carrying Amount			Accumulated Amortization			Net				Gross Carrying Amount			Accumulated Amortization			Net

	Customer relationships	$	642		$	(202	)	$	440			$	622		$	(166	)	$	456

	Bottlers' franchise rights	722			(317		)	405				730			(221		)	509

	Trademarks	105			(26		)	79				65			(43		)	22

	Other	128			(83		)	45				129			(77		)	52

	Total	$	1,597		$	(628	)	$	969			$	1,546		$	(507	)	$	1,039

Estimated amortization expense for the next five years	'
	Based on the carrying value of definite-lived intangible assets as of December 31, 2013, we estimate our amortization expense for the next five years will be as follows (in millions):


			Amortization
			Expense
	2014		$	160

	2015		152

	2016		145

	2017		112

	2018		54

ACCOUNTS_PAYABLE_AND_ACCRUED_E1

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)	12 Months Ended
	Dec. 31, 2013
ACCOUNTS PAYABLE AND ACCRUED EXPENSES Disclosure [Abstract]	'
Schedule of Accounts Payable and Accrued Expenses [Table Text Block]	'
	Accounts payable and accrued expenses consisted of the following (in millions):


	December 31,	2013		2012

	Accrued marketing	$	2,407	$	2,231

	Other accrued expenses	3,515		2,711

	Trade accounts payable	1,933		1,969

	Accrued compensation	933		1,045

	Sales, payroll and other taxes	450		389

	Container deposits	339		335

	Accounts payable and accrued expenses	$	9,577	$	8,680

DEBT_AND_BORROWING_ARRANGEMENT1

DEBT AND BORROWING ARRANGEMENTS (Tables)	12 Months Ended
DEBT AND BORROWING ARRANGEMENTS (Tables)	Dec. 31, 2013
Debt and Borrowing Arrangements Disclosure [Abstract]	'
Components of long-term debt	'
	The Company's long-term debt consisted of the following (in millions, except average rate data):


		December 31, 2013				December 31, 2012
		Amount		Average		Amount		Average
		Amount		Rate 1		Amount		Rate1
	U.S. dollar notes due 2014–2093	$	17,427	1.8	%	$	13,407	1.7	%
	U.S. dollar notes due 2014–2093	$	17,427	1.8	%	$	13,407	1.7	%
	U.S. dollar debentures due 2017–2098	2,191		3.9		2,207		3.7
	U.S. dollar debentures due 2017–2098	2,191		3.9		2,207		3.7
	U.S. dollar zero coupon notes due 20202	138		8.4		135		8.4
	U.S. dollar zero coupon notes due 20202	138		8.4		135		8.4
	Other, due through 20983	370		4		291		4.4
	Other, due through 20983	370		4		291		4.4
	Fair value adjustment4	52		N/A		273		N/A
	Fair value adjustment4	52		N/A		273		N/A
	Total5,6	$	20,178	2.2	%	$	16,313	2.1	%
	Total5,6	$	20,178	2.2	%	$	16,313	2.1	%
	Less current portion	1,024				1,577
	Less current portion	1,024				1,577
	Long-term debt	$	19,154			$	14,736
	Long-term debt	$	19,154			$	14,736

	1	These rates represent the weighted-average effective interest rate on the balances outstanding as of year end, as adjusted for the effects of interest rate swap agreements as well as fair value adjustments, if applicable. Refer to Note 5 for a more detailed discussion on interest rate management.

	2	This amount is shown net of unamortized discounts of $33 million and $36 million as of December 31, 2013 and 2012, respectively.

	3	As of December 31, 2013, the amount shown includes $167 million of debt instruments that are due through 2022.

	4	Refer to Note 5 for additional information about our fair value hedging strategy.

	5	As of December 31, 2013 and 2012, the fair value of our long-term debt, including the current portion, was $20,352 million and $17,157 million, respectively. The fair value of our long-term debt is estimated based on quoted prices for those or similar instruments.

	6	The above notes and debentures include various restrictions, none of which is presently significant to our Company.
Schedule of Maturities of Long-term Debt	'
	Maturities of long-term debt for the five years succeeding December 31, 2013, are as follows (in millions):


		Maturities of
		Long-Term Debt
	2014	$	1,024
	2014	$	1,024
	2015	2,573
	2015	2,573
	2016	2,681
	2016	2,681
	2017	1,394
	2017	1,394
	2018	3,298
	2018	3,298

COMMITMENTS_AND_CONTINGENCIES_

COMMITMENTS AND CONTINGENCIES (Tables)	12 Months Ended
	Dec. 31, 2013
Commitments and Contingencies Disclosure [Abstract]	'
Lease payments under noncancelable operating leases	'
	The following table summarizes our minimum lease payments under noncancelable operating leases with initial or remaining lease terms in excess of one year as of December 31, 2013 (in millions):


	Year Ended December 31,	Operating Lease Payments

	2014	$	252

	2015	180

	2016	142

	2017	107

	2018	88

	Thereafter	276

	Total minimum operating lease payments1	$	1,045


	1	Income associated with sublease arrangements is not significant.

STOCK_COMPENSATION_PLANS_Table

STOCK COMPENSATION PLANS (Tables)	12 Months Ended
	Dec. 31, 2013
STOCK COMPENSATION PLANS [Abstract]	'
Weighted-average fair value of options granted and the weighted-average assumptions used in the Black Scholes Merton option pricing model for such grants	'
	The weighted-average fair value of options granted during the past three years and the weighted-average assumptions used in the Black-Scholes-Merton option-pricing model for such grants were as follows:


		2013				2012				2011

	Fair value of options at grant date	$	3.73			$	3.8			$	4.64

	Dividend yield1	2.8		%		2.7		%		2.7		%
	Expected volatility2	17		%		18		%		19		%
	Risk-free interest rate3	0.9		%		1		%		2.3		%
	Expected term of the option4	5 years				5 years				5 years


	1	The dividend yield is the calculated yield on the Company's stock at the time of the grant.

	2	Expected volatility is based on implied volatilities from traded options on the Company's stock, historical volatility of the Company's stock and other factors.

	3	The risk-free interest rate for the period matching the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of the grant.

	4	The expected term of the option represents the period of time that options granted are expected to be outstanding and is derived by analyzing historical exercise behavior.
Stock option activity for all stock option plans	'
	Stock option activity for all stock option plans for the year ended December 31, 2013, was as follows:


		Shares			Weighted-Average				Weighted-Average		Aggregate
		(In millions)			Exercise Price				Remaining		Intrinsic Value
									Contractual Life		(In millions)
	Outstanding on January 1, 2013	309			$	27.27

	Granted	56			37.68

	Exercised	(53	)		25.02

	Forfeited/expired	(7	)		34.34

	Outstanding on December 31, 20131	305			$	29.42			5.82 years		$	3,636

	Expected to vest at December 31, 2013	302			$	29.33			5.78 years		$	3,614

	Exercisable on December 31, 2013	187			$	25.87			4.25 years		$	2,887


	1	Includes 3 million stock option replacement awards in connection with our acquisition of CCE's former North America business in 2010. These options had a weighted-average exercise price of $18.02, and generally vest over 3 years and expire 10 years from the original date of grant.
Summary of information about performance share units based on the Target Award amounts in the performance share unit agreements	'
	The following table summarizes information about performance share units based on the target award amounts in the performance share unit agreements:


		Share Units			Weighted-Average
		(In thousands)			Grant Date
					Fair Value
	Outstanding on January 1, 2013	17,584			$	28.01

	Granted	6,425			32.67

	Conversions of restricted stock units1	(5,220	)		25.17

	Paid in cash equivalent	(55	)		32.25

	Canceled/forfeited	(760	)		30.33

	Outstanding on December 31, 20132	17,974			$	30.41


	1	Represents the target amount of performance share units converted to restricted stock units based on the financial results for the 2010-2012 performance period. The vesting of restricted stock units is subject to the terms of the performance share unit agreements.

	2	The outstanding performance share units as of December 31, 2013, at the threshold award and maximum award levels were 9.0 million and 27.0 million, respectively.
Summary of conversion of performance share units to restricted stock and restricted stock units	'
	The following table summarizes information about the conversions of performance share units to restricted stock and restricted stock units:


		Share Units			Weighted-Average
		(In thousands)			Grant Date
					Fair Value1
	Nonvested on January 1, 20132	98			$	26.54

	Conversions of restricted stock units3	7,830			25.17

	Vested and released	(406	)		25.52

	Canceled/forfeited	(508	)		25.17

	Nonvested on December 31, 20132	7,014			$	25.17


	1	The weighted-average grant date fair value is based on the fair values of the performance share units granted.

	2	The nonvested shares as of January 1, 2013, and December 31, 2013, are presented at the performance share units' certified award level.

PENSION_AND_OTHER_POSTRETIREME1

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Tables)	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Tables)	Dec. 31, 2013
Pension and Other Postretirement Benefit Plans [Abstract]	'
Changes in benefit obligations and the fair value of plan assets for our benefit plans	'
	The following table sets forth the changes in benefit obligations and the fair value of plan assets for our benefit plans (in millions):


		Pension Benefits								Other Benefits
		2013				2012				2013			2012
		2013				2012				2013			2012
	Benefit obligation at beginning of year1	$	9,693			$	8,255			$	1,104		$	953
	Benefit obligation at beginning of year1	$	9,693			$	8,255			$	1,104		$	953
	Service cost	280				291				36			34
	Service cost	280				291				36			34
	Interest cost	378				388				42			43
	Interest cost	378				388				42			43
	Foreign currency exchange rate changes	(69		)		(7		)		(2		)	3
	Foreign currency exchange rate changes	(69		)		(7		)		(2		)	3
	Amendments	(1		)		(3		)		(73		)	(2		)
	Actuarial loss (gain)	(899		)		1,259				(91		)	115
	Actuarial loss (gain)	(899		)		1,259				(91		)	115
	Benefits paid2	(538		)		(420		)		(77		)	(53		)
	Settlements	(9		)		(35		)		—			—
	Settlements	(9		)		(35		)		—			—
	Curtailments	—				6				—			—
	Curtailments	—				6				—			—
	Special termination benefits	2				1				—			—
	Special termination benefits	2				1				—			—
	Other3	8				(42		)		7			11
	Other3	8				(42		)		7			11
	Benefit obligation at end of year1	$	8,845			$	9,693			$	946		$	1,104
	Benefit obligation at end of year1	$	8,845			$	9,693			$	946		$	1,104
	Fair value of plan assets at beginning of year	$	7,584			$	6,171			$	202		$	185
	Fair value of plan assets at beginning of year	$	7,584			$	6,171			$	202		$	185
	Actual return on plan assets	1,043				822				40			16
	Actual return on plan assets	1,043				822				40			16
	Employer contributions	639				1,056				—			—
	Employer contributions	639				1,056				—			—
	Foreign currency exchange rate changes	(43		)		(17		)		—			—
	Foreign currency exchange rate changes	(43		)		(17		)		—			—
	Benefits paid	(474		)		(366		)		(2		)	(2		)
	Settlements	(5		)		(34		)		—			—
	Settlements	(5		)		(34		)		—			—
	Other3	2				(48		)		3			3
	Other3	2				(48		)		3			3
	Fair value of plan assets at end of year	$	8,746			$	7,584			$	243		$	202
	Fair value of plan assets at end of year	$	8,746			$	7,584			$	243		$	202
	Net liability recognized	$	(99	)		$	(2,109	)		$	(703	)	$	(902	)

	1	For pension benefit plans, the benefit obligation is the projected benefit obligation. For other benefit plans, the benefit obligation is the accumulated postretirement benefit obligation. The accumulated benefit obligation for our pension plans was $8,523 million and $9,345 million as of December 31, 2013 and 2012, respectively.

	2	Benefits paid to pension plan participants during 2013 and 2012 included $64 million and $54 million, respectively, in payments related to unfunded pension plans that were paid from Company assets. Benefits paid to participants of other benefit plans during 2013 and 2012 included $75 million and $51 million, respectively, that were paid from Company assets.

	3	In 2012, primarily relates to the transfer of assets and liabilities associated with the Company's consolidated Philippine bottling operations to assets held for sale and liabilities held for sale as of December 31, 2012. Refer to Note 2 for additional information.
Pension and other benefit amounts recognized in consolidated balance sheets	'
	Pension and other benefit amounts recognized in our consolidated balance sheets are as follows (in millions):


		Pension Benefits								Other Benefits
	December 31,	2013				2012				2013			2012
	December 31,	2013				2012				2013			2012
	Noncurrent asset	$	1,067			$	395			$	—		$	—
	Noncurrent asset	$	1,067			$	395			$	—		$	—
	Current liability	(76		)		(73		)		(21		)	(21		)
	Long-term liability	(1,090		)		(2,431		)		(682		)	(881		)
	Net liability recognized	$	(99	)		$	(2,109	)		$	(703	)	$	(902	)
Schedule of pension plans with projected benefit obligation in excess of fair value of plan assets	'
	Certain of our pension plans have projected benefit obligations in excess of the fair value of plan assets. For these plans, the projected benefit obligations and the fair value of plan assets were as follows (in millions):


	December 31,	2013				2012
	December 31,	2013				2012
	Projected benefit obligation	$	1,521			$	9,161
	Projected benefit obligation	$	1,521			$	9,161
	Fair value of plan assets	374				6,659
	Fair value of plan assets	374				6,659
Accumulated benefit obligations in excess of fair value of plan assets	'
	Certain of our pension plans have accumulated benefit obligations in excess of the fair value of plan assets. For these plans, the accumulated benefit obligations and the fair value of plan assets were as follows (in millions):


	December 31,	2013				2012
	December 31,	2013				2012
	Accumulated benefit obligation	$	1,446			$	8,736
	Accumulated benefit obligation	$	1,446			$	8,736
	Fair value of plan assets	351				6,546
	Fair value of plan assets	351				6,546
Total pension assets for U.S. and non-U.S. plans	'
	The following table presents total assets for our U.S. and non-U.S. pension plans (in millions):


		U.S. Plans								Non-U.S. Plans
	December 31,	2013				2012				2013			2012
	December 31,	2013				2012				2013			2012
	Cash and cash equivalents	$	240			$	299			$	274		$	87
	Cash and cash equivalents	$	240			$	299			$	274		$	87
	Equity securities:
	U.S.-based companies	1,422				1,844				280			37
	U.S.-based companies	1,422				1,844				280			37
	International-based companies	698				324				586			640
	International-based companies	698				324				586			640
	Fixed-income securities:
	Government bonds	464				399				304			163
	Government bonds	464				399				304			163
	Corporate bonds and debt securities	1,369				856				137			126
	Corporate bonds and debt securities	1,369				856				137			126
	Mutual, pooled and commingled funds1	1,134				1,057				453			453
	Mutual, pooled and commingled funds1	1,134				1,057				453			453
	Hedge funds/limited partnerships	526				496				17			29
	Hedge funds/limited partnerships	526				496				17			29
	Real estate	245				248				6			9
	Real estate	245				248				6			9
	Other	245				26				346			491
	Other	245				26				346			491
	Total pension plan assets2	$	6,343			$	5,549			$	2,403		$	2,035
	Total pension plan assets2	$	6,343			$	5,549			$	2,403		$	2,035

	1	Mutual, pooled and commingled funds include investments in equity securities, fixed-income securities and combinations of both. There are a significant number of mutual, pooled and commingled funds from which investors can choose. The selection of the type of fund is dictated by the specific investment objectives and needs of a given plan. These objectives and needs vary greatly between plans.

	2	Fair value disclosures related to our pension assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our pension assets.
Other postretirement benefit plan assets	'
	The following table presents total assets for our other postretirement benefit plans (in millions):


	December 31,	2013				2012
	December 31,	2013				2012
	Cash and cash equivalents	$	10			$	13
	Cash and cash equivalents	$	10			$	13
	Equity securities:
	U.S.-based companies	112				81
	U.S.-based companies	112				81
	International-based companies	8				4
	International-based companies	8				4
	Fixed-income securities:
	Government bonds	79				78
	Government bonds	79				78
	Corporate bonds and debt securities	9				5
	Corporate bonds and debt securities	9				5
	Mutual, pooled and commingled funds	18				16
	Mutual, pooled and commingled funds	18				16
	Hedge funds/limited partnerships	3				3
	Hedge funds/limited partnerships	3				3
	Real estate	2				2
	Real estate	2				2
	Other	2				—
	Other	2				—
	Total other postretirement benefit plan assets1	$	243			$	202
	Total other postretirement benefit plan assets1	$	243			$	202

	1	Fair value disclosures related to our other postretirement benefit plan assets are included in Note 16. Fair value disclosures include, but are not limited to, the levels within the fair value hierarchy in which the fair value measurements in their entirety fall; a reconciliation of the beginning and ending balances of Level 3 assets; and information about the valuation techniques and inputs used to measure the fair value of our other postretirement benefit plan assets.
Net periodic benefit cost for pension and other postretirement benefit plans	'
	Net periodic benefit cost for our pension and other postretirement benefit plans consisted of the following (in millions):


		Pension Benefits											Other Benefits
	Year Ended December 31,	2013				2012				2011			2013				2012			2011
	Year Ended December 31,	2013				2012				2011			2013				2012			2011
	Service cost	$	280			$	291			$	249		$	36			$	34		$	32
	Service cost	$	280			$	291			$	249		$	36			$	34		$	32
	Interest cost	378				388				391			42				43			45
	Interest cost	378				388				391			42				43			45
	Expected return on plan assets1	(659		)		(573		)		(508		)	(9		)		(8		)	(8		)
	Amortization of prior service cost (credit)	(2		)		(2		)		5			(10		)		(52		)	(61		)
	Amortization of prior service cost (credit)	(2		)		(2		)		5			(10		)		(52		)	(61		)
	Amortization of actuarial loss	197				137				82			13				6			2
	Amortization of actuarial loss	197				137				82			13				6			2
	Net periodic benefit cost	$	194			$	241			$	219		$	72			$	23		$	10
	Net periodic benefit cost	$	194			$	241			$	219		$	72			$	23		$	10
	Settlement charge	1				3				3			—				—			—
	Settlement charge	1				3				3			—				—			—
	Curtailment charge	—				6				—			—				—			—
	Curtailment charge	—				6				—			—				—			—
	Special termination benefits2	2				1				8			—				—			3
	Special termination benefits2	2				1				8			—				—			3
	Total cost recognized in the statements of income	$	197			$	251			$	230		$	72			$	23		$	13
	Total cost recognized in the statements of income	$	197			$	251			$	230		$	72			$	23		$	13

	1	The Company has elected to use the actual fair value of plan assets as the market-related value of assets in the determination of the expected return on plan assets.

	2	The special termination benefits primarily relate to the Company's productivity, restructuring and integration initiatives. Refer to Note 18 for additional information related to our productivity, restructuring and integration initiatives.
Changes in AOCI for benefit plans	'
	The following table sets forth the changes in AOCI for our benefit plans (in millions, pretax):


		Pension Benefits								Other Benefits
		2013				2012				2013			2012
		2013				2012				2013			2012
	Beginning balance in AOCI	$	(3,032	)		$	(2,169	)		$	(186	)	$	(34	)
	Recognized prior service cost (credit)	(2		)		(2		)		(10		)	(52		)
	Recognized net actuarial loss (gain)	198				140				13			6
	Recognized net actuarial loss (gain)	198				140				13			6
	Prior service credit (cost) arising in current year	1				3				73			2
	Prior service credit (cost) arising in current year	1				3				73			2
	Net actuarial (loss) gain arising in current year	1,283				(1,009		)		122			(107		)
	Net actuarial (loss) gain arising in current year	1,283				(1,009		)		122			(107		)
	Foreign currency translation gain (loss)	15				5				1			(1		)
	Foreign currency translation gain (loss)	15				5				1			(1		)
	Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
	Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
Amounts in AOCI for benefit plans (pretax)	'
	The following table sets forth amounts in AOCI for our benefit plans (in millions, pretax):


		Pension Benefits								Other Benefits
	December 31,	2013				2012				2013			2012
	December 31,	2013				2012				2013			2012
	Prior service credit (cost)	$	12			$	16			$	86		$	23
	Prior service credit (cost)	$	12			$	16			$	86		$	23
	Net actuarial loss	(1,549		)		(3,048		)		(73		)	(209		)
	Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
	Ending balance in AOCI	$	(1,537	)		$	(3,032	)		$	13		$	(186	)
Amounts in AOCI expected to be recognized as components of net periodic pension cost in next fiscal year	'

	Amounts in AOCI expected to be recognized as components of net periodic pension cost in 2014 are as follows (in millions, pretax):


		Pension Benefits				Other Benefits
	Amortization of prior service cost (credit)	$	(2	)		$	(17	)
	Amortization of actuarial loss	76				2
	Amortization of actuarial loss	76				2
		$	74			$	(15	)
		$	74			$	(15	)
Certain weighted average assumptions used in computing the benefit obligations and net periodic benefit cost	'
	Certain weighted-average assumptions used in computing the benefit obligations are as follows:


		Pension Benefits						Other Benefits
	December 31,	2013			2012			2013			2012
	December 31,	2013			2012			2013			2012
	Discount rate	4.75	%		4	%		4.75	%		4	%
	Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
	Rate of increase in compensation levels	3.5	%		3.5	%		N/A			N/A
	Certain weighted-average assumptions used in computing net periodic benefit cost are as follows:


		Pension Benefits									Other Benefits
	Year Ended December 31,	2013			2012			2011			2013		2012			2011
	Year Ended December 31,	2013			2012			2011			2013		2012			2011
	Discount rate	4	%		4.75	%		5.5	%		4	%	4.75	%		5.25	%
	Rate of increase in compensation levels	3.5	%		3.25	%		4	%		N/A		N/A			N/A
	Rate of increase in compensation levels	3.5	%		3.25	%		4	%		N/A		N/A			N/A
	Expected long-term rate of return on plan assets	8.25	%		8.25	%		8.25	%		4.75	%	4.75	%		4.75	%
Assumed health care cost trend rates	'
	The assumed health care cost trend rates are as follows:


	December 31,	2013			2012
	December 31,	2013			2012
	Health care cost trend rate assumed for next year	8	%		8	%
	Rate to which the cost trend rate is assumed to decline (the ultimate trend rate)	5	%		5	%
	Year that the rate reaches the ultimate trend rate	2020			2019
	Year that the rate reaches the ultimate trend rate	2020			2019
Estimated future benefit payments for funded and unfunded plans	'
	Our estimated future benefit payments for funded and unfunded plans are as follows (in millions):


	Year Ended December 31,	2014				2015				2016			2017				2018			2019–2023
	Year Ended December 31,	2014				2015				2016			2017				2018			2019–2023
	Pension benefit payments	$	471			$	483			$	512		$	554			$	558		$	3,084
	Pension benefit payments	$	471			$	483			$	512		$	554			$	558		$	3,084
	Other benefit payments1	59				62				64			65				66			346
	Other benefit payments1	59				62				64			65				66			346
	Total estimated benefit payments	$	530			$	545			$	576		$	619			$	624		$	3,430
	Total estimated benefit payments	$	530			$	545			$	576		$	619			$	624		$	3,430

	1	The expected benefit payments for our other postretirement benefit plans are net of estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003. Federal subsidies are estimated to be approximately $8 million for the period 2014–2018, and $5 million for the period 2019–2023.

INCOME_TAXES_Tables

INCOME TAXES (Tables)	12 Months Ended
INCOME TAXES (Tables)	Dec. 31, 2013
Income Taxes [Abstract]	'
Schedule of income before income taxes	'
	Income before income taxes consisted of the following (in millions):


	Year Ended December 31,	2013				2012				2011
	Year Ended December 31,	2013				2012				2011
	United States	$	2,451			$	3,526			$	3,029
	United States	$	2,451			$	3,526			$	3,029
	International	9,026				8,283				8,429
	International	9,026				8,283				8,429
	Total	$	11,477			$	11,809			$	11,458
	Total	$	11,477			$	11,809			$	11,458
Schedule of income tax expense (benefit)	'
	Income tax expense consisted of the following for the years ended December 31, 2013, 2012 and 2011 (in millions):


		United States				State and Local				International			Total
		United States				State and Local				International			Total
	2013
	Current	$	713			$	102			$	1,388		$	2,203
	Current	$	713			$	102			$	1,388		$	2,203
	Deferred	305				38				305			648
	Deferred	305				38				305			648
	2012
	Current	$	602			$	74			$	1,415		$	2,091
	Current	$	602			$	74			$	1,415		$	2,091
	Deferred	936				33				(337		)	632
	Deferred	936				33				(337		)	632
	2011
	Current	$	286			$	66			$	1,425		$	1,777
	Current	$	286			$	66			$	1,425		$	1,777
	Deferred	898				27				110			1,035
	Deferred	898				27				110			1,035
Reconciliation of the statutory U.S. federal tax rate and effective tax rates	'
	A reconciliation of the statutory U.S. federal tax rate and our effective tax rate is as follows:


	Year Ended December 31,	2013			2012			2011
	Year Ended December 31,	2013			2012			2011
	Statutory U.S. federal tax rate	35	%		35	%		35	%
	State and local income taxes — net of federal benefit	1			1.1			0.9
	State and local income taxes — net of federal benefit	1			1.1			0.9
	Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate	(10.3	)	1,2,3	(9.5	)	6,7	(9.5	)	10,11,12
	Reversal of valuation allowances	—			(2.4	)	8	—
	Reversal of valuation allowances	—			(2.4	)	8	—
	Equity income or loss	(1.4	)	4	(2.0	)		(1.4	)	13
	Other operating charges	1.2		5	0.4		9	0.3		14
	Other operating charges	1.2		5	0.4		9	0.3		14
	Other — net	(0.7	)		0.5			(0.8	)	15,16,17,18
	Other — net	(0.7	)		0.5			(0.8	)	15,16,17,18
	Effective tax rate	24.8	%		23.1	%		24.5	%

	1	Includes a tax benefit of $26 million (or a 0.2 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	2	Includes a tax expense of $279 million on pretax net gains of $501 million (or a 0.9 percent impact on our effective tax rate) related to the deconsolidation of our Brazilian bottling operations upon their combination with an independent bottler and a loss due to the merger of four of the Company's Japanese bottling partners. Refer to Note 2 and Note 17.

	3	Includes a tax expense of $3 million (or a 0.5 percent impact on our effective tax rate) related to a charge of $149 million due to the devaluation of the Venezuelan bolivar. Refer to Note 19.

	4	Includes an $8 million tax benefit on a pretax charge of $159 million (or a 0.4 percent impact on our effective tax rate) related to our proportionate share of unusual or infrequent items recorded by our equity method investees. Refer to Note 17.

	5	Includes a tax benefit of $175 million on pretax charges of $877 million (or a 1.2 percent impact on our effective tax rate) primarily related to impairment charges recorded on certain of the Company's intangible assets and charges related to the Company's productivity and reinvestment program as well as other restructuring initiatives. Refer to Note 17 and Note 18.

	6	Includes a tax expense of $133 million (or a 1.1 percent impact on our effective tax rate) related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	7	Includes a tax expense of $57 million on pretax net gains of $76 million (or a 0.3 percent impact on our effective tax rate) related to the following: a gain recognized as a result of the merger of Embotelladora Andina S.A. ("Andina") and Embotelladoras Coca-Cola Polar S.A. ("Polar"); a gain recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment; the loss recognized on the pending sale of a majority ownership interest in our consolidated Philippine bottling operations to Coca-Cola FEMSA; and the expense recorded for the premium the Company paid over the publicly traded market price to acquire an ownership interest in Mikuni. Refer to Note 17.

	8	Relates to a net tax benefit of $283 million associated with the reversal of valuation allowances in certain of the Company's foreign jurisdictions.

	9	Includes a tax benefit of $95 million on pretax charges of $416 million (or a 0.4 percent impact on our effective tax rate) primarily related to the Company's productivity and reinvestment program as well as other restructuring initiatives; the refinement of previously established accruals related to the Company's 2008–2011 productivity initiatives; and the refinement of previously established accruals related to the Company's integration of CCE's former North America business. Refer to Note 18.

	10	Includes a tax benefit of $6 million related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in various international jurisdictions.

	11	Includes a zero percent effective tax rate on pretax charges of $17 million due to the impairment of available-for-sale securities. Refer to Note 3 and Note 17.

	12	Includes a tax expense of $299 million on pretax net gains of $641 million (or a 0.7 percent impact on our effective tax rate) related to the net gain recognized as a result of the merger of Embotelladoras Arca, S.A.B. de C.V. ("Arca") and Grupo Continental S.A.B. ("Contal"); the gain recognized on the sale of our investment in Embonor; and gains the Company recognized as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at per share amounts greater than the carrying value of the Company's per share investment. These gains were partially offset by charges associated with certain of the Company's equity method investments in Japan. Refer to Note 17.

	13	Includes a tax benefit of $7 million on pretax net charges of $53 million (or a 0.1 percent impact on our effective tax rate) related to our proportionate share of asset impairments and restructuring charges recorded by certain of our equity method investees. Refer to Note 17.

	14	Includes a tax benefit of $224 million on pretax charges of $732 million (or a 0.3 percent impact on our effective tax rate) primarily related to the Company's productivity, integration and restructuring initiatives; transaction costs incurred in connection with the merger of Arca and Contal; costs associated with the earthquake and tsunami that devastated northern and eastern Japan; and costs associated with the flooding in Thailand. Refer to Note 17.

	15	Includes a tax benefit of $8 million on pretax charges of $19 million related to the amortization of favorable supply contracts acquired in connection with our acquisition of CCE's former North America business.

	16	Includes a tax benefit of $3 million on pretax net charges of $9 million related to the repurchase and/or exchange of certain long-term debt assumed in connection with our acquisition of CCE's former North America business as well as the early extinguishment of certain other long-term debt. Refer to Note 10.

	17	Includes a tax benefit of $14 million on pretax charges of $41 million related to the impairment of an investment in an entity accounted for under the equity method of accounting. Refer to Note 17.

	18	Includes a tax benefit of $2 million related to amounts required to be recorded for changes to our uncertain tax positions, including interest and penalties, in certain domestic jurisdictions.
Reconciliation of the gross balance of unrecognized tax benefit	'
	A reconciliation of the changes in the gross balance of unrecognized tax benefit amounts is as follows (in millions):


	Year Ended December 31,	2013				2012				2011
	Year Ended December 31,	2013				2012				2011
	Beginning balance of unrecognized tax benefits	$	302			$	320			$	387
	Beginning balance of unrecognized tax benefits	$	302			$	320			$	387
	Increases related to prior period tax positions	1				69				9
	Increases related to prior period tax positions	1				69				9
	Decreases related to prior period tax positions	(7		)		(15		)		(19		)
	Increases related to current period tax positions	8				23				6
	Increases related to current period tax positions	8				23				6
	Decreases related to current period tax positions	—				—				(1		)
	Decreases related to current period tax positions	—				—				(1		)
	Decreases related to settlements with taxing authorities	(4		)		(45		)		(5		)
	Reductions as a result of a lapse of the applicable statute of limitations	(59		)		(36		)		(46		)
	Increases (decreases) from effects of foreign currency exchange rates	(11		)		(14		)		(11		)
	Ending balance of unrecognized tax benefits	$	230			$	302			$	320
	Ending balance of unrecognized tax benefits	$	230			$	302			$	320
Deferred tax assets and liabilities	'
	The tax effects of temporary differences and carryforwards that give rise to deferred tax assets and liabilities consist of the following (in millions):


	December 31,	2013				2012
	December 31,	2013				2012
	Deferred tax assets:
	Property, plant and equipment	$	102			$	89
	Property, plant and equipment	$	102			$	89
	Trademarks and other intangible assets	63				77
	Trademarks and other intangible assets	63				77
	Equity method investments (including foreign currency translation adjustment)	243				209
		243				209
	Derivative financial instruments	50				116
	Derivative financial instruments	50				116
	Other liabilities	1,102				1,178
	Other liabilities	1,102				1,178
	Benefit plans	1,237				1,808
	Benefit plans	1,237				1,808
	Net operating/capital loss carryforwards	790				782
	Net operating/capital loss carryforwards	790				782
	Other	225				320
	Other	225				320
	Gross deferred tax assets	$	3,812			$	4,579
	Gross deferred tax assets	$	3,812			$	4,579
	Valuation allowances	(586		)		(487		)
	Total deferred tax assets1,2	$	3,226			$	4,092
	Total deferred tax assets1,2	$	3,226			$	4,092
	Deferred tax liabilities:
	Property, plant and equipment	$	(2,417	)		$	(2,204	)
	Trademarks and other intangible assets	(4,192		)		(4,133		)
	Equity method investments (including foreign currency translation adjustment)	(1,070		)		(712		)
	Derivative financial instruments	(147		)		(140		)
	Other liabilities	(69		)		(144		)
	Benefit plans	(473		)		(495		)
	Other	(810		)		(929		)
	Total deferred tax liabilities3	$	(9,178	)		$	(8,757	)
	Net deferred tax liabilities	$	(5,952	)		$	(4,665	)

	1	Noncurrent deferred tax assets of $328 million and $403 million were included in the line item other assets in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.

	2	Current deferred tax assets of $211 million and $244 million were included in the line item prepaid expenses and other assets in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.

	3	Current deferred tax liabilities of $339 million and $331 million were included in the line item accounts payable and accrued expenses in our consolidated balance sheets as of December 31, 2013 and 2012, respectively.
Deferred tax asset valuation allowances	'
	An analysis of our deferred tax asset valuation allowances is as follows (in millions):


	Year Ended December 31,	2013				2012				2011
	Year Ended December 31,	2013				2012				2011
	Balance at beginning of year	$	487			$	859			$	950
	Balance at beginning of year	$	487			$	859			$	950
	Additions	169				126				138
	Additions	169				126				138
	Decrease due to transfer to assets held for sale	—				(146		)		—
	Decrease due to transfer to assets held for sale	—				(146		)		—
	Deductions	(70		)		(352		)		(229		)
	Balance at end of year	$	586			$	487			$	859
	Balance at end of year	$	586			$	487			$	859

OTHER_COMPREHENSIVE_INCOME_Tab

OTHER COMPREHENSIVE INCOME (Tables)	12 Months Ended
	Dec. 31, 2013
OTHER COMPREHENSIVE INCOME [Abstract]	'
AOCI attributable to the shareowners of The Coca-Cola Company	'
	AOCI attributable to shareowners of The Coca-Cola Company consisted of the following (in millions):


	December 31,	2013				2012

	Foreign currency translation adjustment	$	(2,849	)		$	(1,665	)
	Accumulated derivative net gains (losses)	197				46

	Unrealized net gains (losses) on available-for-sale securities	258				338

	Adjustments to pension and other benefit liabilities	(1,038		)		(2,104		)
	Accumulated other comprehensive income (loss)	$	(3,432	)		$	(3,385	)
Allocation of total comprehensive income or Loss between shareowners of the The Coca-Cola Company and noncontrolling interests [Text Block]	'
	The following table summarizes the allocation of total comprehensive income between shareowners of The Coca-Cola Company and noncontrolling interests (in millions):


		Year Ended December 31, 2013
		Shareowners of			Noncontrolling			Total
		The Coca-Cola Company			Interests
	Consolidated net income	$	8,584		$	42		$	8,626

	Other comprehensive income:
	Net foreign currency translation adjustment	(1,184		)	(3		)	(1,187		)
	Net gain (loss) on derivatives1	151			—			151

	Net unrealized gain (loss) on available-for-sale securities2	(80		)	—			(80		)

	Net change in pension and other benefit liabilities3	1,066			—			1,066

	Total comprehensive income	$	8,537		$	39		$	8,576

OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI	'
	OCI attributable to shareowners of The Coca-Cola Company, including our proportionate share of equity method investees' OCI, for the years ended December 31, 2013, 2012 and 2011, is as follows (in millions):


		Before-Tax Amount				Income Tax				After-Tax Amount

	2013
	Foreign currency translation adjustments:
	Translation adjustment arising in the period	$	(1,046	)		$	56			$	(990	)

	Reclassification adjustments recognized in net income	(194		)		—				(194		)

	Net foreign currency translation adjustment	(1,240		)		56				(1,184		)

	Derivatives:
	Unrealized gains (losses) arising during the year	425				(173		)		252

	Reclassification adjustments recognized in net income	(167		)		66				(101		)

	Net gain (loss) on derivatives1	258				(107		)		151

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	(134		)		42				(92		)

	Reclassification adjustments recognized in net income	12				—				12

	Net change in unrealized gain (loss) on available-for-sale securities2	(122		)		42				(80		)

	Pension and other benefit liabilities:
	Net pension and other benefits arising during the year	1,490				(550		)		940

	Reclassification adjustments recognized in net income	198				(72		)		126

	Net change in pension and other benefit liabilities3	1,688				(622		)		1,066

	Other comprehensive income (loss) attributable to The Coca-Cola Company	$	584			$	(631	)		$	(47	)


	1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

	2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

	3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


		Before-Tax Amount				Income Tax				After-Tax Amount

	2012
	Net foreign currency translation adjustment	$	(219	)		$	(1	)		$	(220	)
	Derivatives:
	Unrealized gains (losses) arising during the year	77				(29		)		48

	Reclassification adjustments recognized in net income	82				(31		)		51

	Net gain (loss) on derivatives1	159				(60		)		99

	Available-for-sale securities:
	Unrealized gains (losses) arising during the year	248				(64		)		184

	Reclassification adjustments recognized in net income	(6		)		—				(6		)

	Net change in unrealized gain (loss) on available-for-sale securities2	242				(64		)		178

	Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,132		)		405				(727		)

Reclassification adjustments recognized in net income	92				(33		)		59

Net change in pension and other benefit liabilities3	(1,040		)		372				(668		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(858	)		$	247			$	(611	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.


	Before-Tax Amount				Income Tax				After-Tax Amount

2011
Net foreign currency translation adjustment	$	(639	)		$	(1	)		$	(640	)
Derivatives:
Unrealized gains (losses) arising during the year	(3		)		(1		)		(4		)
Reclassification adjustments recognized in net income	243				(94		)		149

Net gain (loss) on derivatives1	240				(95		)		145

Available-for-sale securities:
Unrealized gains (losses) arising during the year	(4		)		(8		)		(12		)
Reclassification adjustments recognized in net income	10				(5		)		5

Net change in unrealized gain (loss) on available-for-sale securities2	6				(13		)		(7		)

Pension and other benefit liabilities:
Net pension and other benefits arising during the year	(1,206		)		423				(783		)

Reclassification adjustments recognized in net income	31				(11		)		20

Net change in pension and other benefit liabilities3	(1,175		)		412				(763		)

Other comprehensive income (loss) attributable to The Coca-Cola Company	$	(1,568	)		$	303			$	(1,265	)


1	Refer to Note 5 for additional information related to the net gain or loss on derivative instruments designated and qualifying as cash flow hedging instruments.

2	Includes reclassification adjustments related to divestitures of certain available-for-sale securities. Refer to Note 3 for additional information related to these divestitures.

3	Refer to Note 13 for additional information related to the Company's pension and other postretirement benefit liabilities.
Disclosure of Reclassification Amount [Text Block]	'
	The following table presents the amounts and line items in our condensed consolidated statements of income where adjustments reclassified from AOCI into income were recorded during the year ended December 31, 2013 (in millions):


	Description of AOCI Component	Location of Gain (Loss)	Amount Reclassified from
		Recognized in Income	AOCI into Income
	Foreign currency translation adjustments:
	Divestitures, deconsolidations and other	Other income (loss) — net	$	(194	)	1
		Income before income taxes	$	(194	)
		Income taxes	—

		Consolidated net income	$	(194	)
	Derivatives:
	Foreign currency contracts	Net operating revenues	$	(149	)
	Foreign currency contracts	Cost of goods sold	(30		)
	Interest rate contracts	Interest expense	12

		Income before income taxes	$	(167	)
		Income taxes	66

		Consolidated net income	$	(101	)
	Available-for-sale securities:
	Sale of securities	Other income (loss) — net	$	12

		Income before income taxes	$	12

		Income taxes	—

		Consolidated net income	$	12

	Pension and other benefit liabilities:
	Insignificant items	Other income (loss) — net	$	(1	)
	Amortization of net actuarial loss	*	211

	Amortization of prior service cost (credit)	*	(12		)
		Income before income taxes	$	198

		Income taxes	(72		)
		Consolidated net income	$	126


	*	This component of AOCI is included in the Company's computation of net periodic benefit cost and is not reclassified out of AOCI into a single line item in our condensed consolidated statements of income in its entirety. Refer to Note 13 for additional information.

	1	Related to the disposition of our Philippine bottling operations in January 2013, the deconsolidation of our Brazilian bottling operations in July 2013 and the merger of four of the Company's Japanese bottling partners in July 2013. Refer to Note 2 and Note 17 for additional information related to these transactions.

FAIR_VALUE_MEASUREMENTS_Tables

FAIR VALUE MEASUREMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Fair Value Measurements Disclosure [Abstract]	'
Assets and liabilities measured at fair value on a recurring basis	'
	The following tables summarize those assets and liabilities measured at fair value on a recurring basis (in millions):


		December 31, 2013
		Level 1				Level 2				Level 3				Netting			Fair Value
														Adjustment1			Measurements
	Assets:
	Trading securities2	$	206			$	163			$	3			$	—		$	372

	Available-for-sale securities2	1,453				3,281				108			3	—			4,842

	Derivatives4	17				822				—				(150		)	689			5

	Total assets	$	1,676			$	4,266			$	111			$	(150	)	$	5,903

	Liabilities:
	Derivatives4	$	10			$	165			$	—			$	(151	)	$	24		5

	Total liabilities	$	10			$	165			$	—			$	(151	)	$	24


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.

	5	The Company's derivative financial instruments are recorded at fair value in our consolidated balance sheet as follows: $129 million in the line item prepaid expenses and other assets; $560 million in the line item other assets; $12 million in the line item accounts payable and accrued expenses; and $12 million in the line item other liabilities. Refer to Note 5 for additional information related to the composition of our derivative portfolio.


		December 31, 2012
		Level 1				Level 2				Level 3				Netting			Fair Value
														Adjustment1			Measurements
	Assets:
	Trading securities2	$	146			$	116			$	4			$	—		$	266

	Available-for-sale securities2	1,390				3,068				135			3	—			4,593

	Derivatives4	47				583				—				(116		)	514			5

	Total assets	$	1,583			$	3,767			$	139			$	(116	)	$	5,373

	Liabilities:
	Derivatives4	$	35			$	98			$	—			$	(121	)	$	12		5

	Total liabilities	$	35			$	98			$	—			$	(121	)	$	12


	1	Amounts represent the impact of legally enforceable master netting agreements that allow the Company to settle net positive and negative positions and also cash collateral held or placed with the same counterparties. There are no amounts subject to legally enforceable master netting agreements that management has chosen not to offset or that do not meet the offsetting requirements. Refer to Note 5.

	2	Refer to Note 3 for additional information related to the composition of our trading securities and available-for-sale securities.

	3	Primarily related to long-term debt securities that mature in 2018.

	4	Refer to Note 5 for additional information related to the composition of our derivative portfolio.
Assets measured at fair value on a nonrecurring basis	'
	Assets measured at fair value on a nonrecurring basis for the years ended December 31, 2013 and 2012, are summarized below (in millions):


		Gains (Losses)
	December 31,	2013				2012

	Exchange of investment in equity securities	$	(114	)	1	$	185		4

	Valuation of shares in equity method investee	139			2	10			5

	Intangible assets	(195		)	3	—

	Assets held for sale	—				(108		)	6

	Cost method investments	—				(16		)	7

	Total	$	(170	)		$	71


	1	The Company recognized a net loss of $114 million on the exchange of shares it previously owned in certain equity method investees for shares in the newly formed entity CCEJ. CCEJ is also an equity method investee. The net loss represents the difference between the carrying value of the shares the Company relinquished and the fair value of the CCEJ shares received as a result of the transaction. The net loss and the initial carrying value of the Company's investment were calculated based on Level 1 inputs. Refer to Note 17.

	2	The Company recognized a gain of $139 million as a result of Coca-Cola FEMSA, an equity method investee, issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if the Company had sold a proportionate share of its investment in Coca-Cola FEMSA. These gains were determined using Level 1 inputs. Refer to Note 17.

	3	The Company recognized a loss of $195 million due to impairment charges on certain intangible assets. The charges were primarily determined by comparing the fair value of the assets to the current carrying value. The fair value of the assets was derived using discounted cash flow analyses based on Level 3 inputs. Refer to Note 17.

	4	As a result of the merger of Andina and Polar, the Company recognized a gain of $185 million on the exchange of shares we previously owned in Polar for shares in Andina. This gain primarily represents the difference between the carrying value of the Polar shares we relinquished and the fair value of the Andina shares we received as a result of the transaction. The gain was calculated based on Level 1 inputs. Refer to Note 17.

	5	The Company recognized a gain of $92 million as a result of Coca-Cola FEMSA issuing additional shares of its own stock at a per share amount greater than the carrying value of the Company's per share investment. Accordingly, the Company is required to treat this type of transaction as if we sold a proportionate share of our investment in Coca-Cola FEMSA. This gain was partially offset by a loss of $82 million the Company recognized due to the Company acquiring an ownership interest in Mikuni for which we paid a premium over the publicly traded market price. This premium was expensed on the acquisition date. The gain and loss described above were determined using Level 1 inputs. Refer to Note 17.

	6	The Company and Coca-Cola FEMSA executed a share purchase agreement for the sale of a majority ownership interest in our consolidated Philippine bottling operations. As a result of this agreement, the Company was required to classify our Philippine bottling operations as held for sale in our consolidated balance sheet as of December 31, 2012. We also recognized a loss of $108 million during the year ended December 31, 2012, based on the agreed-upon sale price and related transaction costs. The loss was calculated based on Level 3 inputs. Refer to Note 17.

	7	The Company recognized impairment charges of $16 million due to other-than-temporary declines in the fair values of certain cost method investments. These charges were determined using Level 3 inputs. Refer to Note 17.
Summary of the fair value of pension plan assets for U.S. and non-U.S. pension plans	'
	The following table summarizes the levels within the fair value hierarchy for our pension plan assets as of December 31, 2013 and 2012 (in millions):


		December 31, 2013															December 31, 2012
		Level 1				Level 2				Level 3				Total			Level 1				Level 2				Level 3				Total

	Cash and cash equivalents	$	331			$	183			$	—			$	514		$	187			$	199			$	—			$	386

	Equity securities:
	U.S.-based companies	1,680				7				15				1,702			1,847				20				14				1,881

	International-based companies	1,271				13				—				1,284			910				54				—				964

	Fixed-income securities:
	Government bonds	—				719				49				768			—				562				—				562

	Corporate bonds and debt securities	—				1,466				40				1,506			—				982				—				982

	Mutual, pooled and commingled funds	56				1,531				—				1,587			504				1,006				—				1,510

	Hedge funds/limited partnerships	—				190				353				543			—				125				400				525

	Real estate	—				—				251				251			—				—				257				257

	Other	—				7				584			1	591			—				7				510			1	517

	Total	$	3,338			$	4,116			$	1,292			$	8,746		$	3,448			$	2,955			$	1,181			$	7,584


	1	Includes purchased annuity contracts and insurance-linked securities.
Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans	'
	The following table provides a reconciliation of the beginning and ending balance of Level 3 assets for our U.S. and non-U.S. pension plans for the years ended December 31, 2013 and 2012 (in millions):


		Corporate				Hedge				Real Estate				Equity			Mutual,				Other				Total
		Bonds and				Funds/Limited								Securities			Pooled and
		Debt Securities				Partnerships											Commingled
																	Funds
	2012
	Balance at beginning of year	$	—			$	349			$	270			$	20		$	5			$	518			$	1,162

	Actual return on plan assets:
	Related to assets still held at the reporting date	—				(8		)		13				—			—				1				6

	Related to assets sold during the year	—				24				3				—			—				—				27

	Purchases, sales and settlements — net	—				35				(27		)		—			(5		)		(2		)		1

	Transfers in or out of Level 3 — net	—				—				(2		)		(6		)	—				(4		)		(12		)

	Foreign currency translation	—				—				—				—			—				(3		)		(3		)

	Balance at end of year	$	—			$	400			$	257			$	14		$	—			$	510		1	$	1,181

	2013
	Balance at beginning of year	$	—			$	400			$	257			$	14		$	—			$	510			$	1,181

	Actual return on plan assets:
	Related to assets still held at the reporting date	(4		)		(6		)		13				—			—				39				42

	Related to assets sold during the year	(2		)		24				6				—			—				—				28

	Purchases, sales and settlements — net	95				14				(24		)		1			—				193				279

	Transfers in or out of Level 3 — net	—				(78		)		—				—			—				(172		)		(250		)

	Foreign currency translation	—				(1		)		(1		)		—			—				14				12

	Balance at end of year	$	89			$	353			$	251			$	15		$	—			$	584		1	$	1,292


	1	Includes purchased annuity contracts and insurance-linked securities.
Summary of the fair value of postretirement benefit plan assets	'
	The following table summarizes the levels within the fair value hierarchy for our other postretirement benefit plan assets as of December 31, 2013 and 2012 (in millions):


		December 31, 2013															December 31, 2012
		Level 1				Level 2				Level 3 1				Total			Level 1				Level 2				Level 3 1				Total

	Cash and cash equivalents	$	—			$	10			$	—			$	10		$	1			$	12			$	—			$	13

	Equity securities:
	U.S.-based companies	112				—				—				112			81				—				—				81

	International-based companies	8				—				—				8			4				—				—				4

	Fixed-income securities:
	Government bonds	76				3				—				79			75				3				—				78

	Corporate bonds and debt securities	—				9				—				9			—				5				—				5

	Mutual, pooled and commingled funds	11				7				—				18			11				5				—				16

	Hedge funds/limited partnerships	—				1				2				3			—				1				2				3

	Real estate	—				—				2				2			—				—				2				2

	Other	—				—				2				2			—				—				—				—

	Total	$	207			$	30			$	6			$	243		$	172			$	26			$	4			$	202


	1	Level 3 assets are not a significant portion of other postretirement benefit plan assets.

PRODUCTIVITY_INTEGRATION_AND_R1

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES (Tables)	12 Months Ended
	Dec. 31, 2013
PRODUCTIVITY INTEGRATION AND RESTRUCTURING INITIATIVES [Abstract]	'
Productivity and Reinvestment	'
	The following table summarizes the balance of accrued expenses related to these productivity and reinvestment initiatives and the changes in the accrued amounts since the commencement of the plan (in millions):


		Severance Pay			Outside Services			Other			Total
		and Benefits						Direct Costs
	2012
	Costs incurred	$	21		$	61		$	188		$	270

	Payments	(8		)	(55		)	(167		)	(230		)
	Noncash and exchange	(1		)	—			(13		)	(14		)

	Accrued balance as of December 31	$	12		$	6		$	8		$	26

	2013
	Costs incurred	$	188		$	59		$	247		$	494

	Payments	(113		)	(59		)	(209		)	(381		)
	Noncash and exchange	1			—			(28		)	(27		)

	Accrued balance as of December 31	$	88		$	6		$	18		$	112

OPERATING_SEGMENTS_Tables

OPERATING SEGMENTS (Tables)	12 Months Ended
	Dec. 31, 2013
Segment Reporting Information [Line Items]	'
Schedule of total net operating revenues related to concentrate and finished products operation	'
	The following table sets forth the percentage of total net operating revenues related to concentrate operations and finished product operations:


	Year Ended December 31,	2013		2012			2011

	Concentrate operations1	38	%	38	%		39	%
	Finished product operations2	62		62			61

	Net operating revenues	100	%	100	%		100	%

	1	Includes concentrates sold by the Company to authorized bottling partners for the manufacture of fountain syrups. The bottlers then typically sell the fountain syrups to wholesalers or directly to fountain retailers.

	2	Includes fountain syrups manufactured by the Company, including consolidated bottling operations, and sold to fountain retailers or to authorized fountain wholesalers or bottling partners who resell the fountain syrups to fountain retailers.
Schedule of net revenue and property plant and equipment by Geography	'
	The following table provides information related to our net operating revenues (in millions):


	Year Ended December 31,	2013			2012				2011

	United States	$	19,820		$	19,732			$	18,699

	International	27,034			28,285				27,843

	Net operating revenues	$	46,854		$	48,017			$	46,542

	The following table provides information related to our property, plant and equipment — net (in millions):


	Year Ended December 31,	2013			2012				2011

	United States	$	8,841		$	8,509			$	8,043

	International	6,126			5,967				6,896

	Property, plant and equipment — net	$	14,967		$	14,476			$	14,939

Schedule of Segment Reporting Information, by Segment [Table Text Block]	'


		Eurasia &			Europe				Latin			North			Pacific			Bottling				Corporate				Eliminations				Consolidated
		Africa							America			America						Investments
	2013
	Net operating revenues:
	Third party	$	2,763		$	4,645			$	4,748		$	21,574		$	5,372		$	7,598			$	154			$	—			$	46,854

	Intersegment	—			689				191			16			497			78				—				(1,471		)		—

	Total net revenues	2,763			5,334				4,939			21,590			5,869			7,676				154				(1,471		)		46,854

	Operating income (loss)	1,087			2,859				2,908			2,432			2,478			115				(1,651		)		—				10,228

	Interest income	—			—				—			—			—			—				534				—				534

	Interest expense	—			—				—			—			—			—				463				—				463

	Depreciation and amortization	42			86				58			1,192			130			335				134				—				1,977

	Equity income (loss) — net	22			24				13			2			19			524				(2		)		—				602

	Income (loss) before income taxes	1,109			2,923				2,920			2,434			2,494			679				(1,082		)		—				11,477

	Identifiable operating assets1	1,273			3,713			2	2,918			33,964			1,922			7,011			2	27,742				—				78,543

	Investments3	1,157			106				545			49			143			9,424				88				—				11,512

	Capital expenditures	40			34				63			1,374			117			643				279				—				2,550

	2012
	Net operating revenues:
	Third party	$	2,697		$	4,481			$	4,560		$	21,665		$	5,680		$	8,807			$	127			$	—			$	48,017

	Intersegment	—			642				271			15			628			88				—				(1,644		)		—

	Total net revenues	2,697			5,123				4,831			21,680			6,308			8,895				127				(1,644		)		48,017

	Operating income (loss)	1,078			2,960				2,879			2,597			2,516			140				(1,391		)		—				10,779

	Interest income	—			—				—			—			—			—				471				—				471

	Interest expense	—			—				—			—			—			—				397				—				397

	Depreciation and amortization	33			100				70			1,083			119			406				171				—				1,982

	Equity income (loss) — net	20			45				4			13			2			732				3				—				819

	Income (loss) before income taxes	1,101			3,015				2,882			2,624			2,523			904				(1,240		)		—				11,809

	Identifiable operating assets1	1,299			2,976			2	2,759			34,114			2,163			9,648			2	22,767				—				75,726

	Investments3	1,155			271				539			39			127			8,253				64				—				10,448

	Capital expenditures	51			30				88			1,447			107			867				190				—				2,780

	2011
	Net operating revenues:
	Third party	$	2,590		$	4,777			$	4,403		$	20,559		$	5,553		$	8,501			$	159			$	—			$	46,542

	Intersegment	—			697				287			12			536			90				—				(1,622		)		—

	Total net revenues	2,590			5,474				4,690			20,571			6,089			8,591				159				(1,622		)		46,542

Operating income (loss)	1,003			3,090				2,815			2,319			2,239			224				(1,517		)		—				10,173

Interest income	—			—				—			—			—			—				483				—				483

Interest expense	—			—				—			—			—			—				417				—				417

Depreciation and amortization	30			109				63			1,065			115			403				169				—				1,954

Equity income (loss) — net	(3		)	33				20			6			1			646				(13		)		—				690

Income (loss) before income taxes	1,001			3,134				2,832			2,327			2,242			897				(975		)		—				11,458

Identifiable operating assets1	1,160			3,204			2	2,446			33,422			2,170			8,905			2	20,293				—				71,600

Investments3	284			243				475			26			133			7,140				73				—				8,374

Capital expenditures	50			38				105			1,364			128			1,039				196				—				2,920


1	Principally cash and cash equivalents, short-term investments, marketable securities, trade accounts receivable, inventories, goodwill, trademarks and other intangible assets and property, plant and equipment — net.

2	Property, plant and equipment — net in Germany represented 11 percent of consolidated property, plant and equipment — net in 2013, 10 percent in 2012 and 10 percent in 2011.

3	Principally equity method investments, available-for-sale securities and nonmarketable investments in bottling companies.

NET_CHANGE_IN_OPERATING_ASSETS1

NET CHANGE IN OPERATING ASSETS AND LIABILITIES (Tables)	12 Months Ended
	Dec. 31, 2013
NET CHANGE IN OPERATING ASSETS AND LIABILITIES DISCLOSURE [Abstract]	'
Net change in operating assets and liabilities	'
	Net cash provided by (used in) operating activities attributable to the net change in operating assets and liabilities is composed of the following (in millions):


	Year Ended December 31,	2013			2012			2011

	(Increase) decrease in trade accounts receivable	$	28		$	(33	)	$	(562	)

	(Increase) decrease in inventories	(105		)	(286		)	(447		)
	(Increase) decrease in prepaid expenses and other assets	(163		)	(29		)	(350		)
	Increase (decrease) in accounts payable and accrued expenses	(158		)	(556		)	63

	Increase (decrease) in accrued taxes	22			770			(132		)

	Increase (decrease) in other liabilities	(556		)	(946		)	(465		)
	Net change in operating assets and liabilities	$	(932	)	$	(1,080	)	$	(1,893	)

BUSINESS_AND_SUMMARY_OF_SIGNIF3

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details) (USD $)	12 Months Ended
Share data in Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Summary of Significant Accounting Policies [Abstract]	'	'	'
Number of brands owned or licensed and marketed by reporting entity	500	'	'
Number, of the top five brands in the world, of owned and marketed nonalcoholic sparkling beverage brands	4	'	'
Number of countries where finished beverage products bearing our trademarks are sold	200	'	'
Beverage servings consumed per day, number	57,000,000,000	'	'
Beverage servings consumed per day which bears trademarks owned by or licensed by the entity, number	1,900,000,000	'	'
Period of marketing agreement with customers, low end of the range (in years)	'4 years	'	'
Period of marketing agreement with customers, high end of the range (in years)	'10	'	'
Amortization expense for infrastructure programs	$69,000,000	$86,000,000	$90,000,000
Aggregate deductions for expenses including amortization expense, incurred in relation to infrastructure programs	6,900,000,000	6,100,000,000	5,800,000,000
Advertising costs included in selling, general and administrative expenses	3,300,000,000	3,300,000,000	3,300,000,000
Advertising and production costs recorded in prepaid expenses and other assets	363,000,000	295,000,000	'
Shipping and handling costs included in selling, general and administrative expenses	2,700,000,000	2,800,000,000	2,400,000,000
Stock option award excluded from computation of diluted net income per share (in millions of shares)	28	34	32
Investments classified as cash equivalents, maximum maturity period (in months)	3	'	'
Investments classified as short term investments maturity period, low end of the range (in months)	3	'	'
Investments classified as short term investments maturity period, high end of the range (in years)	1	'	'
Property, Plant and Equipment	'	'	'
Depreciation expense	1,727,000,000	1,704,000,000	1,654,000,000
Amortization for leasehold improvements	$16,000,000	$19,000,000	$18,000,000
Goodwill, Trademarks and Other Intangible Assets	'	'	'
Finite Lived Intangible Assets, Minimum Useful Life	'1 year	'	'
Finite Lived Intangible Assets, Maximum Useful Life	'20 years	'	'
Percentage of indefinite-lived intangible assets, other than goodwill, for which a qualitative assessment was performed	10.00%	'	'
Percentage of goodwill for which a qualitative assessment was performed	11.00%	'	'
Buildings and improvements	'	'	'
Property, Plant and Equipment	'	'	'
Property, Plant and Equipment, Useful Life, Maximum	'40 years	'	'
Machinery equipment and vehicle fleet	'	'	'
Property, Plant and Equipment	'	'	'
Property, Plant and Equipment, Useful Life, Maximum	'20 years	'	'
Stock Options	'	'	'
Property, Plant and Equipment	'	'	'
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period	'4 years	'	'

BUSINESS_AND_SUMMARY_OF_SIGNIF4

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Not primary beneficiary	'	'
Variable interest entity	'	'
VIEs maximum exposures to loss	$2,171	$1,776
Primary beneficiary	'	'
Variable interest entity	'	'
VIEs maximum exposures to loss	$284	$234

BUSINESS_AND_SUMMARY_OF_SIGNIF5

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 3) (Allowance for doubtful accounts, USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Allowance for doubtful accounts	'	'	'
Activity in the allowance for doubtful accounts	'	'	'
Balance, beginning of year	$53	$83	$48
Net charges to costs and expenses	30	5	56
Write-offs	-14	-19	-12
Other	-8	-16	-9
Balance, end of year	$61	$53	$83

BUSINESS_AND_SUMMARY_OF_SIGNIF6

BUSINESS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details 4) (Venezuelan subsidiary, USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Corporate
Translation and Remeasurement	'	'	'
Remeasurement of official exchange rate set by government for nonessential goods (in bolivars per U.S.dollar)	6.3	'	'
Remeasurement Charges on Subsidiary Assets	'	'	$140
Monetary assets	426	'	'
Monetary Liabilities	45	'	'
Accounts Receivable Carrying Value	267	109	'
Carrying value of intangible assets	$107	'	'

ACQUISITIONS_AND_DIVESTITURES_1

ACQUISITIONS AND DIVESTITURES (Details) (USD $)	12 Months Ended						12 Months Ended		12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2011	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2011	Mar. 28, 2014	Dec. 31, 2007
	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Great Plains Coca Cola Bottling Company [Member]	Aujan Industries Trademark owner [Member]	Aujan bottling and distribution company [Member]	Coca-Cola Embonor SA [Member]	CCEAG [Member]	Integration of German Bottling and Distribution Operation [Member]
Significant Acquisitions and Disposals [Line Items]	'	'	'	'	'	'	'	'	'
Acquisitions and Investments, Principally Beverage and Bottling Companies and Trademarks	$353	$1,486	$971	$360	$820	'	'	'	'
Equity Method Investment, Ownership Percentage	'	'	'	'	50.00%	49.00%	'	'	'
Cash paid at closing	'	'	'	321	'	'	'	'	'
Proceeds from Disposals of Bottling Companies and Other Investments	872	20	398	'	'	'	'	'	'
Number of German bottling and distribution operations for which integration initiatives began in 2008	'	'	'	'	'	'	'	'	18
Put Option Exercise Price	'	'	'	'	'	'	'	498	'
Proceeds from Divestiture of Businesses	'	'	'	'	'	'	$394	'	'

ACQUISITIONS_AND_DIVESTITURES_2

ACQUISITIONS AND DIVESTITURES (Details 2) (USD $)	Dec. 31, 2012	Dec. 31, 2019	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2012	Dec. 31, 2013	Dec. 31, 2013
In Millions, unless otherwise specified	Total Bottling Operations Held for Sale	Brazilian Bottling Operations	Brazilian Bottling Operations	Brazilian Bottling Operations	Philippines Bottling Operations	Philippines Bottling Operations	Corporate
Divestitures	'	'	'	'	'	'	'
Loss on disposal group held for sale	'	'	'	'	$107	'	'
Deconsolidation, Gain (Loss), Amount	'	'	'	'	'	'	615
Equity Method Investment, Ownership Percentage	'	'	44.00%	'	'	49.00%	'
Exercise of Options	'	24.00%	'	'	'	'	'
Cash, cash equivalents and short-term investments	178	'	'	45	133	'	'
Trade Accounts Receivable, less allowances	196	'	'	88	108	'	'
Inventories	272	'	'	85	187	'	'
Prepaid expenses and other assets	397	'	'	174	223	'	'
Other Assets	135	'	'	128	7	'	'
Property, plant and equipment - net	1,260	'	'	419	841	'	'
Bottlers' franchise rights with indefinite lives	471	'	'	130	341	'	'
Goodwill	170	'	'	22	148	'	'
Other intangible assets	1	'	'	1	0	'	'
Allowance for reduction of assets held for sale	-107	'	'	0	-107	'	'
Total Assets	2,973	'	'	1,092	1,881	'	'
Accounts payable and accrued expenses	398	'	'	157	241	'	'
Loans and notes payable	6	'	'	6	0	'	'
Current maturities of long-term debt	28	'	'	28	0	'	'
Accrued income taxes	0	'	'	4	-4	'	'
Long-term debt	147	'	'	147	0	'	'
Other liabilities	95	'	'	75	20	'	'
Deferred income taxes	122	'	'	20	102	'	'
Total liabilities	$796	'	'	$437	$359	'	'

INVESTMENTS_Details

INVESTMENTS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Trading Securities	'	'	'
Trading securities, net unrealized gains (losses)	$12	$19	($5)
Marketable securities	286	184	'
Other assets	86	82	'
Trading Securities	$372	$266	'

INVESTMENTS_Details_2

INVESTMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Available-for-sale securities, by type	'	'
Available-for-sale securities, cost	$4,485	$4,126
Available-for-sale Securities, Gross Unrealized Gains	397	487
Available-for-sale Securities, Gross Unrealized Losses	-40	-20
Available-for-sale securities	4,842	4,593
Equity securities	'	'
Available-for-sale securities, by type	'	'
Available-for-sale securities, cost	1,097	957
Available-for-sale Securities, Gross Unrealized Gains	373	441
Available-for-sale Securities, Gross Unrealized Losses	-17	-10
Available-for-sale securities	1,453	1,388
Debt securities	'	'
Available-for-sale securities, by type	'	'
Available-for-sale securities, cost	3,388	3,169
Available-for-sale Securities, Gross Unrealized Gains	24	46
Available-for-sale Securities, Gross Unrealized Losses	-23	-10
Available-for-sale securities	$3,389	$3,205

INVESTMENTS_Details_3

INVESTMENTS (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Other-than-temporary impairment charges, available-for-sale securities	'	'	$17
Proceeds from Sale of Available-for-sale Securities	4,212	5,036	37
Gross realized gains	12	41	5
Gross realized losses	-24	-35	-1
Available-for-Sale Securities	'	'	'
Schedule of Available-for-sale Securities [Line Items]	'	'	'
Solvency Funds of Insurance Captive	$667	$451	'

INVESTMENTS_Details_4

INVESTMENTS (Details 4) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Available-for-sale and held-to-maturity securities by balance sheet line item	'	'	'	'
Cash and cash equivalents	$10,414	$8,442	$12,803	$8,517
Marketable securities	3,147	3,092	'	'
OTHER INVESTMENTS, PRINCIPALLY BOTTLING COMPANIES	1,119	1,232	'	'
OTHER ASSETS	4,661	3,585	'	'
Available-for-sale securities	4,842	4,593	'	'
Available-for-Sale Securities	'	'	'	'
Available-for-sale and held-to-maturity securities by balance sheet line item	'	'	'	'
Cash and cash equivalents	245	9	'	'
Marketable securities	2,861	2,908	'	'
OTHER INVESTMENTS, PRINCIPALLY BOTTLING COMPANIES	958	1,087	'	'
OTHER ASSETS	778	589	'	'
Available-for-sale securities	$4,842	$4,593	'	'

INVESTMENTS_Details_5

INVESTMENTS (Details 5) (USD $)	Dec. 31, 2013
In Millions, unless otherwise specified	Dec. 31, 2013
Investments Disclosure [Abstract]	'
Available-for-sale securities, within 1 year, cost	$1,227
Available-for-sale securities, within 1 year, fair value	1,227
Available-for-sale securities, after 1 years through 5 years, cost	1,669
Available-for-sale securities, after 1 years through 5 years, fair value	1,672
Available-for-sale securities, after 5 years through 10 years, cost	156
Available-for-sale securities, after 5 years through 10 years, fair value	161
Available-for-sale securities, after 10 years, cost	336
Available-for-sale securities, after 10 years, fair value	$329

INVESTMENTS_Details_6

INVESTMENTS (Details 6) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2012	Dec. 31, 2013
Cost Method Investments [Abstract]	'	'
Cost method investments, carrying value	$145	$162
Cost method investments, other-than-temporary decline in fair value	$16	'

INVENTORIES_Details

INVENTORIES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Inventory balances	'	'
Raw materials and packaging	$1,692	$1,773
Finished goods	1,240	1,171
Other	345	320
Total inventories	$3,277	$3,264

HEDGING_TRANSACTIONS_AND_DERIV2

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Maximum length of time over which future cash flow exposures are hedged (in years)	'3 years	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	$604	$491
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	235	139
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	125	62
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	50	71
Anticipated gains (losses) cash flows hedges, estimated reclassification to earnings	119	'
Increase in the carrying value of long-term debt, in relation to interest rate fair value hedge adjustment	52	'
Foreign currency contracts \| Prepaid expenses and other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	211	149
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	21	19
Foreign currency contracts \| Other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	109	0
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	171	42
Foreign currency contracts \| Accounts payable and accrued expenses	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	84	55
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	24	24
Foreign currency contracts \| Other liabilities	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	40	0
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	1
Commodity contracts \| Prepaid expenses and other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	1	0
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	33	72
Commodity contracts \| Other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	1	0
Commodity contracts \| Accounts payable and accrued expenses	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	1	1
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	23	43
Commodity contracts \| Other liabilities	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	1
Interest Rate Contract [Member] \| Prepaid expenses and other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	0	7
Interest Rate Contract [Member] \| Other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Assets, at Fair Value	283	335
Interest Rate Contract [Member] \| Other liabilities	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivatives Designated as Hedging Instruments, Liabilities, at Fair Value	0	6
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	3	0
Other Derivative Instruments \| Prepaid expenses and other assets	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative Instruments Not Designated as Hedging Instruments, Asset, at Fair Value	9	6
Other Derivative Instruments \| Accounts payable and accrued expenses	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative Instruments Not Designated as Hedging Instruments, Liability, at Fair Value	0	2
Cash Flow Hedges \| Foreign currency contracts	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	8,450	4,715
Cash Flow Hedges \| Commodity contracts	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	26	17
Cash Flow Hedges \| Interest Rate Swap [Member]	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	1,828	1,764
Fair Value Hedges \| Available-for-Sale Securities	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	996	850
Fair Value Hedges \| Interest Rate Swap [Member]	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	5,600	6,700
Net Investment Hedges \| Foreign currency contracts	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	2,024	1,718
Not Designated as Hedging Instrument [Member] \| Foreign currency contracts	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	3,871	3,865
Not Designated as Hedging Instrument [Member] \| Commodity contracts	'	'
Fair Value, Derivatives Designated and Not Designated as Hedges	'	'
Derivative, Notional Amount	$1,441	$1,084

HEDGING_TRANSACTIONS_AND_DERIV3

HEDGING TRANSACTIONS AND DERIVATIVE FINANCIAL INSTRUMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Cash Flow Hedges	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	$441	$90	($9)
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	167	-82	-243
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-2	2	-1
Cash Flow Hedges \| Interest rate contracts \| Interest expense	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	169	1	-11
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	-12	-12	-12
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-3	0	-1
Cash Flow Hedges \| Foreign currency contracts \| Net operating revenues	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	218	59	3
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	149	-46	-231
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	1	2	0
Cash Flow Hedges \| Foreign currency contracts \| Cost of goods sold	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	52	34	'
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	32	-23	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	'
Cash Flow Hedges \| Commodity contracts \| Cost of goods sold	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	2	-4	-1
Gain (Loss) Reclassified from AOCI into Income (Effective Portion)	-2	-1	0
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	0	0	0
Fair Value Hedges	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	23	43	'
Fair Value Hedges \| Interest expense	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	47	47	10
Fair Value Hedges \| Other income (loss) - net	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-24	-4	'
Fair Value Hedges \| Interest rate contracts \| Interest expense	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-193	89	343
Fair Value Hedges \| Foreign currency contracts \| Other income (loss) - net	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	24	42	'
Fair Value Hedges \| Available-for-Sale Securities \| Other income (loss) - net	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	-48	-46	'
Fair Value Hedges \| Fixed Rate Debt \| Interest expense	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in Income (Ineffective Portion and Amount Excluded from Effectiveness Testing)	240	-42	-333
Net Investment Hedges \| Foreign currency contracts	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Gain (Loss) Recognized in OCI	61	-61	-3
Derivatives Not Designated as Hedging Instruments	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	111	-62	-87
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Net operating revenues	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	5	-7	7
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Other income (loss) - net	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	162	24	-37
Derivatives Not Designated as Hedging Instruments \| Foreign currency contracts \| Cost of goods sold	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	2	0	-12
Derivatives Not Designated as Hedging Instruments \| Interest rate swaps \| Interest expense	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-3	0	0
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Net operating revenues	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	5	4	0
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Cost of goods sold	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	-122	-110	-42
Derivatives Not Designated as Hedging Instruments \| Commodity contracts \| Selling, general and administrative expenses	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	7	9	-11
Derivatives Not Designated as Hedging Instruments \| Other Derivative Instruments \| Selling, general and administrative expenses	'	'	'
Gains and (losses) related to derivative instruments	'	'	'
Derivative, Gain (Loss) on Derivative, Net	$55	$18	$8

EQUITY_METHOD_INVESTMENTS_Deta

EQUITY METHOD INVESTMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Equity method investments, disclosures	'	'	'
Investment in equity method investees in excess of the proportionate share of net assets	$2,202	'	'
Summarized financial information - Income statement	'	'	'
Equity income (loss) - net	602	819	690
Summarized financial information - Balance sheet	'	'	'
Company equity investment	10,393	9,216	'
Other Equity Method Investees [Member]	'	'	'
Summarized financial information - Income statement	'	'	'
Net operating revenues	53,038	47,087	42,472
Cost of goods sold	32,377	28,821	26,271
Gross profit	20,661	18,266	16,201
Operating income	4,380	4,605	4,181
Consolidated net income	2,364	2,993	2,237
Less: Net income attributable to noncontrolling interests	62	89	99
Net income attributable to common shareowners	2,302	2,904	2,138
Summarized financial information - Balance sheet	'	'	'
Current Assets	19,229	16,054	'
Noncurrent assets	40,427	32,687	'
Total assets	59,656	48,741	'
Current liabilities	14,386	12,004	'
Noncurrent liabilities	17,779	12,272	'
Total liabilities	32,165	24,276	'
Equity attributable to shareowners of investees	26,668	23,827	'
Equity attributable to noncontrolling interests	823	638	'
Total Equity	27,491	24,465	'
Company equity investment	10,393	9,216	'
Other Equity Method Investments	'	'	'
Summary of significant transactions with equity method investees	'	'	'
Concentrate, syrup and finished product sales	9,178	7,082	6,874
Purchases of finished product	415	392	430
Marketing payments made by us	$1,807	$1,587	$1,147
Coca-Cola FEMSA	'	'	'
Equity method investments, disclosures	'	'	'
Ownership interest in Equity investee (as a percent)	28.00%	'	'
Coca-Cola Hellenic	'	'	'
Equity method investments, disclosures	'	'	'
Ownership interest in Equity investee (as a percent)	23.00%	'	'
Coca-Cola Amatil	'	'	'
Equity method investments, disclosures	'	'	'
Ownership interest in Equity investee (as a percent)	29.00%	'	'

EQUITY_METHOD_INVESTMENTS_Deta1

EQUITY METHOD INVESTMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Schedule of Equity Method Investments [Line Items]	'	'	'
Excess of quoted market value over carrying value	$9,155	'	'
Total net receivables due	1,308	1,280	'
Dividends received	401	393	421
Coca-Cola Hellenic	'	'	'
Schedule of Equity Method Investments [Line Items]	'	'	'
Special dividend included in total dividends	'	$35	$60

PROPERTY_PLANT_AND_EQUIPMENT_D

PROPERTY, PLANT AND EQUIPMENT (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Property, Plant and Equipment	'	'	'
Property, plant and equipment, gross	$25,032	$23,486	'
Less accumulated depreciation	10,065	9,010	'
Property, plant and equipment-net	14,967	14,476	14,939
Land	'	'	'
Property, Plant and Equipment	'	'	'
Property, plant and equipment, gross	1,011	997	'
Buildings and improvements	'	'	'
Property, Plant and Equipment	'	'	'
Property, plant and equipment, gross	5,605	5,307	'
Machinery equipment and vehicle fleet	'	'	'
Property, Plant and Equipment	'	'	'
Property, plant and equipment, gross	17,551	16,203	'
Construction in progress	'	'	'
Property, Plant and Equipment	'	'	'
Property, plant and equipment, gross	$865	$979	'

INTANGIBLE_ASSETS_Details

INTANGIBLE ASSETS (Details) (USD $)

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2010

Oct. 02, 2010

Trademarks

Bottlers' Franchise Rights

Goodwill

Other.

Customer Relationships

Dr Pepper Snapple Group [Member]

Indefinite-lived Intangible Assets

Indefinite-lived intangible assets

$26,642

$26,298

$6,744

$6,527

$7,415

$7,405

$12,312

$12,255

$171

$111

Indefinite-Lived License Agreements

865

Term of License Agreement

Renewal Period of License Agreement

Definite-lived Intangible Assets

Gross carrying amount

1,597

1,546

105

722

730

128

129

642

622

Accumulated amortization

-628

-507

-26

-43

-317

-221

-83

-77

-202

-166

Net definite-lived intangible assets

969

1,039

405

509

440

456

Total amortization expense for intangible assets subject to amortization

165

173

192

Amortization Expense

2014

160

2015

152

2016

145

2017

112

2018

$54

INTANGIBLE_ASSETS_Details_2

INTANGIBLE ASSETS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Goodwill by operating segment	'	'
Balance as of January 1	$12,255	$12,219
Effect of foreign currency translation	18	-13
Acquisitions	127	257
Adjustments related to the finalization of purchase accounting	-5	-38
Impairment	-82	'
Divestitures, deconsolidations and other	-1	-170
Balance as of December 31	12,312	12,255
Eurasia and Africa	'	'
Goodwill by operating segment	'	'
Balance as of January 1	34	35
Effect of foreign currency translation	-3	-1
Acquisitions	5	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment	0	'
Divestitures, deconsolidations and other	0	0
Balance as of December 31	36	34
Europe	'	'
Goodwill by operating segment	'	'
Balance as of January 1	691	710
Effect of foreign currency translation	29	-19
Acquisitions	102	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment	0	'
Divestitures, deconsolidations and other	0	0
Balance as of December 31	822	691
Latin America	'	'
Goodwill by operating segment	'	'
Balance as of January 1	168	163
Effect of foreign currency translation	-12	5
Acquisitions	0	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment	0	'
Divestitures, deconsolidations and other	0	0
Balance as of December 31	156	168
North America	'	'
Goodwill by operating segment	'	'
Balance as of January 1	10,577	10,515
Effect of foreign currency translation	0	0
Acquisitions	0	100
Adjustments related to the finalization of purchase accounting	-4	-38
Impairment	0	'
Divestitures, deconsolidations and other	-1	0
Balance as of December 31	10,572	10,577
Pacific	'	'
Goodwill by operating segment	'	'
Balance as of January 1	123	117
Effect of foreign currency translation	-6	6
Acquisitions	0	0
Adjustments related to the finalization of purchase accounting	0	0
Impairment	0	'
Divestitures, deconsolidations and other	0	0
Balance as of December 31	117	123
Bottling Investments	'	'
Goodwill by operating segment	'	'
Balance as of January 1	662	679
Effect of foreign currency translation	10	-4
Acquisitions	20	157
Adjustments related to the finalization of purchase accounting	-1	0
Impairment	-82	'
Divestitures, deconsolidations and other	0	-170
Balance as of December 31	$609	$662

ACCOUNTS_PAYABLE_AND_ACCRUED_E2

ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
ACCOUNTS PAYABLE AND ACCRUED EXPENSES Disclosure [Abstract]	'	'
Accrued marketing	$2,407	$2,231
Other accrued expenses	3,515	2,711
Trade accounts payable	1,933	1,969
Accrued compensation	933	1,045
Sales, payroll and other taxes	450	389
Container deposits	339	335
Accounts payable and accrued expenses	$9,577	$8,680

DEBT_AND_BORROWING_ARRANGEMENT2

DEBT AND BORROWING ARRANGEMENTS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Short-term borrowings	'	'
Commercial paper borrowings outstanding	$16,853	$16,204
Weighted-average interest rates for commercial paper outstanding (as a percent)	0.20%	0.30%
Line of Credit Facility, Maximum Borrowing Capacity	7,413	'
Lines of credit and other short-term credit facilities outstanding	48	'
Lines of credit for general corporate purposes	$6,410	'

DEBT_AND_BORROWING_ARRANGEMENT3

DEBT AND BORROWING ARRANGEMENTS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Long-term debt	'	'	'
Issuance of long term debt	$7,500	$2,750	$2,979
Repurchase of long-term debt	'	'	61
Debt instrument Average Rate (as a percent)	2.20%	2.10%	'
Fair value adjustment	52	273	'
Debt issued in exchange of assumed debt	'	'	979
Premium on exchange of long term debt	'	'	208
Net charge on exchange, repayment or extinguishment of long-term debt	50	'	9
Long-term Debt	20,178	16,313	'
Less current portion	1,024	1,577	'
Long-term debt non current	19,154	14,736	'
Total interest paid	498	574	573
Maturities of Long-Term Debt	'	'	'
2014	1,024	'	'
2015	2,573	'	'
2016	2,681	'	'
2017	1,394	'	'
2018	3,298	'	'
Total principal notes due March 5, 2015	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	500	'	'
Variable interest rate used	'P3M	'	'
Basis spread on variable rate used (as a percent)	0.02%	'	'
Total principal notes due November 1, 2016	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	500	'	'
Variable interest rate used	'P3M	'	'
Basis spread on variable rate used (as a percent)	0.10%	'	'
Fixed interest rate (as a percent)	0.75%	'	'
Total principal notes due April 1, 2018	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	1,250	'	'
Fixed interest rate (as a percent)	1.15%	'	'
Total principal notes due November 1, 2018	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	1,250	'	'
Fixed interest rate (as a percent)	1.65%	'	'
Total principal notes due November 1, 2020	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	1,250	'	'
Fixed interest rate (as a percent)	2.45%	'	'
Total principal notes due April 1, 2023	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	750	'	'
Fixed interest rate (as a percent)	2.50%	'	'
Total principal notes due November 1, 2023	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	1,500	'	'
Fixed interest rate (as a percent)	3.20%	'	'
Total principal notes due August 15, 2013	'	'	'
Long-term debt	'	'	'
Fixed interest rate (as a percent)	5.00%	'	'
Total principal notes due March 3, 2014	'	'	'
Long-term debt	'	'	'
Fixed interest rate (as a percent)	7.38%	'	'
Total principal notes due March 15, 2014	'	'	'
Long-term debt	'	'	'
Fixed interest rate (as a percent)	3.63%	'	'
Total principal notes due March 1, 2015	'	'	'
Long-term debt	'	'	'
Fixed interest rate (as a percent)	4.25%	'	'
Total princiapl notes due on March 14 2014	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	'	1,000	'
Variable interest rate used	'	'3	'
Basis spread on variable rate used (as a percent)	'	0.05%	'
Total principal notes due on March 13 2015	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	'	1,000	'
Fixed interest rate (as a percent)	'	0.75%	'
Total principal notes due on March 14 2018	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	'	750	'
Fixed interest rate (as a percent)	'	1.65%	'
Total principal notes due September 1 2016	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	'	'	1,655
Fixed interest rate (as a percent)	'	'	1.80%
Total principal notes due September 1 2021	'	'	'
Long-term debt	'	'	'
Issuance of long term debt	'	'	1,324
Fixed interest rate (as a percent)	'	'	3.30%
U.K. pound sterling notes	'	'	'
Long-term debt	'	'	'
Repurchase of long-term debt	'	'	674
US dollar notes due 2014 through 2093	'	'	'
Long-term debt	'	'	'
Debt instrument Average Rate (as a percent)	1.80%	1.70%	'
Long-term Debt	17,427	13,407	'
US dollar debentures due 2017 through 2098	'	'	'
Long-term debt	'	'	'
Debt instrument Average Rate (as a percent)	3.90%	3.70%	'
Long-term Debt	2,191	2,207	'
U.S. dollar zero coupon notes due in 2020	'	'	'
Long-term debt	'	'	'
Debt instrument Average Rate (as a percent)	8.40%	8.40%	'
Unamortized discounts as of the acquisition date	33	36	'
Long-term Debt	138	135	'
Other Due 2098	'	'	'
Long-term debt	'	'	'
Debt instrument Average Rate (as a percent)	4.00%	4.40%	'
Long-term Debt	370	291	'
Other, due through 2022	'	'	'
Long-term debt	'	'	'
Long-term Debt	167	'	'
CCE's North American business	'	'	'
Long-term debt	'	'	'
Exchanged debt assumed	'	'	1,022
repayment assumed debt unamortized fair value adjustments	'	'	99
Assumed long term debt \| Coca-Cola Enterprises Inc.	'	'	'
Long-term debt	'	'	'
Fair value adjustment related to the debt assumed	514	617	'
Fair value adjustments weighted-average amortization period (in years)	19	'	'
upon maturity	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	1,250	1,250	'
Prior to Maturity	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	2,154	'	20
Prior to Maturity \| Total principal notes due August 15, 2013	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	225	'	'
Prior to Maturity \| Total principal notes due March 3, 2014	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	675	'	'
Prior to Maturity \| Total principal notes due March 15, 2014	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	900	'	'
Prior to Maturity \| Total principal notes due March 1, 2015	'	'	'
Long-term debt	'	'	'
Extinguishment of long-term debt	354	'	'
Level 2	'	'	'
Long-term debt	'	'	'
Long-term Debt, Fair Value	$20,352	$17,157	'

COMMITMENTS_AND_CONTINGENCIES_1

COMMITMENTS AND CONTINGENCIES (Details) (USD $)	12 Months Ended				12 Months Ended	144 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 2013	Dec. 31, 1981	Dec. 31, 2013	Dec. 31, 2012
	Dec. 31, 2013	North America [Member]	United States	Guarantees of indebtedness owed by third parties	Aqua-Chem, Inc. (now know as Cleaver-Brooks, Inc.)	Aqua-Chem, Inc. (now know as Cleaver-Brooks, Inc.)	Risk Management Programs	Risk Management Programs
Loss Contingencies By Nature Of Contingency Line Items	'	'	'	'	'	'	'	'
Low end of range for which insurance coverage for substantially all defense and indemnity costs would be available	'	'	'	'	10	'	'	'
High end of range for which insurance coverage for substantially all defense and indemnity costs would be available	'	'	'	'	15	'	'	'
Period for which Defense and Indemnity Costs are in Same Range	'	'	'	'	5	'	'	'
Guarantees	'	'	'	'	'	'	'	'
Guarantees of indebtedness owed by third parties	'	'	'	$662	'	'	'	'
Guarantees of indebtedness related to VIEs	'	'	'	288	'	'	'	'
Legal Contingencies	'	'	'	'	'	'	'	'
Loss contingency insurance policy purchased	'	'	'	'	'	400	'	'
Third Party Number of Pending Active Claims	'	'	'	'	40,000	'	'	'
Number of plaintiff insurance companies filing declaratory judgment action against Aqua-Chem, the Company, and defendant insurance companies	'	'	'	'	5	'	'	'
Number of insurance companies included as defendants in declaratory judgment requested by plaintiff	'	'	'	'	16	'	'	'
Approximate amount of out-of-pocket litigation related expenses demanded as reimbursement by plaintiff	'	'	'	'	10	'	'	'
Wisconsin trial court final declaratory judgment of each individual insurer's joint and several liability percentage of plaintiff's losses up to policy limits	'	'	'	'	100.00%	'	'	'
Risk Management Programs	'	'	'	'	'	'	'	'
Self-insurance reserves	'	'	'	'	'	'	537	508
Workforce (Unaudited)	'	'	'	'	'	'	'	'
Number of associates	130,600	'	66,800	'	'	'	'	'
Number of associates covered by collective bargaining agreements	'	18,000	'	'	'	'	'	'
Collective bargaining agreements period, low end of range (in years)	'	3	'	'	'	'	'	'
Collective bargaining agreements period, high end of range (in years)	'	5	'	'	'	'	'	'
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]	'	'	'	'	'	'	'	'
2014	252	'	'	'	'	'	'	'
2015	180	'	'	'	'	'	'	'
2016	142	'	'	'	'	'	'	'
2017	107	'	'	'	'	'	'	'
2018	88	'	'	'	'	'	'	'
Thereafter	276	'	'	'	'	'	'	'
Total minimum operating lease payments	$1,045	'	'	'	'	'	'	'

STOCK_COMPENSATION_PLANS_Detai

STOCK COMPENSATION PLANS (Details) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, except Share data, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2010

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Oct. 02, 2010

Dec. 31, 1989

Dec. 31, 1983

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

CCE's North American business

Stock Options

1999 Option Plan

2002 Option Plan

2008 Option Plan

Stock options granted in December 2003 and thereafter

Stock options granted from 1999 through July 2003

Performance share units

1989 Restricted Stock Award Plan

1983 Restricted Stock Award Plan

Time-Based Restricted Stock Unit Awards

Performance-based Restricted Stock Unit Awards

Restricted stock award plan [Member]

2011-2013 Performace Period

2012 to 2014 Performance Period

Performance Period 2013 to 2015 [Member]

CCE's North American business

STOCK COMPENSATION PLANS [Abstract]

Total stock-based compensation expense

$227

$259

$354

Total income tax benefit recognized in consolidated statements of income for share-based compensation arrangements

Total unrecognized compensation cost related to nonvested share-based compensation arrangements granted

416

Weighted-average period over which the total unrecognized compensation cost is expected to be recognized (in years)

'1 year 9 months 11 days

Stock-based compensation awards

Share-based Compensation Arrangement by Share-based Payment Award Performance Share Unit Projected Payout Percentage

200.00%

Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage

150.00%

Vesting period of stock-based awards (in years)

'3 years

'4 years

Weighted-average assumptions used in the Black Scholes Merton option pricing model

Fair value of options at grant date (in dollars per share)

$3.73

$3.80

$4.64

Dividend yield (as a percent)

2.80%

2.70%

Expected volatility (as a percent)

17.00%

18.00%

19.00%

Risk-free interest rate (as a percent)

0.90%

1.00%

2.30%

Expected term of the option (in years)

'5 years

Share-based compensation disclosure

Common stock was approved to be issued or transferred through the grant of stock options (in shares)

240,000,000

280,000,000

Granted (in shares)

56,000,000

Exercised (in shares)

-53,000,000

-61,000,000

-65,000,000

Forfeited/expired (in shares)

-7,000,000

Outstanding on December 31 (in shares)

305,000,000

309,000,000

3,000,000

Expected to vest at December 31, 2013

302,000,000

Granted, Weighted-Average Exercise Price (in dollars per share)

$37.68

Exercised, Weighted-Average Exercise Price (in dollars per share)

$25.02

Forfeited/expired, Weighted-Average Exercise Price (in dollars per share)

$34.34

Outstanding on December 31, Weighted-Average Exercise Price (in dollars per share)

$29.42

$27.27

$18.02

Expected to vest at December 31, 2013, Weighted-Average Exercise Price (in dollars per share)

$29.33

Expected to Vest, Weighted Average Remaining Contractual Life (in years)

'5 years 9 months 11 days

Outstanding on December 31, 2013, Weighted-Average Remaining Contractual Life (in years)

'P5Y9M26D

Exercisable on December 31, 2013, Weighted-Average Remaining Contractual Life (in years)

'4 years 3 months

Outstanding on December 31, 2013, Aggregate Intrinsic Value (in dollars)

3,636

Expected to vest at December 31, 2013, Aggregate Intrinsic Value (in dollars)

3,614

Exercisable on December 31, 2013

187,000,000

Exercisable on December 31, 2013, Aggregate Intrinsic Value (in dollars)

2,887

Expiration period of stock-based awards (in years)

'10 years

'10

'15 years

Total intrinsic value of options exercised

815

780

631

Number of Shares Available for Grant (in shares)

84,000,000

29,000,000

3,800,000

80,000,000

48,000,000

25,000,000

Summary disclosures

Paid in cash equivalent (in shares)

-54,999

-55,000

-16,267

-19,462

Canceled/forfeited (in shares)

-760,000

-508,000

Outstanding on December 31 (in shares)

17,974,000

17,584,000

Granted

6,425,000

Outstanding on January 1, 2013, Weighted-Average Grant-Date Fair Value (in dollars per share)

$28.01

$26.54

Paid in cash equivalent, Weighted-Average Grant-Date Fair Value (in dollars per share)

$32.25

Canceled/forfeited, Weighted-Average Grant-Date Fair Value (in dollars per share)

$30.33

$25.17

Outstanding on December 31, 2013, Weighted-Average Grant-Date Fair Value (in dollars per share)

$30.41

$28.01

$25.17

$26.54

Restricted shares units vested and released (in shares)

-405,963

-406,000

-4,301,732

-2,084,912

Vested and released, Weighted-Average Grant-Date Fair Value (in dollars per share)

$25.52

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

3,300,000

Number of shares issued due to modification in the performance awards

100,000

600,000

3,100,000

Intrinsic value of shares issued due to modification in the performance awards

Outstanding performance share units at the Threshold Award Level (in shares)

9,000,000

Outstanding performance share units at the Maximum Award Level (in shares)

27,000,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value

$32.67

$29.95

$25.58

$29.56

Restricted shares vested and released under performance share unit awards, total intrinsic value

148

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period

'3 years

Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards, Granted before 2008

'2 years

Share-based Compensation Arrangement by Share-based Payment Award, Award Requisite Holding Period Awards Granted 2008 and beyond

'1 year

Exercisable on December 31, 2013 weighted average exercise price (in dollars per share)

$25.87

Performance share units outstanding based on the target award amounts (in shares)

5,365,000

6,487,000

6,122,000

700,000

59,000

81,000

7,014,000

98,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted in Restricted Stock Units in Period

-5,220,000

-7,830,000

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Converted in Restricted Stock in Period, Weighted Average Grant Date Fair Value

$25.17

Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other-than-Options Paid in Cash Equivalent in Period Value

$1.80

$0.60

$0.70

PENSION_AND_OTHER_POSTRETIREME2

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Defined Benefit Plan Disclosure	'	'
Prescription Drug Benefit, Reduction in Accumulated Postretirement Benefit Obligation for Subsidy	$71	'
Pension benefits	'	'
Changes in benefit obligations	'	'
Benefit obligation at January 1	9,693	8,255
Service cost	280	291
Interest cost	378	388
Foreign currency exchange rate changes	-69	-7
Amendments	-1	-3
Actuarial loss (gain)	-899	1,259
Benefits paid	-538	-420
Settlements	-9	-35
Curtailments	0	6
Special termination benefits	2	1
Other	8	-42
Benefit obligation at December 31	8,845	9,693
Fair value of plan assets	'	'
Fair value of plan assets at January 1	7,584	6,171
Actual return on plan assets	1,043	822
Employer contributions	639	1,056
Foreign currency exchange rate changes	-43	-17
Benefits paid	-474	-366
Settlements	-5	-34
Other	2	-48
Fair value of plan assets at December 31	8,746	7,584
Net liability recognized	-99	-2,109
Accumulated benefit obligation for pension plans	8,523	9,345
Benefits paid from company assets for unfunded pension plans	64	54
Pension and other benefit amounts recognized in our consolidated balance sheets	'	'
Noncurrent asset	1,067	395
Current liability	-76	-73
Long-term liability	-1,090	-2,431
Net liability recognized	-99	-2,109
Projected benefit obligations in excess of the fair value of plan assets	'	'
Projected benefit obligation	1,521	9,161
Fair value of plan assets	374	6,659
Accumulated benefit obligations in excess of the fair value of plan assets	'	'
Accumulated benefit obligation	1,446	8,736
Fair value of plan assets	351	6,546
U.S. Plan	'	'
Fair value of plan assets	'	'
Fair value of plan assets at December 31	6,343	5,549
Primary U.S. Plan	'	'
Defined Benefit Plan Disclosure	'	'
Portion of projected pension benefit obligation represented by the defined benefit plan (as a percent)	57.00%	'
Portion of projected pension plan assets represented by the defined benefit plan (as a percent)	63.00%	'
Non U. S. Plan	'	'
Fair value of plan assets	'	'
Fair value of plan assets at December 31	2,403	2,035
Other benefits	'	'
Changes in benefit obligations	'	'
Benefit obligation at January 1	1,104	953
Service cost	36	34
Interest cost	42	43
Foreign currency exchange rate changes	-2	3
Amendments	-73	-2
Actuarial loss (gain)	-91	115
Benefits paid	-77	-53
Settlements	0	0
Curtailments	0	0
Special termination benefits	0	0
Other	7	11
Benefit obligation at December 31	946	1,104
Fair value of plan assets	'	'
Fair value of plan assets at January 1	202	185
Actual return on plan assets	40	16
Employer contributions	0	0
Foreign currency exchange rate changes	0	0
Benefits paid	-2	-2
Settlements	0	0
Other	3	3
Fair value of plan assets at December 31	243	202
Net liability recognized	-703	-902
Benefits paid from company assets for unfunded pension plans	75	51
Pension and other benefit amounts recognized in our consolidated balance sheets	'	'
Noncurrent asset	0	0
Current liability	-21	-21
Long-term liability	-682	-881
Net liability recognized	($703)	($902)

PENSION_AND_OTHER_POSTRETIREME3

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 2) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	$8,746	$7,584	$6,171
Defined Benefit Plan, Benefits Paid for Unfunded Plans	64	54	'
U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	6,343	5,549	'
Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	2,403	2,035	'
Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	243	202	185
Defined Benefit Plan, Benefits Paid for Unfunded Plans	75	51	'
Cash and cash equivalents \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	514	386	'
Cash and cash equivalents \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	240	299	'
Cash and cash equivalents \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	274	87	'
Cash and cash equivalents \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	10	13	'
Equity securities U.S.-based companies \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,702	1,881	'
Equity securities U.S.-based companies \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,422	1,844	'
Equity securities U.S.-based companies \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	280	37	'
Equity securities U.S.-based companies \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	112	81	'
Equity securities International-based companies \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,284	964	'
Equity securities International-based companies \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	698	324	'
Equity securities International-based companies \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	586	640	'
Equity securities International-based companies \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	8	4	'
Government bonds \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	768	562	'
Government bonds \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	464	399	'
Government bonds \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	304	163	'
Government bonds \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	79	78	'
Corporate bonds and debt securities \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,506	982	'
Corporate bonds and debt securities \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,369	856	'
Corporate bonds and debt securities \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	137	126	'
Corporate bonds and debt securities \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	9	5	'
Mutual, pooled and commingled funds \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,587	1,510	'
Mutual, pooled and commingled funds \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	1,134	1,057	'
Mutual, pooled and commingled funds \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	453	453	'
Mutual, pooled and commingled funds \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	18	16	'
Hedge funds/limited partnerships \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	543	525	'
Hedge funds/limited partnerships \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	526	496	'
Hedge funds/limited partnerships \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	17	29	'
Hedge funds/limited partnerships \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	3	3	'
Real estate \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	251	257	'
Real estate \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	245	248	'
Real estate \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	6	9	'
Real estate \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	2	2	'
Other \| Pension benefits	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	591	517	'
Other \| U.S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	245	26	'
Other \| Non U. S. Plan	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	346	491	'
Other \| Other Postretirement Benefit Plan, Defined Benefit [Member]	'	'	'
Defined Benefit Plan Disclosure	'	'	'
Fair Value of Plan Assets	$2	$0	'

PENSION_AND_OTHER_POSTRETIREME4

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 3)	12 Months Ended
PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 3)	Dec. 31, 2013
U.S. Plan	'
Defined Benefit Plan Disclosure	'
Maximum portion of plan assets for which an investment manager is responsible (as a percent)	10.00%
Target allocation, equity securities (as a percent)	42.00%
Target allocation, fixed-income securities (as a percent)	30.00%
Target allocation, alternative investments (as a percent)	28.00%
Investment in Company common stock (as a percent)	2.00%
Non U. S. Plan	'
Defined Benefit Plan Disclosure	'
Investment Strategy Allocation Targets For International Plans	59.00%
Target allocation, equity securities (as a percent)	21.00%
Target allocation, alternative investments (as a percent)	41.00%
Target allocation, fixed income securities (as a percent)	7.00%
Target allocation, mutual, pooled and commingled funds (as a percent)	31.00%
European Pensions Plans [Member]	'
Defined Benefit Plan Disclosure	'
Investment Strategy Allocation Targets For International Plans	41.00%
Target allocation, equity securities (as a percent)	62.00%
Target allocation, fixed income securities (as a percent)	38.00%
Global equities [Member] \| U.S. Plan	'
Defined Benefit Plan Disclosure	'
Target allocation, equity securities (as a percent)	60.00%
Investment in Company common stock (as a percent)	5.00%
Emerging market equities \| U.S. Plan	'
Defined Benefit Plan Disclosure	'
Target allocation, equity securities (as a percent)	16.00%
Domestic small- and mid-cap equities \| U.S. Plan	'
Defined Benefit Plan Disclosure	'
Target allocation, equity securities (as a percent)	24.00%
Long-duration bonds \| U.S. Plan	'
Defined Benefit Plan Disclosure	'
Target allocation, fixed-income securities (as a percent)	33.00%
Multi-strategy alternative credit managers \| U.S. Plan	'
Defined Benefit Plan Disclosure	'
Target allocation, fixed-income securities (as a percent)	67.00%

PENSION_AND_OTHER_POSTRETIREME5

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 4) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Pension benefits	'	'	'
Net periodic pension and other Postretirement benefit cost	'	'	'
Service cost	$280	$291	$249
Interest cost	378	388	391
Expected return on plan assets	-659	-573	-508
Amortization of prior service cost (credit)	-2	-2	5
Amortization of actuarial loss	197	137	82
Net periodic benefit cost (credit)	194	241	219
Settlement charge	1	3	3
Curtailment charge	0	6	0
Special termination benefits	2	1	8
Total cost (credit) recognized in the statement of income	197	251	230
Changes in AOCI for our benefit plans, pretax	'	'	'
Beginning balance in AOCI	-3,032	-2,169	'
Recognized prior service cost (credit)	-2	-2	'
Recognized net actuarial loss (gain)	198	140	'
Prior service credit (cost) arising in the current year	1	3	'
Net actuarial (loss) gain arising in the current year	1,283	-1,009	'
Foreign currency translation gain (loss)	15	5	'
Ending balance in AOCI	-1,537	-3,032	-2,169
Prior service credit (cost)	12	16	'
Net actuarial loss	-1,549	-3,048	'
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]	'	'	'
Amounts in AOCI expected to be recognized as component of net periodic pension cost in next fiscal year	74	'	'
Amortization of prior service cost (credit)	-2	'	'
Amortization of actuarial loss	76	'	'
Weighted average assumptions used in computing the benefit obligations	'	'	'
Discount rate (as a percent)	4.75%	4.00%	'
Rate of increase in compensation levels (as a percent)	3.50%	3.50%	'
Weighted-average assumptions used in computing net periodic benefit cost	'	'	'
Discount rate (as a percent)	4.00%	4.75%	5.50%
Rate of increase in compensation levels (as a percent)	3.50%	3.25%	4.00%
Expected long-term rate of return on plan assets (as a percent)	8.25%	8.25%	8.25%
U.S. Plan	'	'	'
Weighted-average assumptions used in computing net periodic benefit cost	'	'	'
Expected long-term rate of return on plan assets (as a percent)	8.50%	'	'
The 10-year annualized return on plan assets (as a percent)	6.90%	'	'
The 15-year annualized return on plan assets (as a percent)	6.20%	'	'
Annualized return on plan assets since inception (as a percent)	11.10%	'	'
Other benefits	'	'	'
Net periodic pension and other Postretirement benefit cost	'	'	'
Service cost	36	34	32
Interest cost	42	43	45
Expected return on plan assets	-9	-8	-8
Amortization of prior service cost (credit)	-10	-52	-61
Amortization of actuarial loss	13	6	2
Net periodic benefit cost (credit)	72	23	10
Settlement charge	0	0	0
Curtailment charge	0	0	0
Special termination benefits	0	0	3
Total cost (credit) recognized in the statement of income	72	23	13
Changes in AOCI for our benefit plans, pretax	'	'	'
Beginning balance in AOCI	-186	-34	'
Recognized prior service cost (credit)	-10	-52	'
Recognized net actuarial loss (gain)	13	6	'
Prior service credit (cost) arising in the current year	73	2	'
Net actuarial (loss) gain arising in the current year	122	-107	'
Foreign currency translation gain (loss)	1	-1	'
Ending balance in AOCI	13	-186	-34
Prior service credit (cost)	86	23	'
Net actuarial loss	-73	-209	'
Defined Benefit Plan, Amount to be Amortized from Accumulated Other Comprehensive Income (Loss) Next Fiscal Year [Abstract]	'	'	'
Amounts in AOCI expected to be recognized as component of net periodic pension cost in next fiscal year	-15	'	'
Amortization of prior service cost (credit)	-17	'	'
Amortization of actuarial loss	$2	'	'
Weighted average assumptions used in computing the benefit obligations	'	'	'
Discount rate (as a percent)	4.75%	4.00%	'
Weighted-average assumptions used in computing net periodic benefit cost	'	'	'
Discount rate (as a percent)	4.00%	4.75%	5.25%
Expected long-term rate of return on plan assets (as a percent)	4.75%	4.75%	4.75%

PENSION_AND_OTHER_POSTRETIREME6

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 5) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Estimated future benefit payments for funded and unfunded plans	'	'
2014	$530	'
2015	545	'
2016	576	'
2017	619	'
2018	624	'
2019-2023	3,430	'
Assumed health care cost trend rates	'	'
Health care cost trend rate assumed for the next year (as a percent)	8.00%	8.00%
Rate at which the cost trend rate is assumed to decline, the ultimate trend rate (as a percent)	5.00%	5.00%
Year in which the rate reaches the ultimate trend rate	'2020	'2019
Pension benefits	'	'
Estimated future benefit payments for funded and unfunded plans	'	'
2014	471	'
2015	483	'
2016	512	'
2017	554	'
2018	558	'
2019-2023	3,084	'
Other benefits	'	'
Estimated future benefit payments for funded and unfunded plans	'	'
2014	59	'
2015	62	'
2016	64	'
2017	65	'
2018	66	'
2019-2023	346	'
Estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, for the period 2014-2018	8	'
Estimated federal subsidies expected to be received under the Medicare Prescription Drug, Improvement and Modernization Act of 2003, for the period 2019-2023	5	'
Non U. S. Plan	'	'
Defined Benefit Plan Disclosure	'	'
Contributions expected to be made in next fiscal year	$175	'

PENSION_AND_OTHER_POSTRETIREME7

PENSION AND OTHER POSTRETIREMENT BENEFIT PLANS (Details 6) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Multi-Employer Plans	'	'	'
Pension expense for multi-employer plans	$37	$31	$69
Defined contribution plan - U. S. Plan	'	'	'
Defined Contribution Plan Disclosures	'	'	'
Maximum employer contribution as a percentage of compensation (as a percent)	3.50%	'	'
Company costs associated with defined contribution plans	97	93	78
Defined contribution plan - Non U. S. Plan	'	'	'
Defined Contribution Plan Disclosures	'	'	'
Company costs associated with defined contribution plans	32	29	31
Integration of CCE's North American Operations [Member]	'	'	'
Multi-Employer Plans	'	'	'
Multiemployer Plan Withdrawal Plan Contribution	'	'	$32

INCOME_TAXES_Details

INCOME TAXES (Details) (USD $)	12 Months Ended
INCOME TAXES (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Income Taxes [Abstract]	'	'	'
Income before income taxes, United States	$2,451,000,000	$3,526,000,000	$3,029,000,000
Income before income taxes, International	9,026,000,000	8,283,000,000	8,429,000,000
INCOME BEFORE INCOME TAXES	11,477,000,000	11,809,000,000	11,458,000,000
Income tax payments	2,162,000,000	981,000,000	1,612,000,000
Income tax expense (benefit)	'	'	'
Current income tax expense (benefit), United States	713,000,000	602,000,000	286,000,000
Deferred income tax expense (benefit), United States	305,000,000	936,000,000	898,000,000
Current income tax expense (benefit), State and Local	102,000,000	74,000,000	66,000,000
Deferred income tax expense (benefit), State and Local	38,000,000	33,000,000	27,000,000
Current income tax expense (benefit), International	1,388,000,000	1,415,000,000	1,425,000,000
Deferred income tax expense (benefit), International	305,000,000	-337,000,000	110,000,000
Current income tax expense (benefit), total	2,203,000,000	2,091,000,000	1,777,000,000
Deferred income tax expense (benefit), total	648,000,000	632,000,000	1,035,000,000
Reconciliation of the statutory U.S. federal tax rate and effective tax rates	'	'	'
Statutory U.S. federal tax rate (as a percent)	35.00%	35.00%	35.00%
State and local income taxes - net of federal benefit (as a percent)	1.00%	1.10%	0.90%
Earnings in jurisdictions taxed at rates different from the statutory U.S. federal rate (as a percent)	-10.30%	-9.50%	-9.50%
Reversal of valuation allowances (as a percent)	0.00%	-2.40%	0.00%
Equity income or loss (as a percent)	-1.40%	-2.00%	-1.40%
Other operating charges (as a percent)	1.20%	0.40%	0.30%
Other - Net	-0.70%	0.50%	-0.80%
Effective tax rate (as a percent)	24.80%	23.10%	24.50%
Tax expense (benefit) related to uncertain tax positions, including interest and penalties, foreign	-26,000,000	133,000,000	-6,000,000
Uncertain tax positions, including interest and penalties, foreign (as a percent)	-0.20%	1.10%	'
Income Tax Expense (Benefit) Unusual or Infrequent Items Transaction Gains (Losses)	279,000,000	57,000,000	299,000,000
Net Gains From Investee Transactions and Equity Investment Sales	501,000,000	76,000,000	641,000,000
Effective Income Tax Rate Reconciliation, net gains and other transactions	0.90%	0.30%	0.70%
Effective Income Tax Rate Reconciliation, Other than temporary Impairment Losses	'	'	0.00%
Our proportionate share of unusual or infrequent items recorded by our equity method investees	159,000,000	-8,000,000	53,000,000
Other-than-temporary impairment charges, available-for-sale securities	'	'	17,000,000
Effective Income Tax Rate Reconciliation, related to currency devaluation in a subsidiary	3,000,000	'	'
Effective Income Tax Rate Reconciliation, related to currency devaluation, Percent	0.50%	'	'
Remeasurement and Translation loss due to currency devaluation	149,000,000	'	'
Income Tax expenses (benefit) of unusual or infrequent items recorded by our equity method investees	-8,000,000	'	-7,000,000
Effective tax impact of unusual or infrequent items recorded by our equity method investees (as a percent)	0.40%	'	0.10%
Income Tax Expense (Benefit) Unusual or Infrequent Items Productivity, Integration, Restructuring, Transaction Costs and other activities	-175,000,000	-95,000,000	-224,000,000
Unusual or Infrequent Item Operating	895,000,000	447,000,000	732,000,000
Effective tax impact of restructuring charges, asset impairments, transacton gains and others one-time items (as a percent)	1.20%	0.40%	0.30%
Income Tax Expense (Benefit) Amortization of Favorable Supply Contracts	'	'	-8,000,000
Income Tax Expense (Benefit) Debt Repurchased, Extinguished and other Financial Items	'	'	-3,000,000
Other infrequent or unusual charges net	'	'	19,000,000
Net charge on exchange, repayment or extinguishment of long-term debt	50,000,000	'	9,000,000
Income Tax Reconciliation, tax benefit due to impairments	'	'	-14,000,000
Tax expense (benefit) related to uncertain tax positions, including interest and penalties, domestic	'	'	-2,000,000
Tax benefit (charge) associated with the reversal of valuation allowance	'	283,000,000	'
Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount	279,000,000	280,000,000	193,000,000
Gross balance of unrecognized tax benefit	'	'	'
Beginning balance of unrecognized tax benefits	302,000,000	320,000,000	387,000,000
Increases related to prior period tax positions	1,000,000	69,000,000	9,000,000
Decreases related to prior period tax positions	-7,000,000	-15,000,000	-19,000,000
Increases related to current period tax positions	8,000,000	23,000,000	6,000,000
Decreases related to current period tax positions	0	0	-1,000,000
Decreases related to settlements with taxing authorities	-4,000,000	-45,000,000	-5,000,000
Reductions as a result of a lapse of the applicable statute of limitations	-59,000,000	-36,000,000	-46,000,000
Increases (decreases) from effects of foreign currency exchange rates	-11,000,000	-14,000,000	-11,000,000
Ending balance of unrecognized tax benefits	230,000,000	302,000,000	320,000,000
Alternative jurisdictional tax benefits if tax positions do not prevail	64,000,000	'	'
Impact of unrecognized tax benefits on effective tax rate if Company were to prevail on all uncertain tax positions	166,000,000	'	'
Unrecognized tax benefits, interest and penalties accrued	105,000,000	113,000,000	110,000,000
Unrecognized tax benefits, benefits recognized through income tax expenses	8,000,000	'	2,000,000
Unrecognized tax benefits, interest and penalties expense	'	33,000,000	'
Undistributed earnings of foreign subsidiaries	30,600,000,000	'	'
Corporate	'	'	'
Income Taxes [Abstract]	'	'	'
INCOME BEFORE INCOME TAXES	-1,082,000,000	-1,240,000,000	-975,000,000
Reconciliation of the statutory U.S. federal tax rate and effective tax rates	'	'	'
Net Gains From Investee Transactions and Equity Investment Sales	'	'	122,000,000
Equity Method Investments Impairment	'	'	41,000,000
Productivity and Reinvestment [Member]	'	'	'
Reconciliation of the statutory U.S. federal tax rate and effective tax rates	'	'	'
Unusual or Infrequent Item Operating	$877,000,000	$416,000,000	$732,000,000

INCOME_TAXES_Details_2

INCOME TAXES (Details 2) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Deferred tax assets:	'	'
Property, plant and equipment	$102	$89
Trademarks and other intangible assets, deferred tax asset	63	77
Equity method investments (including foreign currency translation adjustment), deferred tax asset	243	209
Derivative financial instrument, deferred tax asset	50	116
Other liabilities, deferred tax asset	1,102	1,178
Benefit plans, deferred tax asset	1,237	1,808
Net operating/capital loss carryforwards, deferred tax asset	790	782
Other, deferred tax asset	225	320
Gross deferred tax assets	3,812	4,579
Valuation allowances	-586	-487
Total deferred tax assets	3,226	4,092
Deferred tax liabilities:	'	'
Property, plant and equipment	-2,417	-2,204
Trademarks and other intangible assets, deferred tax liabilities	-4,192	-4,133
Equity method investments (including foreign currency translation adjustment), deferred tax liability	-1,070	-712
Derivative financial instruments, deferred tax liabilities	-147	-140
Other liabilities, deferred tax liability	-69	-144
Benefit Plans, deferred tax liabilities	-473	-495
Other, deferred tax liability	-810	-929
Total deferred tax liabilities	-9,178	-8,757
Net deferred tax liabilities	-5,952	-4,665
Noncurrent deferred tax assets recorded in other assets	328	403
Current deferred tax assets recorded in prepaid expenses and other assets	211	244
Current deferred tax liabilities recorded in accounts payable and accrued expenses	339	331
Net deferred tax assets or (liabilities) located in countries outside the United States	-198	70
Loss carryforwards	6,914	'
Loss carryforwards expiring within next five years	$488	'

INCOME_TAXES_Details_3

INCOME TAXES (Details 3) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Deferred tax asset valuation allowances	'	'	'
Balance at beginning of year	$487	'	'
Balance at end of year	586	487	'
Net increase or (decrease) in valuation allowances	99	-372	-91
Valuation Allowance of Deferred Tax Assets [Member]	'	'	'
Deferred tax asset valuation allowances	'	'	'
Balance at beginning of year	487	859	950
Additions	169	126	138
Decrease due to transfer to assets held for sale	0	-146	0
Deductions	-70	-352	-229
Balance at end of year	$586	$487	$859

OTHER_COMPREHENSIVE_INCOME_Det

OTHER COMPREHENSIVE INCOME (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
AOCI attributable to the shareowners of The Coca-Cola Company	'	'	'
Accumulated other comprehensive income (loss)	($3,432)	($3,385)	'
CONSOLIDATED NET INCOME	8,626	9,086	8,646
Total comprehensive income	8,576	8,513	7,329
Foreign currency translation adjustments:	'	'	'
Translation adjustment arising in the period	-1,046	'	'
Reclassification adjustments recognized in net income	-194	'	'
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	-167	'	'
Available-for-sale securities:	'	'	'
Reclassification adjustments recognized in net income	12	'	'
Pension and other benefit liabilities:	'	'	'
Reclassification adjustments recognized in net income	198	'	'
Foreign currency translation adjustments:	'	'	'
Translation adjustment arising in the period	56	'	'
Reclassification adjustments recognized in the period	0	'	'
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	66	'	'
Availiable-for-sale securities:	'	'	'
Reclassification adjustments recognized in net income	0	'	'
Pension and other benefits liabilities:	'	'	'
Reclassification adjustments recognized in income	-72	'	'
Foreign currency translation adjustments:	'	'	'
Translation adjustment arising in the period	-990	'	'
Reclassification adjustments recognized in net income	-194	'	'
Net foreign currency translation adjustment	-1,187	-182	-692
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	-101	'	'
Net gain (loss) on derivatives	151	99	145
Available-for-sale securities:	'	'	'
Reclassification adjustments recognized in net income	12	'	'
Net change in unrealized gain (loss) on available-for-sale securities	-80	178	-7
Pension and other benefits liabilities:	'	'	'
Reclassification adjustments recognized in net income	126	'	'
Net change in pension and other benefit liabilities	1,066	-668	-763
Amortization of prior service cost (credit)	-12	'	'
TOTAL EQUITY ATTRIBUTABLE TO SHAREOWNERS OF THE COCA-COLA COMPANY	'	'	'
AOCI attributable to the shareowners of The Coca-Cola Company	'	'	'
Foreign currency translation adjustment	-2,849	-1,665	'
Accumulated derivative net gains (losses)	197	46	'
Unrealized net gains (losses) on available-for-sale securities	258	338	'
Adjustments to pension and other benefit liabilities	-1,038	-2,104	'
Accumulated other comprehensive income (loss)	-3,432	-3,385	'
CONSOLIDATED NET INCOME	8,584	'	'
Total comprehensive income	8,537	'	'
Foreign currency translation adjustments:	'	'	'
Net foreign currency translation adjustment	-1,240	-219	-639
Derivatives:	'	'	'
Unrealized gains (losses) arising during the year	425	77	-3
Reclassification adjustments recognized in net income	-167	82	243
Net gain (loss) on derivatives	258	159	240
Available-for-sale securities:	'	'	'
Unrealized gains (losses) arising during the year	-134	248	-4
Reclassification adjustments recognized in net income	12	-6	10
Net change in unrealized gain (loss) in available-for-sale securities	-122	242	6
Pension and other benefit liabilities:	'	'	'
Net pension and other benefits arising during the year	1,490	-1,132	-1,206
Reclassification adjustments recognized in net income	198	92	31
Net change in pension and other benefits liabilities	1,688	-1,040	-1,175
Other comprehensive income (loss) attributable to The Coca-Cola Company	584	-858	-1,568
Foreign currency translation adjustments:	'	'	'
Net foreign currency translation adjustment	56	-1	-1
Derivatives:	'	'	'
Unrealized gains (losses) arising during the year	-173	-29	-1
Reclassification adjustments recognized in net income	66	-31	-94
Net gain (loss) on derivatives	-107	-60	-95
Availiable-for-sale securities:	'	'	'
Unrealized gains (losses) arising during the year	42	-64	-8
Reclassification adjustments recognized in net income	0	0	-5
Net change in unrealized gain (loss) on availiable-for-sale securities	42	-64	-13
Pension and other benefits liabilities:	'	'	'
Net pension and other benefits arising during the year	-550	405	423
Reclassification adjustments recognized in income	-72	-33	-11
Net change in pension and other benefit liabilities	-622	372	412
Other comprehensive income (loss) attributable to The Coca-Cola Company	-631	247	303
Foreign currency translation adjustments:	'	'	'
Net foreign currency translation adjustment	-1,184	-220	-640
Derivatives:	'	'	'
Unrealized gains (losses) arising during the year	252	48	-4
Reclassification adjustments recognized in net income	-101	51	149
Net gain (loss) on derivatives	151	99	145
Available-for-sale securities:	'	'	'
Unrealized gains (losses) arising during the year	-92	184	-12
Reclassification adjustments recognized in net income	12	-6	5
Net change in unrealized gain (loss) on available-for-sale securities	-80	178	-7
Pension and other benefits liabilities:	'	'	'
Net pension and other benefits arising during the year	940	-727	-783
Reclassification adjustments recognized in net income	126	59	20
Net change in pension and other benefit liabilities	1,066	-668	-763
Other comprehensive income (loss) attributable to The Coca-Cola Company	-47	-611	-1,265
Noncontrolling Interest [Member]	'	'	'
AOCI attributable to the shareowners of The Coca-Cola Company	'	'	'
CONSOLIDATED NET INCOME	42	'	'
Total comprehensive income	39	'	'
Foreign currency translation adjustments:	'	'	'
Net foreign currency translation adjustment	-3	'	'
Derivatives:	'	'	'
Net gain (loss) on derivatives	0	'	'
Available-for-sale securities:	'	'	'
Net change in unrealized gain (loss) on available-for-sale securities	0	'	'
Pension and other benefits liabilities:	'	'	'
Net change in pension and other benefit liabilities	0	'	'
Total	'	'	'
AOCI attributable to the shareowners of The Coca-Cola Company	'	'	'
CONSOLIDATED NET INCOME	8,626	'	'
Total comprehensive income	8,576	'	'
Foreign currency translation adjustments:	'	'	'
Net foreign currency translation adjustment	-1,187	'	'
Derivatives:	'	'	'
Net gain (loss) on derivatives	151	'	'
Available-for-sale securities:	'	'	'
Net change in unrealized gain (loss) on available-for-sale securities	-80	'	'
Pension and other benefits liabilities:	'	'	'
Net change in pension and other benefit liabilities	1,066	'	'
Amortization of net actuarial loss	'	'	'
Pension and other benefit liabilities:	'	'	'
Reclassification adjustments recognized in net income	211	'	'
Net operating revenues \| Foreign currency contracts	'	'	'
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	-149	'	'
Cost of goods sold \| Foreign currency contracts	'	'	'
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	-30	'	'
Interest expense \| Interest rate contracts	'	'	'
Derivatives:	'	'	'
Reclassification adjustments recognized in net income	12	'	'
Other income (loss) - net \| Divestitures deconsolidations and other	'	'	'
Foreign currency translation adjustments:	'	'	'
Reclassification adjustments recognized in net income	-194	'	'
Other income (loss) - net \| Available-for-Sale Securities	'	'	'
Available-for-sale securities:	'	'	'
Reclassification adjustments recognized in net income	12	'	'
Other income (loss) - net \| Insignificant items [Member]	'	'	'
Pension and other benefit liabilities:	'	'	'
Reclassification adjustments recognized in net income	($1)	'	'

FAIR_VALUE_MEASUREMENTS_Detail

FAIR VALUE MEASUREMENTS (Details) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	$372	$266
Available-for-sale securities	4,842	4,593
Level 1	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	206	146
Available-for-sale securities	1,453	1,390
Derivatives	17	47
Total assets	1,676	1,583
Derivatives	10	35
Total liabilities	10	35
Level 2	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	163	116
Available-for-sale securities	3,281	3,068
Derivatives	822	583
Total assets	4,266	3,767
Derivatives	165	98
Total liabilities	165	98
Level 3	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	3	4
Available-for-sale securities	108	135
Derivatives	0	0
Total assets	111	139
Derivatives	0	0
Total liabilities	0	0
Netting Adjustment	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	0	0
Available-for-sale securities	0	0
Derivatives	-150	-116
Total assets	-150	-116
Derivatives	-151	-121
Total liabilities	-151	-121
Fair Value Measurements	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Trading securities	372	266
Available-for-sale securities	4,842	4,593
Derivatives	689	514
Total assets	5,903	5,373
Derivatives	24	12
Total liabilities	24	12
Prepaid expenses and other assets	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Derivatives	129	145
Other assets	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Derivatives	560	369
Accounts payable and accrued expenses	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Derivatives	12	11
Other liabilities	'	'
Assets and liabilities measured at fair value on a recurring basis	'	'
Derivatives	$12	$1

FAIR_VALUE_MEASUREMENTS_Detail1

FAIR VALUE MEASUREMENTS (Details 2) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Mar. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Coca-Cola FEMSA

Mikuni

Cost method investment

Level 1

Level 3

Andina and Polar merger

Philippines Bottling Operations

CCEJ

Coca-Cola FEMSA

Cost method investment

Level 1

Level 3

Level 1

Equity method investments

Assets measured at fair value on a nonrecurring basis

Exchange of investment in equity securities

$185

($114)

Nonrecurring gain (Loss) fair value adjustment

-170

Valuation of shares in equity method investee

501

641

139

Asset Impairment Charges

-195

Assets held for sale

-108

Cost method investments

-16

Premium paid for ownership interest

Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee

139

Available-for-sale securities

$4,842

$4,593

FAIR_VALUE_MEASUREMENTS_Detail2

FAIR VALUE MEASUREMENTS (Details 3) (USD $)

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

In Millions, unless otherwise specified

Pension Plans, Defined Benefit [Member]

Other postretirement benefits

Level 1

Level 2

Level 3

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Pension Plans, Defined Benefit [Member]

Other postretirement benefits

Pension Plans, Defined Benefit [Member]

Other postretirement benefits

Pension Plans, Defined Benefit [Member]

Other postretirement benefits

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Cash and cash equivalents

Equity securities U.S.-based companies

Equity securities International-based companies

Government bonds

Corporate bonds and debt securities

Mutual, pooled and commingled funds

Hedge funds/limited partnerships

Real estate

Other

Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]

Fair Value of Plan Assets

$8,746

$7,584

$6,171

$514

$386

$1,702

$1,881

$1,284

$964

$768

$562

$1,506

$982

$1,587

$1,510

$543

$525

$251

$257

$591

$517

$243

$202

$185

$10

$13

$112

$81

$79

$78

$18

$16

$3,338

$3,448

$331

$187

$1,680

$1,847

$1,271

$910

$56

$504

$207

$172

$112

$81

$76

$75

$11

$4,116

$2,955

$183

$199

$20

$13

$54

$719

$562

$1,466

$982

$1,531

$1,006

$190

$125

$30

$26

$10

$12

$1,292

$1,181

$15

$14

$49

$40

$353

$400

$251

$257

$584

$510

Reconciliation of the beginning and ending balance of Level 3 assets for U.S. and non-U.S. pension plans

Balance at the beginning of the period

1,181

1,162

400

349

257

270

510

518

Actual return on plan assets:

Related to assets still held at the reporting date

-4

-6

-8

Related to assets sold during the year

-2

Purchases, sales and settlements-net

279

-5

-24

-27

193

-2

Transfers in and/or out of Level 3-net

-250

-12

-6

-78

-2

-172

-4

Foreign currency translation

-3

-1

-3

Balance at the end of the period

$1,292

$1,181

$15

$14

$89

$353

$400

$251

$257

$584

$510

FAIR_VALUE_MEASUREMENTS_FAIR_V

FAIR VALUE MEASUREMENTS FAIR VALUE MEASUREMENTS (Details 4) (USD $)	Dec. 31, 2013	Dec. 31, 2012
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Long-term Debt	$20,178	$16,313
Level 2	'	'
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]	'	'
Long-term Debt, Fair Value	$20,352	$17,157

SIGNIFICANT_OPERATING_AND_NONO1

SIGNIFICANT OPERATING AND NONOPERATING ITEMS (Details) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Mar. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Andina and Polar merger

Philippines Bottling Operations

Pacific

Corporate

Venezuelan subsidiary

CCEJ

Coca-Cola FEMSA

Mikuni [Member]

Productivity and Reinvestment [Member]

Restructuring charges other than productivity and productivity and reinvestments initiatives [Member]

Productivity Initiatives

Integration of CCE's North American Operations [Member]

Japan events [Member]

Thailand events [Member]

License Agreement with Nestle [Member]

BPW Nestle Joint Venture [Member]

Deductions from Revenue

Cost of goods sold

Other operating charges [Member]

Merger of Embotelladoras Arca SAB de CV and Grupo Continental SAB [Member]

Coca-Cola Embonor SA [Member]

Andina and Polar merger

Disposal of Norwegian and Swedish Bottling Operations [Member]

Corporate

Pacific

Corporate

Pacific

Japan events [Member]

Brazil Juice Expenses [Member]

Japan events [Member]

Brazil Juice Expenses [Member]

Other Operating Items [Abstract]

Unusual or Infrequent Event Charges

$84

$82

$10

$23

$11

$13

$50

Asset Impairment Charges Operating

Other Operating Charges

Other operating charges

895

447

732

Asset Impairment Charges

195

Productivity, integration and restructuring initiatives

633

121

164

494

270

188

163

156

Restructuring and Related Cost, Accelerated Depreciation

Impairment of trademarks

113

Goodwill, Impairment Loss

Reversal of restructuring accruals

Costs related to exchange of equity securities of an investee

Equity Income (Loss) - Net

Our proportionate share of unusual or infrequent items recorded by our equity method investees

159

-8

Other Income (Loss) - Net

Net gain or (loss) in exchange of equity securities

185

417

185

-114

Loss on disposal group held for sale

108

Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee

139

Premium paid for ownership interest

Net Gains From Investee Transactions and Equity Investment Sales

501

641

122

Impairment of certain cost method investments

Equity Method Investment, Realized Gain (Loss) on Disposal

102

Equity Method Investments Impairment

Other-than-temporary impairment charges, available-for-sale securities

Gain (Loss) on the sale of Norwegian and Swedish bottling operations to New CCE

-5

Gain on sale of investment in subsidiary

615

Remeasurement Charges on Subsidiary Assets

$140

PRODUCTIVITY_INTEGRATION_AND_R2

PRODUCTIVITY, INTEGRATION AND RESTRUCTURING INITIATIVES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2007
Restructuring Reserve	'	'	'	'
Costs incurred	'	'	$633	'
Integration of German Bottling and Distribution Operation [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Restructuring and Related Cost, Cost Incurred to Date	627	'	'	'
Number of German bottling and distribution operations for which integration initiatives began in 2008	'	'	'	18
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	96	'	'	'
Costs incurred	187	148	67	'
Accrued Balance, Ending Balance	127	96	'	'
Integration of Coca Cola Enterprises North American Operations [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Reversal of restructuring accruals	1	6	'	'
Restructuring and Related Cost, Cost Incurred to Date	486	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	3	'	'	'
Costs incurred	'	'	358	'
Accrued Balance, Ending Balance	'	3	'	'
Productivity Initiatives	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Reversal of restructuring accruals	2	10	'	'
Restructuring and Related Cost, Cost Incurred to Date	496	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	11	'	'	'
Costs incurred	'	'	156	'
Accrued Balance, Ending Balance	'	11	'	'
Productivity and Reinvestment [Member]	'	'	'	'
Restructuring Cost and Reserve [Line Items]	'	'	'	'
Restructuring and Related Cost, Cost Incurred to Date	764	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	26	'	'	'
Costs incurred	494	270	'	'
Payments	-381	-230	'	'
Noncash and exchange	-27	-14	'	'
Accrued Balance, Ending Balance	112	26	'	'
Productivity and Reinvestment [Member] \| Severance pay and benefits	'	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	12	'	'	'
Costs incurred	188	21	'	'
Payments	-113	-8	'	'
Noncash and exchange	1	-1	'	'
Accrued Balance, Ending Balance	88	12	'	'
Productivity and Reinvestment [Member] \| Outside Services [Member]	'	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	6	'	'	'
Costs incurred	59	61	'	'
Payments	-59	-55	'	'
Noncash and exchange	0	0	'	'
Accrued Balance, Ending Balance	6	6	'	'
Productivity and Reinvestment [Member] \| Other direct costs [Member]	'	'	'	'
Restructuring Reserve	'	'	'	'
Accrued Balance, Beginning Balance	8	'	'	'
Costs incurred	247	188	'	'
Payments	-209	-167	'	'
Noncash and exchange	-28	-13	'	'
Accrued Balance, Ending Balance	18	8	'	'
Other Initiatives [Member]	'	'	'	'
Restructuring Reserve	'	'	'	'
Costs incurred	'	$15	$52	'

OPERATING_SEGMENTS_Details

OPERATING SEGMENTS (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Segment Reporting Information [Line Items]	'	'	'
Concentrate operations	38.00%	38.00%	39.00%
Finished products operations	62.00%	62.00%	61.00%
Sales Revenue Net Percentage	100.00%	100.00%	100.00%
Sales Revenue, Goods, Net	$46,854	$48,017	$46,542
Property, Plant and Equipment, Net	14,967	14,476	14,939
United States	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Sales Revenue, Goods, Net	19,820	19,732	18,699
Property, Plant and Equipment, Net	8,841	8,509	8,043
International	'	'	'
Segment Reporting Information [Line Items]	'	'	'
Sales Revenue, Goods, Net	27,034	28,285	27,843
Property, Plant and Equipment, Net	$6,126	$5,967	$6,896

OPERATING_SEGMENTS_Details_2

OPERATING SEGMENTS (Details 2) (USD $)

12 Months Ended

3 Months Ended

12 Months Ended

In Millions, unless otherwise specified

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Mar. 31, 2012

Dec. 31, 2012

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Dec. 31, 2012

Dec. 31, 2011

Dec. 31, 2013

Andina and Polar merger

Philippines Bottling Operations

Eurasia and Africa

Europe

Latin America

North America

Pacific

Bottling Investments

Corporate

Eliminations

Thailand events [Member]

License Agreement with Nestle [Member]

BPW Nestle Joint Venture [Member]

Japan events [Member]

Other operating charges [Member]

United States

CCEJ

Venezuelan subsidiary

Andina and Polar merger

Merger of Embotelladoras Arca SAB de CV and Grupo Continental SAB [Member]

Coca-Cola Embonor SA [Member]

Disposal of Norwegian and Swedish Bottling Operations [Member]

Coca Cola Enterprises Incs North American business [Member]

Corporate

North America

Eurasia and Africa

Europe

Latin America

Pacific

North America

Pacific

Brazil Juice Expenses [Member]

Japan events [Member]

Corporate

North America

Operations, Reportable Information, by Operating Segment

Sales Revenue Concentrate Operations Net Percentage

38.00%

39.00%

Net operating revenues:

Sales Revenue, Goods, Net

$46,854

$48,017

$46,542

$2,763

$2,697

$2,590

$4,645

$4,481

$4,777

$4,748

$4,560

$4,403

$21,574

$21,665

$20,559

$5,372

$5,680

$5,553

$7,598

$8,807

$8,501

$154

$127

$159

$19,820

$19,732

$18,699

Intersegment Revenue

689

642

697

191

271

287

497

628

536

-1,471

-1,644

-1,622

Revenue for Reportable Segments

46,854

48,017

46,542

2,763

2,697

2,590

5,334

5,123

5,474

4,939

4,831

4,690

21,590

21,680

20,571

5,869

6,308

6,089

7,676

8,895

8,591

154

127

159

-1,471

-1,644

-1,622

Operating Income (Loss)

10,228

10,779

10,173

1,087

1,078

1,003

2,859

2,960

3,090

2,908

2,879

2,815

2,432

2,597

2,319

2,478

2,516

2,239

115

140

224

-1,651

-1,391

-1,517

Interest income

534

471

483

534

471

483

Interest expense

463

397

417

463

397

417

Depreciation and amortization

1,977

1,982

1,954

100

109

1,192

1,083

1,065

130

119

115

335

406

403

134

171

169

Equity income (loss) - net

602

819

690

-3

524

732

646

-2

-13

Income (loss) before income taxes

11,477

11,809

11,458

1,109

1,101

1,001

2,923

3,015

3,134

2,920

2,882

2,832

2,434

2,624

2,327

2,494

2,523

2,242

679

904

897

-1,082

-1,240

-975

Identifiable operating assets

78,543

75,726

71,600

1,273

1,299

1,160

3,713

2,976

3,204

2,918

2,759

2,446

33,964

34,114

33,422

1,922

2,163

2,170

7,011

9,648

8,905

27,742

22,767

20,293

Investments

11,512

10,448

8,374

1,157

1,155

284

106

271

243

545

539

475

143

127

133

9,424

8,253

7,140

Capital expenditures

2,550

2,780

2,920

105

1,374

1,447

1,364

117

107

128

643

867

1,039

279

190

196

Ratio of net property, plant and equipment in Germany to total consolidated property, plant and equipment - net (as a percent)

11.00%

10.00%

Debt Related Commitment Fees and Debt Issuance Costs

Equity Method Investments Impairment

Other than Temporary Impairment Losses, Investments, Portion Recognized in Earnings, Net, Available-for-sale Securities

Other operating charges

895

447

732

Productivity, integration and restructuring initiatives

633

282

227

374

194

164

121

164

Asset Impairment Charges

195

Restructuring and Related Cost, Accelerated Depreciation

Our proportionate share of unusual or infrequent items recorded by our equity method investees

159

-8

159

-8

Gains (Losses) on Extinguishment of Debt

-53

Remeasurement Charges on Subsidiary Assets

140

Cost method investments, other-than-temporary decline in fair value

Gain (Loss) on the sale of Norwegian and Swedish bottling operations to New CCE

-5

Gain (Loss) on Sale of Previously Unissued Stock by Equity Investee

139

Premium paid for ownership interest

Gain on sale of investment in subsidiary

615

Unusual or Infrequent Event Charges

Net gain or (loss) in exchange of equity securities

185

417

-114

Loss on disposal group held for sale

108

Net Gains From Investee Transactions and Equity Investment Sales

501

641

122

Equity Method Investment, Realized Gain (Loss) on Disposal

$102

NET_CHANGE_IN_OPERATING_ASSETS2

NET CHANGE IN OPERATING ASSETS AND LIABILITIES (Details) (USD $)	12 Months Ended
In Millions, unless otherwise specified	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011
Net change in operating assets and liabilities	'	'	'
(Increase) decrease in trade accounts receivable	$28	($33)	($562)
(Increase) decrease in inventories	-105	-286	-447
(Increase) decrease in prepaid expenses and other assets	-163	-29	-350
Increase (decrease) in accounts payable and accrued expenses	-158	-556	63
Increase (decrease) in accrued taxes	22	770	-132
Increase (decrease) in other liabilities	-556	-946	-465
Net change in operating assets and liabilities	($932)	($1,080)	($1,893)

SUBSEQUENT_EVENT_SUBSEQUENT_EV

SUBSEQUENT EVENT SUBSEQUENT EVENT (Details) (Green Mountain Coffee Roasters, Inc. [Member], Subsequent Event [Member], USD $)	Feb. 27, 2014
In Billions, except Share data, unless otherwise specified	Feb. 27, 2014
Green Mountain Coffee Roasters, Inc. [Member] \| Subsequent Event [Member]	'
Subsequent Event [Line Items]	'
Cost Method Investment, ownership percentage	10.00%
Cost Method Investment, Shares	16,684,139
Cost Method Investments, Original Cost	$1.25
Share Price	$74.98